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ABSTRACT 
Diabetes is a lifelong debilitating and deadly chronic disease affecting nearly one out of 
every eleven Americans. This public health problem costs $245 billion annually in the United 
States. Long term research trials have shown that diabetes complications can be prevented with 
good glycemic control, but it is difficult for patients to maintain control without much support 
from their healthcare team. U.S. healthcare remains fragmented. With the passage of the 
Affordable Care Act, there are opportunities to redesign health care delivery to minimize 
fragmentation and improve patient outcomes.  
The aim of this study is to determine if a redesigned care delivery model of nurse-led 
interprofessional collaborative care-coordinated teams improved patient engagement, healthcare 
utilization and clinical indicators for adults with Type II diabetes. This was a retrospective, 
longitudinal, matched design using secondary data from one year prior to the intervention to one 
year post intervention. The study sample included two groups: 204 patients with Type 2 diabetes 
who were care coordinated in the redesigned primary care clinic and a matched sample of 
patients at the same health system receiving standard care. Dependent variables included patient 
engagement (missed visits, influenza immunizations, and annual eye examinations); healthcare 
utilization (number of hospitalizations, hospital days and emergency room visits); and clinical 
indicators (Hgb A1C, weight, systolic and diastolic blood pressure). Findings indicated a 
statistically significant improvement in Hgb A1C for both the pre/post data and the 
Intervention/Matched data, and a statistically significant improvement in weight
 xvii 
 
change and diastolic blood pressure at goal (<90) for the pre/post intervention group. However, 
eye examinations were significantly better in the matched comparison group. There was no 
difference in healthcare utilization for either the pre/post intervention group or the intervention 
group in comparison to the propensity matched group.
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CHAPTER ONE 
INTRODUCTION 
Diabetes is a lifelong debilitating and deadly disease affecting nearly one out of every 
eleven Americans (Centers for Disease Control and Prevention [CDC], 2014a). It is a national 
public health problem costing the United Stated billions of dollars annually making it an 
expensive disease that essentially affects every American’s pocketbook, whether or not 
personally afflicted (Centers for Disease Control and Prevention [CDC], 2014c). Long-term 
diabetes research trials have demonstrated not only that maintaining good glycemic control can 
prevent diabetes complications but also that patients need a lot of support from their healthcare 
team to accomplish the necessary daily health behavior changes (Gerstein et al., 2008; The 
Diabetes Control and Complications Trial Research Group [DCCT], 1986). Changing health 
behavior is a very difficult endeavor.  
The current healthcare system in the United States remains fragmented and, with the 
passage of new healthcare legislation, is in a state of flux. The goal is to change from a 
healthcare system focused on acute, episodic care to one focused on health prevention and 
promotion. Research is needed to guide this American healthcare system redesign. This study 
will determine whether one potential health system redesign—that of a nurse-led, 
interprofessional, collaborative, care-coordinated team approach in primary care—improves 
patient engagement, healthcare utilization, and clinical indicators for the Type II diabetic 
population. 
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Magnitude and Importance of the Problem 
 
Uncontrolled diabetes leads to death. In 2010, diabetes was listed as the seventh leading 
cause of death in the United States (Centers for Disease Control and Prevention [CDC], 2014c). 
The Centers for Disease Control (2014) further suggest that diabetes as a cause of death is likely 
underreported since the data indicates that only about 35-40% of death certificates of the diabetic 
population list diabetes as a diagnosis of the deceased. In the Swedish population, research 
demonstrated that the risk of mortality in Type 2 diabetes substantially increases with poor 
glycemic control, renal complications or impaired renal function, and younger age of diabetes 
onset (Tancredi et al., 2015). According to Healthy People 2020, diabetes lowers life expectancy 
by as much as fifteen years (Office of Disease Prevention and Health Promotion, 2016). 
Consequently, diabetes is a very serious, deadly disease.  
Diabetes is prevalent in the United States. The CDC estimates that approximately 29.1 
million Americans or 9.3% of the U.S. population have diabetes (Centers for Disease Control 
and Prevention [CDC], 2014c). Of these numbers, only 21 million Americans have been 
diagnosed with diabetes, with about 8.1 million Americans unaware that they have diabetes. 
Approximately 1.7 million people are diagnosed with diabetes in the United States each year 
(Centers for Disease Control and Prevention [CDC], 2014c) and one of every three adults is 
projected to develop diabetes by 2050 (Boyle, Thompson, Gregg, Barker, & Williamson, 2010). 
In Illinois, the prevalence of diagnosed diabetes has been increasing from 5.4% in 1995 to 9.4% 
in 2014 (Centers for Disease Control and Prevention [CDC], 2015b). Diabetes continues to be a 
major public health problem in the United States. 
Type 2 diabetes is the most prevalent type of diabetes in the adult population accounting 
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for 90-95% of all diagnosed cases (Centers for Disease Control and Prevention [CDC], 2014c). 
Although Type 2 diabetes affects all ages from the very young to the very old, it is most 
prevalent in the adult population with one in four older adults (65 or older) currently diagnosed 
with diabetes (Kirkman et al., 2012). Today, in the 65 years or older adult population, 25.9% or 
11.2 million older adults are living with diabetes (Centers for Disease Control and Prevention 
[CDC], 2014c). These people are often living with not just one chronic illness but several 
(Parekh, Goodman, Gordon, Koh, & HHS Interagency Workgroup on Multiple Chronic 
Conditions, 2011; Partnership for Solutions, 2004), creating an even larger health burden for our 
nation.  
Diabetes is a serious chronic disease that affects people for a long time. According to the 
CDC, approximately 60% of diabetics have been diagnosed for ten years or less, with about 40% 
diagnosed for more than 10 years, and of those, 4.7 % have been diagnosed for more than 35 
years (Centers for Disease Control and Prevention [CDC], 2014b). Although Type 2 diabetes is a 
more predominate affliction as people age, just over 5,000 children less than 20 years of age 
were diagnosed with Type 2 diabetes in 2008 and 2009, demonstrating that Type 2 diabetes is 
occurring at earlier ages than ever before and will continue to be a healthcare problem for many 
years to come (Centers for Disease Control and Prevention [CDC], 2014c). Furthermore, Type 2 
diabetes tends to be insidious and is often first detected when a complication of the disease 
reveals a diagnosis of diabetes (Khardori & Griffing, 2016; Spears, Schub, & Pravikoff, 2015). 
In fact, at the time of diagnosis of Type 2 diabetes, the patient has likely had undiagnosed 
diabetes for 4-7 years (Khardori & Griffing, 2016). As more American children are diagnosed 
with Type 2 diabetes, both the prevalence and the number of years patients live with this serious, 
debilitating disease is likely to increase. 
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Many complications are associated with diabetes. Despite large national studies  
demonstrating the decrease of diabetes sequelae with good blood sugar control, there remains a 
high prevalence of diabetes complications (Centers for Disease Control and Prevention [CDC], 
2014c; Centers for Disease Control and Prevention [CDC], 2015b; Skyler et al., 2009; The 
Diabetes Control and Complications Trial Research Group [DCCT], 1993; UK Prospective 
Diabetes Study Group, 1998). Diabetes is linked to both micro- and macro-vascular 
complications including heart disease, stroke, neuropathy, nephropathy and retinopathy (Centers 
for Disease Control and Prevention [CDC], 2014c). Diabetes is the leading cause of renal failure, 
adult-onset blindness and lower limb amputations (Institutes of Health [NIH], 2017). In 2011, 
diabetes accounted for 44% of all diagnosed renal failure cases as well as 60% of non-traumatic 
lower-limb amputations in adults (Centers for Disease Control and Prevention [CDC], 2014c). 
Between 2009 and 2012, 71% of adults (18 or older) with diabetes had a blood pressure greater 
than or equal to 140/90 mm Hg or were on antihypertensive medications and 65% had an LDL 
cholesterol level greater than or equal to 100 mg/dl (Centers for Disease Control and Prevention 
[CDC], 2014c), increasing the risk of heart disease and stroke (American Diabetes Association 
[ADA], 2017). In 2010, the incidence of hospitalization for strokes was 1.5 times higher and for 
heart attacks was 1.8 times higher for the adult diabetic population than those who were not 
afflicted with diabetes (Centers for Disease Control and Prevention [CDC], 2014c). With patients 
living with diabetes longer, the complications of diabetes are also likely to increase. 
Diabetes is a disease that places a major financial burden on our healthcare system. The 
CDC estimated that in 2012, diabetes costs the United States 245 billion dollars (Centers for 
Disease Control and Prevention [CDC], 2014c). The cost of healthcare for a person with diabetes 
in 2012 was 2.3 times that of a person without diabetes (Centers for Disease Control and 
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Prevention [CDC], 2014c). Diabetes and hypertension were responsible for much of the growth 
in Medicare spending from 1987–2006 (Thorpe, Ogden, & Galactionova, 2010).  
Diabetes in and of itself is very expensive, but when the cost of the many complications 
attributed to diabetes are included, it becomes even more taxing to the American healthcare 
system. In fact, estimates of the costs of complications are as much as 250% higher than the cost 
of diabetes without complications (Liebl, Khunti, Orozco-Beltran, & Yale, 2015). 
Approximately 6% of the Medicare budget ($29 billion), was spent on chronic kidney disease 
alone in 2012 (Centers for Disease Control and Prevention [CDC], 2015a), and it has been 
estimated that in the last decade, diabetes accounts for about 8% of the increase in Medicare 
costs (Thorpe, 2012). An estimated 72% of kidney failure patients (approximately three out of 
four cases) developed kidney failure due to diabetes and hypertension (Centers for Disease 
Control and Prevention [CDC], 2015a). It is estimated that 40-60 % of the cost of diabetes care 
has been for inpatient care for the complications of diabetes (Liebl et al., 2015). Consequently, 
preventing diabetic complications has the potential to significantly reduce the cost of healthcare 
in the United States. 
Preventing Complications 
The complications from diabetes are preventable. It is well recognized that the sequelae 
of diabetes occur and progress most often in patients who are not able to maintain good glycemic 
control (Skyler et al., 2009; The Diabetes Control and Complications Trial Research Group 
[DCCT], 1993; UK Prospective Diabetes Study Group, 1998). The current evidence-based 
recommendation for optimal diabetes type II management is to maintain A1C levels of < 7.0% 
(American Diabetes Association [ADA], 2016; American Diabetes Association [ADA], 2017). 
This level has been demonstrated to reduce microvascular complications (kidney disease, 
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retinopathy and peripheral vascular disease) while decreasing macrovascular disease in newly 
diagnosed patients with no previous heart disease (American Diabetes Association [ADA], 2016; 
American Diabetes Association [ADA], 2017). Improvements in glycemic control have 
demonstrated effectiveness in delaying the complications of diabetes.  
Current national recommendations to delay the complications of Type 2 diabetes involve 
improved glycemic control. The National Institute of Health (NIH) recommends improving 
blood sugar, blood pressure and cholesterol as the most important methods of decreasing the 
complications of diabetes (National Institute of Diabetes and Digestive and Kidney Diseases 
[NIDDK], 2016). Healthy People 2020 sets target goals for population health for diabetes in the 
United States (Office of Disease Prevention and Health Promotion, 2016). For example, the goal 
of improving glycemic control is to decrease the number of diabetics with A1C of > 9% from 
17.9% to 16.1% and to increase the proportion of diabetics with A1Cs < 7% from 53.5% to 
58.9%. Generally, goals for the next decade are set at 10% improvement of actual health 
indicators for diabetes. While these goals are not necessarily lofty, they do provide information 
on overall goals for improving diabetes management in the United States. These goals are set not 
only to improve the quality of life for people afflicted with diabetes but also to reduce both the 
economic burden and the incidence of diabetes sequelae. Healthy People 2020 lends further 
credence to the need for improving glycemic control, lipid levels and blood pressure; increasing 
the numbers who receive both annual foot and eye exams; and providing diabetes education 
(Office of Disease Prevention and Promotion [ODPHP], 2019). 
Diabetic patients must change their health behaviors to prevent complications. They must 
assume responsibility for managing health behaviors including diet, exercise, smoking; 
monitoring their diabetes status through blood testing, foot care and medication use; as well as 
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optimally navigating the healthcare system by setting and keeping appointments as needed 
(Lorincz et al., 2011). Health behaviors are not easy to change. However, for diabetic patients, it 
has been recognized that even small changes in health behavior effectively improve health 
outcomes (Golay et al., 2013). Golay et al. further indicated that patient engagement in their own 
health can be challenging but is necessary to effectively achieve even the smallest changes in 
health behaviors. In the ambulatory setting, patients spend the majority of their time outside of 
the clinic setting and, therefore, must be prepared to manage their own health.  
Health behavior change begins with diabetes education. Diabetes self-management 
education incorporates health behavior changes including exercise, healthy eating, managing 
emotions, managing medications, communicating with the healthcare team, using community 
resources, problem solving, and decision making. Diabetes self-management education, by 
empowering diabetic patients to make health behavior decisions, not only lowers A1C levels in 
patients with A1Cs greater than 7% but also improves health outcomes for diabetic patients 
regardless of A1C levels (Lorig, Ritter, Ory, & Whitelaw, 2013). A meta-analysis of diabetes 
self-management education and support programs in older adults found a small but significant 
reduction in both A1C and total cholesterol levels with an insignificant reduction in both systolic 
and diastolic blood pressure (Sherifali, Bai, Kenny, Warren, & Ali, 2015). In their joint position 
statement, the American Diabetes Association, the American Association of Diabetes Educators, 
and the Academy of Nutrition and Dietetics state that that there are numerous tasks and decisions 
about health that diabetic patients must manage to achieve optimal health outcomes (Powers et 
al., 2015). They further state that diabetes self-management education and support are essential 
ingredients for people with diabetes to effectively manage their own health and modify their own 
health behaviors (Powers et al., 2015).  
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Healthcare System Infrastructure Limitations 
The US healthcare system was not designed to prevent health problems. Healthcare in the 
US has focused on acute care (Haas, Swan, & Haynes, 2013; Institute for Healthcare 
Improvement [IHI], 2016; Loehrer, McCarthy, Coleman, & Cross-Continuum Study Panel, 
2015; McCarthy & Klein, 2010). However, the number of days a patient is hospitalized for acute 
conditions has been decreasing (Thomas et al., 2015). This trend has led to patients, especially 
those with chronic conditions like diabetes, frequently discharged with continued healthcare 
needs, which are left for the patient and primary care physician to manage (Thomas et al., 2015). 
Patients with chronic diseases require more health care to successfully manage these diseases, 
and, if not well-managed, these patients will require more acute care. This creates a cyclical 
hospital-home utilization pattern.  
The current healthcare system is not providing safe healthcare. In 1999, the Institute of 
Medicine (IOM) published their first report on the quality of healthcare in the United States in 
which they estimated that between 44,000 to 98,000 people die every year due to medical errors 
in U.S. hospitals. They further surmised that these findings were not due to individual healthcare 
providers but rather should be extrapolated to the U.S. healthcare system (Institute of Medicine, 
1999). They pointed out that these problems with our healthcare system are due to many factors 
including the increased complexity of the system, increased specialization in healthcare fields 
leading to increased fragmentation of care, the silence surrounding errors, as well as the acute-
care-focused, fee-for-service payment structure of healthcare (Institute of Medicine, 1999). The 
report suggested that multiple patients with multiple problems see multiple providers in multiple 
locations, which increases the potential for mixed messages, duplication of care, increased costs, 
and increased confusion for the patient, which then leads to errors (Institute of Medicine, 1999).  
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This report put an end to the silence surrounding healthcare errors (Institute of Medicine, 
1999). It maintained that patient errors were not the product of the individual healthcare provider 
but of the healthcare delivery system and, therefore, every healthcare organization should have a 
patient safety committee focused on identifying problems and improving their systems of care 
(Institute of Medicine, 1999). To ensure patient safety, the IOM made the following two 
recommendations: 1) to provide monitoring of reportable error events and 2) to analyze and 
identify solutions to these errors by developing the Center for Patient Safety within the Agency 
for Healthcare Research and Quality (AHRQ) (Institute of Medicine, 1999). This began the 
American search for a safer healthcare system. 
The current healthcare system is not providing quality healthcare. In their second report, 
Crossing the Quality Chasm, the IOM (2001) focused on the quality of the system of healthcare 
rather than individual patient safety. Thoroughly analyzing all the literature of the time, they 
concluded that the U.S. healthcare system continued to be flawed and needed redesign to 
improve the quality of healthcare in the US (Institute of Medicine, 2001). They found the need to 
focus on redesigning care for the chronically ill patient to ensure seamless care across both 
settings and clinicians, as well as focusing on team effectiveness and collaboration rather than 
encouraging healthcare members to work in silos (Institute of Medicine, 2001). Interprofessional 
collaborative care is defined as two or more healthcare workers from different professions 
working together with patients and families to ensure the delivery of the highest quality care 
(World Health Organization, 2010). To achieve this, they further recommended a focus on 
information technology to communicate within and between healthcare systems effectively as 
well as to focus on outcomes and improving performance through evidence and best practice 
(Institute of Medicine, 2001).  
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Despite significant efforts to improve safety after the IOM report, the National Patient 
Safety Foundation (NPSF) reported in 2015 that patient safety continues to be a significant 
problem in the US. The NPSF suggested that improving healthcare would require a shift from 
reactive healthcare to a systems approach, which includes partnering with patients and all 
members of the healthcare team to increase safety across the continuum of care (National Patient 
Safety Foundation, 2015). Furthermore, they recommended that interventions focus not only on 
the safety culture of the health system but also on teamwork and patient engagement (National 
Patient Safety Foundation, 2015). 
Healthcare in the US still continues to be fragmented (Haas et al., 2013; Institute of 
Medicine, 2001). In fact, the focus of the triple aim has been on coordinating care through 
primary care redesign and population health management in the lived environment rather than 
acute care (Institute for Healthcare Improvement [IHI], 2016). Most recently, the National Safety 
Patient Foundation Lucian Leape Institute recommended five areas of focus necessary to 
improve patient safety. Improved care integration and patient/consumer engagement continue to 
be prominent focal points for improved patient safety (National Patient Safety Foundation 
Lucian Leape Institute, 2016). This report delineated the many barriers to integrating care 
(National Patient Safety Foundation Lucian Leape Institute, 2016). First, increased specialization 
of health care professionals with a subsequent decrease in the number of family practitioners and 
generalists has led to increased fragmentation and decreased integration (National Patient Safety 
Foundation Lucian Leape Institute, 2016). A second barrier is the public’s belief that our current 
health care model is the best in the world, which leads to a reluctance to embrace changing the 
healthcare system (National Patient Safety Foundation Lucian Leape Institute, 2016). Finally, 
even the U.S. method of healthcare reimbursement, which focuses on fee-for-service (FFS) 
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rather than value, is a barrier to integrating care (Lucian Leape Institute Round Table, 2012; 
National Patient Safety Foundation Lucian Leape Institute, 2016). It has been recognized that 
FFS programs reward more care from more providers rather than coordinated care. This, along 
with the growing belief in specialization, has contributed to the fragmentation of care and has left 
patients unsure how to manage their conditions (Calsyn & Lee, 2012; Chernys, 2013).  
The increased number of specialty areas in medicine has created more fragmented health 
care in which no single provider has assumed the responsibility of coordinating the care of the 
whole patient (Schoen et al., 2011). To be effective, healthcare must involve relationships 
between the consumer, the provider and the community (Stange, 2009). Without someone 
managing the whole patient, care can cause harm and cost significantly more (Calsyn & Lee, 
2012; Chernys, 2013; Stange, 2009).   
It has become clear that currently patient care is disorganized and that patients do need 
assistance to “navigate” the “complex maze of providers and health systems” (Eidus, Pace, & 
Staton, 2012). For example, diabetic patients often see multiple providers for just diabetes-
related conditions, which can include their primary care provider, other ancillary health care 
professionals (e.g., social worker, nurse, dietitian, and physical therapist), and specialty care 
providers (e.g., nephrologist, cardiologist, psychologist, and podiatrist). Considering the 
likelihood of multiple chronic conditions, the list of potential providers grows. Without proper 
communication between providers, the plan of care from one provider can negate the plan of care 
from another provider, which becomes very confusing for the patient. The IOM report, Crossing 
the Quality Chasm (2001), demonstrated a model of care in which health professionals were 
providing excellent care focused on their specialty area in isolation from the rest of the care team 
with no one taking responsibility for managing the health needs of the whole patient. This lack of 
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coordination created frustration for the provider and mixed messages for the patient, who was 
often given conflicting advice from his many care providers. Furthermore, with the countless 
number of providers diabetic patients see, there is often difficulty keeping multiple appointments 
in multiple locations.  
Assisting patients to effectively navigate the current healthcare system is difficult, even 
for healthcare providers. The Commonwealth Fund publishes a report called Mirror, Mirror that 
compares the quality of healthcare in industrialized nations (Davis, Stremikis, Squires, & 
Schoen, 2014). In their 2014 update, all primary care doctors in the 10 nations surveyed, 
including the US, indicated that they struggled to coordinate care for their patients and to 
effectively communicate with all other care providers (Davis et al., 2014). In addition, the 
Mirror, Mirror report indicates that unsafe and poorly coordinated care is responsible for 
decreasing the quality of care in the US (Davis et al., 2014). Progress in care coordination and 
care processes continues to be slow. In Mirror, Mirror's 2017 update, despite continuing to 
spend more than any of the other 10 high-income countries, the US made no progress in their 
ranking on coordinated care or overall care which includes 4 subdomains: coordination, safety, 
prevention and engagement. In fact, the US continues to rank 5
th
 out of 11 in overall care 
processes and 6
th
 in the subdomain of coordinated care (Schneider, Sarnak, Squires, Shah, & 
Doty, 2017). Finding a new model of care that can assist diabetic patients to meet their health 
goals and effectively navigate the healthcare system remains an essential ingredient to improve 
health outcomes for the Type 2 diabetic population in the U.S. (Schneider et al., 2017). 
Health Care Redesign Solutions 
Care coordination was seen as an essential ingredient to improve population health. The 
Agency for Healthcare Research and Quality (Agency for Healthcare Research and Quality, 
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2014) through a systematic review of over 40 definitions of “care coordination” integrated these 
definitions to the following: 
Care coordination is the deliberate organization of patient care activities between two or 
more participants (including the patient) involved in a patient’s care to facilitate the 
appropriate delivery of health care services. Organizing care involves the marshalling of 
personnel and other resources needed to carry out all required patient care activities and 
is often managed by the exchange of information among participants responsible for 
different aspects of care.  
 
Transitional Care Coordination Models emerged as a solution to the short-term hospital 
readmission dilemma. In the 1990s, due to the high rate and cost of 30-day hospital 
readmissions, the United States began to focus on care transitions with care coordination 
emerging as a solution to prevent hospital readmissions. Since the 1990s, the evidence 
supporting transitional care coordination models has grown significantly. The evidence indicated 
that care transitions could be better managed with care that is well-coordinated, particularly for 
the increasing number of U.S. citizens with chronic illnesses (Institute of Medicine, 2001).  
Likely from the success of these transitional care coordination programs and the IOM 
reports, U.S. health policy began to focus on care coordination as a method to improve 
population health. The policy goal was to prevent hospital admissions to decrease the 
skyrocketing cost of healthcare for Medicare patients. With the recognition of health care 
fragmentation, policy makers began to understand the need for care coordination for all patients 
whether transitioning from one level of care to another. Consequently, the IOM emphasis on the 
need for increased quality through care that is coordinated became a focus for the redesign of US 
healthcare systems (Institute of Medicine, 2001).  
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Patient Protection and Affordable Care Act 
Despite legislative weakening of the Patient Protection and Affordable Care Act (ACA), 
it remains the US health care financing legislation (Congress.gov, 2010). The ACA focused on 
the need for increased health promotion efforts to provide higher quality of health care at lower 
costs (Henry J. Kaiser Family Foundation, 2013; Kaiser Family Foundation, 2011; Congress.gov, 
2010). To meet this goal, the ACA provided funds for transitional care coordination for high-risk 
Medicare participants and emphasized the need for interprofessional collaborative and 
coordinated care to increase health outcomes and decrease hospitalizations (Henry J. Kaiser 
Family Foundation, 2013; Kaiser Family Foundation, 2011; Congress.gov, 2010).  
In addition, the ACA encouraged interprofessional care coordination through such 
programs as CMS demonstration projects, which received $10 billion dollars in funding for 
improving quality and reducing costs for chronically ill patients enrolled in both Medicare and 
Medicaid (Henry J. Kaiser Family Foundation, 2013; Congress.gov, 2010). The ACA supported 
payment reform measures including Accountable Care Organizations, bundled payments and 
penalties for hospital readmissions (Henry J. Kaiser Family Foundation, 2013; Congress.gov, 
2010). These reforms were meant to increase quality and promote coordinating care efforts and 
collaboration among all health professionals. The US government and the Commonwealth 
Foundation weighed the evidence for care coordination. Both demonstrate their beliefs through 
healthcare policy and reports that interprofessional care coordination will improve quality of care 
and should be promoted as an important element in health care redesign processes. 
With new financing incentives, there is an opportunity to develop multidisciplinary 
models of care that are care-coordinated and fully collaborative. However, research is needed to 
guide the development and evaluation of these new models of care.  
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New healthcare models are emerging. Research has demonstrated that transitional care 
coordination models in the acute care setting do improve the quality of care through a decreased 
need for emergency room visits and hospital readmissions in the 30 days post-hospitalization 
(Naylor et al., 1994; Naylor et al., 1999; Naylor et al., 2004; Naylor, Aiken, Kurtzman, Olds, & 
Hirschman, 2011a; Naylor et al., 2011b; Robinson, 2010). Transitional care coordination 
involves engaging the patient and/or caregiver in planning and assisting in achieving health care 
goals through a 30-day post-acute care continued relationship with the healthcare team. By 
decreasing emergency room visits and hospital readmissions, these transitional care models have 
also been cost-effective (Naylor et al., 1994; Naylor et al., 1999; Naylor et al., 2004; Naylor et 
al., 2011a; Naylor et al., 2011b; Robinson, 2010). The motivation for transitional care models 
was the need to decrease healthcare utilization and spending rather than targeting long-term 
healthcare goals or health behavior change. The focus of these care-coordinated models has been 
to provide short-term support for patients during the first month post-discharge because it has 
been demonstrated that many patients seem to struggle with both understanding and following 
their discharge plan of care, leading to readmissions (Coleman, 2003). Research has supported 
the effectiveness of transitional care to prevent 30-day readmissions, but less is known about 
long-term benefits of the transitional care models or the effects of fully integrated 
multidisciplinary care coordination on health behavior, and health outcomes (Coleman, 2003). 
However, the financial success of transitional care coordination models demonstrated that 
patients need assistance in understanding and following their discharge plan of care to meet even 
short-term (30-day) post-acute care health goals (Coleman, 2003).  
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New Legislative Opportunities 
Acknowledging the acute care focus and high degree of fragmentation of our current 
healthcare system, the ACA highlights a redesigned healthcare system that focuses on population 
health emphasizing prevention rather than illness. The ACA was designed to radically alter the 
way healthcare is delivered in the US by placing the focus for care improvement on the primary 
care team through the use of Patient-Centered Medical Homes (PCMH) and Accountable Care 
Organizations (ACO)(Haas et al., 2013). One critical element of the PCMH and ACO is the 
emphasis on care coordination to improve population health (Burton, 2012). The goal is to work 
with the individual to help him/her achieve his/her healthcare goals while learning what will 
work for the population (Institute for Healthcare Improvement [IHI], 2016).  
According to the Agency for Healthcare Research and Quality [AHRQ], the PCMH with 
care coordination and collaboration at the helm is designed to improve “patient outcomes; patient 
safety; patient experience; and possibly lower costs through reduced duplication of services, 
increased delivery of preventive services and more evidence-based patient care…” (E. Taylor, 
Lake, Nysenbaum, Peterson, & Meyers, 2011). Along with the IHI, the Commonwealth Fund, 
the National Committee for Quality Assurance (NCQA), the National Patient Safety Foundation 
(NPSF)—and government departments like the U.S. Department of Health and Human Services 
(HHS), and AHRQ—recognize the need for radical change with an emphasis on learning what 
successfully improves the health of the population while rejecting those efforts that do not 
demonstrate improvements in population health. Research is needed to guide this health system 
redesign.  
However, despite the passage of the ACA, the US continues to experience low scores in 
all five areas of the 2014 and 2017 Mirror, Mirror reports (i.e., quality/care process, access, 
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efficiency, equity, and healthy lives/health care outcomes) compared to the other ten countries 
(Davis et al., 2014; Schneider et al., 2017). This demonstrates that radical change in any system 
does not come quickly or easily and the U.S. healthcare system remains in last place when it 
comes to healthcare performance and first place in cost. The NPSF in their report, Free from 
Harm (2015) recommended coordinating care, increased collaboration, and partnering with 
patients and families as key ingredients to improve patient safety. Their report further states that 
to ensure safety, our healthcare system must include all areas of care including ambulatory care 
where the majority of patient care occurs, and it must focus on communication, teamwork, and 
patient engagement. Based on the success of transitional care models in the acute care setting, 
healthcare models are being developed for the ambulatory setting. However, to effectively 
improve the healthcare system in the United States and the health of the U.S. population, much 
more research needs to be done to identify the best ambulatory programs to provide the best care 
to patients with chronic health needs.  
One suggested healthcare redesign model focuses on nurse-led interprofessional 
collaborative care-coordination teams in primary care. Interprofessional collaborative teams 
involve members from different healthcare professions partnering with each other and the patient 
to share responsibility for the patient’s health outcomes while providing support to patients in 
their efforts to meet their health goals. The Interprofessional Collaborative Care Coordination 
Model of care [ICCCM] is a nurse-led team-partnered approach in the ambulatory care setting 
including the patient as the primary team member. These healthcare teams share responsibility 
with the patient and help the patient identify healthcare needs and goals through education and 
active patient engagement. Team members include the patient’s caregiver/support system, the 
nurse, physician, social worker, and dietitian as indicated by the patient’s identified goals and 
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healthcare needs. To increase patient engagement, patient convenience and collaboration with 
and among team members, all team members are available to the patient in the same location.  
Care-coordination assists patients both in navigating the many facets of the healthcare 
system and improving their health self-management skills. This system combines ten essential 
elements including engaged leadership, data-driven improvement, empanelment, team-based 
care, patient-team partnership, population management, continuity of care, prompt access to care, 
comprehensiveness and care-coordination to build a model for increased patient engagement, 
revamped patterns of healthcare utilization and improved patient outcomes (Bodenheimer, 
Ghorob, Willard-Grace, & Grumbach, 2014).  
Research Hypotheses 
Diabetes is a deadly and costly chronic disease. The US continues to be poorly designed 
to address chronic conditions. Despite emerging models of care, none has emerged as the gold 
standard. Care-coordination and interprofessional teams have been identified as potentially 
improving patient engagement, healthcare utilization and clinical indicators, but it is unclear 
whether these care delivery elements truly improve healthcare.  Therefore, this research study 
determined the effectiveness of this nurse-led Interprofessional Collaborative Care Coordination 
Model of care [ICCCM] in the Type 2 diabetes population in terms of patient engagement, 
healthcare utilization and health outcomes over time and in comparison to a matched sample. 
This study addressed the following questions: 
 H1a: Adult patients with Type 2 diabetes had better patient engagement (number of 
missed visits (no show encounters/same day cancellations), annual influenza 
immunizations, and annual eye examinations) after one year's participation in the ICCCM 
model in comparison to one year prior to participation in the ICCCM model. 
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 H1b: Adult patients with Type 2 diabetes, who received care at the ICCCM (intervention) 
site, had better patient engagement (number of missed visits (no show encounters/same 
day cancellations), annual influenza immunizations, and annual eye examinations) after 
one year than a sample of matched patients with Type 2 diabetes who received standard 
primary care within the same health system over that same year. 
 H2a: Adult patients with Type 2 diabetes had better health care utilization (fewer 
hospitalizations, fewer hospital days, and fewer emergency room visits) after one year's 
participation in the ICCCM model in comparison to one year prior to participation in the 
ICCCM model. 
 H2b: Adult patients with Type 2 diabetes who received care at the ICCCM (intervention) 
site had better health care utilization (fewer hospitalizations, fewer hospital days, and 
fewer emergency room visits) after one year than a sample of matched patients with Type 
2 diabetes who received standard primary care within the same health system over that 
same year. 
 H3a: Adult patients with Type 2 diabetes had better clinical indicators (percent of 
patients with Hgb A1C levels > 9.0; change and difference in Hgb A1C, weight, and 
systolic and diastolic blood pressure, systolic blood pressure < 140, diastolic blood 
pressure < 90) after one year's participation in the ICCCM model in comparison to one 
year prior to participation in the ICCCM model. 
 H3b: Adult patients with Type 2 diabetes who received care at the ICCCM (intervention) 
site will have better clinical indicators (percent of patients with Hgb A1C levels > 9.0; 
change in Hgb A1C, weight, and systolic and diastolic blood pressure, systolic blood 
pressure < 140, diastolic blood pressure < 90) for one year than a sample of matched 
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patients with Type 2 diabetes who received standard primary care within the same health 
system over that same year.
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CHAPTER TWO 
LITERATURE REVIEW 
The focus of this research will be to determine whether care-coordination in 
interprofessional teams improves patient engagement, health care utilization, and clinical health 
indicators for patients with Type 2 diabetes. Care-coordination as a delivery system redesign first 
emerged in 1985 and since then, care-coordination has been incorporated into a variety of care 
models with varying degrees of team collaboration. To understand care-coordination in the U.S. 
health care system, this literature review takes a historical approach describing both the models 
and research conducted on those models.  
Care-coordination includes collaborating interprofessionally to meet the total health care 
needs of patients across the lifespan. However, details of interprofessional collaboration have not 
been included in most care-coordination model descriptions, making it difficult to determine 
whether interprofessional collaboration was included in the models. Therefore, the final section 
of this literature review will focus on what is known about interprofessional collaborative care in 
the primary care setting.  
Literature Review Search Strategy 
First, a literature review was conducted to identify what is known about care-coordinated 
teams as a method of healthcare system redesign and the effect of this redesign on patient 
engagement, health care utilization, and clinical outcomes. This search was followed by a search 
of interprofessional collaborative care models for patients with chronic conditions in the primary
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care setting. A total of 238 articles were included in the literature search, as described in Table 1. 
The literature search included three core strategies:  
1. a focused literature review of Pubmed, Cumulative Index of Nursing and Allied 
Health Literature (CINAHL), PsychInfo, the Cochrane library, and Joanna Briggs 
Institute; 
2. mining selected articles for applicable references as well as mining Scopus for articles 
that cited identified seminal articles; and  
3. a Google search of websites (government, public and private) on the Patient Centered 
Medical Home, care-coordination and collaboration.  
Websites reviewed for additional information and articles include  the Agency for 
Healthcare Research and Quality (AHRQ), the Patient-Centered Primary Care Collaborative, 
National Committee for Quality Assurance (NCQA), American College of Physicians, Care 
Coordination (Group Health Research Institute), FamiliesUSA, Institute for Healthcare 
Improvement (IHI), Congressional Budget Office (CBO), National Center for Interprofessional 
Practice and Education (NEXUS), and the National Quality Forum (NQF). 
All articles in each search were reviewed for relevance by first evaluating the title. If the 
title was relevant, the abstract was reviewed and if relevant, the article was reviewed. Care-
coordination articles were rejected if they (a) pertained to populations outside the US; (b) 
pertained to children with diabetes transitioning to adult care; (c) did not mention any nursing 
involvement as part of the care-coordination intervention; (d) focused on electronic monitoring 
devices or internet-based interventions; (e) focused on a highly specific patient population in 
which disease management was unrelated to diabetes management (e.g., HIV disease; obstetrics, 
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pediatrics, cancer, or mental health); (f) focused on acute care, rehabilitation, skilled nursing care 
or rural health only; and (g) focused only on patient perception/satisfaction or provider 
perception/satisfaction. However, due to the limited number of articles obtained when searching 
for articles specific to collaborative care combined with both primary care and chronic illness, 
articles that included populations with both diabetes and depression as well as articles outside the 
U.S. were reviewed. The citations of all relevant articles were then searched to elicit any missed 
applicable articles. Finally, to ensure that nothing was missed, sentinel articles were mined in 
Scopus to identify additional articles. 
Table 1. Literature Search 
Database Key Words  Search 
limitations 
Number Articles 
found 
Articles chosen 
to read 
CINAHL Care coordination English,  
Adult, 
Research  
261 42 
Transitional Care English 54 7 
 
Transitional Care 
AND Type 2 
diabetes 
 
English  
Adult 
0 0 
(Case 
management OR 
patient centered 
care OR 
transitional care 
OR secondary 
health care) AND 
(Chronic disease 
OR diabetes 
mellitus type 2)  
Research, 
English, 
Adult, Human 
255 38 
  
24 
 
Database Key Words  Search 
limitations 
Number Articles 
found 
Articles chosen 
to read 
 (Multidisciplinary 
team OR 
collaborative care 
OR inter-
professional team 
OR intra-
professional team) 
AND (Primary 
Health Care OR 
Ambulatory Care 
OR Outpatients) 
AND (Diabetes 
mellitus type 2 OR 
Chronic Disease) 
English 41 8 
Pubmed (Care coordination 
or integrated care 
OR continuity of 
care OR care 
management OR 
coordinated care 
OR case 
management) AND 
diabetes mellitus 
English  
Adult 
 
4,182 103 
Patient outcomes 
AND (inter-
professional 
collaborative 
practice OR 
multidisciplinary 
OR inter-
professional OR 
intraprofessional) 
AND (Team OR 
Practice OR patient 
care team) AND 
(patient care 
management OR 
comprehensive 
health care OR 
disease 
management OR 
care coordination)  
English 
 
200 11 
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Database Key Words  Search 
limitations 
Number Articles 
found 
Articles chosen 
to read 
 Patient outcomes 
AND 
(interprofessional 
collaborative 
practice OR 
multidisciplinary 
OR 
interprofessional 
OR 
intraprofessional) 
AND (Team OR 
Practice OR patient 
care team) AND 
(patient care 
management OR 
comprehensive 
health care OR 
disease 
management OR 
care coordination) 
AND (Primary care 
OR ambulatory care 
OR outpatients) 
English 183 5 
PsychInfo (case management 
OR managed care 
OR continuum of 
care) AND 
(collaboration OR 
cooperation) AND 
(primary health care 
OR health care 
delivery) 
 42 7 
Cochrane library Care coordination 
Coordination 
Care management 
Case management 
Collaborative Care 
 
 5 
14 
601 
293 
19 
0 
0 
7 
3 
3 
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Database Key Words  Search 
limitations 
Number Articles 
found 
Articles chosen 
to read 
Joanna Briggs 
Institute 
Evidence Based 
Practice 
Database 
(care coordination 
OR continuity of 
care OR disease 
management OR 
case management 
OR care 
management) AND 
(collaborative care 
OR 
multidisciplinary 
OR 
interprofessional 
OR 
intraprofessional) 
AND primary care 
 
 6 4 
Nexus:  National 
Center for 
Interprofessional 
Practice and 
Education 
Collaborative 
Practice OR 
Teamwork 
NA 788 0 
 
A search of the Nexus website database revealed 788 articles of which the vast majority 
were editorials, individual site models, theories, and standards of collaborative care with most 
research limited to instruments to measure collaboration or qualitative studies of provider and/or 
patient satisfaction. Only three quantitative studies of collaborative care interventions were 
found, and all three evaluated the effectiveness of interventions to improve collaboration from 
the healthcare team perspective. No studies that evaluated the effect of collaborative care on 
patient outcomes were found in the Nexus. However, a few quantitative studies were found 
through detailed Pubmed, CINAHL, and PsychInfo searches with the TEAMcare model, 
providing the most quantitative research results on patient outcomes from a collaborative care 
model in the US (Katon et al., 2010). However, articles were identified that described 
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collaborative team models in primary care without providing any research evidence as to the 
efficacy of these models (Kruger et al., 2012; Pilon, Ketel, & Davidson, 2015; Tapp et al., 2012; 
Tracy, Bell, Nickell, Charles, & Upshur, 2013). 
Theory and Substructure  
 The study of the effectiveness of a delivery system redesign is complex. Therefore, 
Wagner’s The Care Model provided the theoretical framework to design, describe, and measure 
the effectiveness of care coordination in this study. The following section will present both the 
concepts of the model and apply each of these concepts to the study environment and health care 
redesign.  
Wagner’s The Care Model 
The theoretical model used to guide this study is based on The Care Model (see Figure 1) 
(MacColl Center, 2002). The Care Model is a model of care that includes four major hierarchical 
constructs: Community/Health Systems, Services, Productive Interactions and Improved 
Outcomes. The Community/Health Systems together form the overarching environment from 
which needed Services are identified and provided to the patient and his/her support system. The 
Services provided lead to Productive Interactions that the informed, empowered patient and 
family have with the prepared and proactive health care team. These Productive Interactions lead 
to Improved Outcomes for the patient. 
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Figure 1. Wagner’s The Care Model 
 
Community/Health systems. The green oval of the Care Model establishes that there are 
two areas in which health care is met, the Health Systems, where patients and families interact 
with the healthcare team, and the Community where the patient and family reside and often 
obtain further health resources, services and support (See Figure 1 Wagner Care Model) 
(MacColl Center, 2016b; MacColl Center, 2016e).  
These two co-dependent systems, the Health System and the Community together form 
the environment that supports the chronically ill patient and his/her support system. Through 
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partnerships, the Health System and the Community interact to provide the services required for 
the patient and his/her support system to maintain and promote health. By mobilizing and 
maximizing the services of both the Community and the Health System, the gaps that exist 
between health care encounters can be minimized (MacColl Center, 2016c).  
Health system. The Health System is the provider of health care services to the patient 
and family. Through an active partnership with the Community, the Health System can ensure 
that all appropriate, available resources to enhance the health and support the chronically ill 
patient and his/her support system are provided. The Organization of Health Care within the 
Health System is designed to provide a culture of excellence within the organizational system to 
ensure effective, safe and high quality care (MacColl Center, 2016e). Finally, the Community 
and the Health System together advocate for improved local, state, and federal health policies to 
positively impact patient outcomes. Thus, the Community and Health System are synergistic 
open systems within the environment. 
The ICCCM 
The Care Model provides a conceptual framework for a delivery system redesign and the 
outcomes in this study. Table 2 demonstrates how The Care Model guides the system redesign 
(see Table 2). It compares the theoretical definition from the model to the application of that 
concept in this study. The Community/Health System and Services constructs were used in the 
interprofessional team care-coordination redesign. The redesign affected the Productive 
Interactions and the effect of the redesign was measured by the Outcomes. Each concept will be 
defined theoretically and then applied to the study site. 
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Table 2. Wagner’s The Care Model: Concepts and Adaptation 
The Care Model Concepts ICCCM Adaptation of The Care Model Concepts 
Health System Health system with ambulatory primary care clinics 
Community Surrounding collar community of a large 
Midwestern city 
Self-Management Support 
 
 
Achieved through interprofessional collaboration 
with patients to identify needs, goals and action 
plan; problem-solve; and provide resources to help 
patients achieve their self-management goals 
Delivery System Design Interprofessional collaborative care-coordination 
Decision Support Phytel reports used to conduct population level 
analysis to identify target population and care needs 
Clinical Information Systems Epic & Phytel 
Services  
Patient-Centered Patient/family set goals and assist in developing 
individualized care plan, care is holistic, 
individualized, respectful and empowering 
Timely and Efficient Access to care coordinator with touchback phone 
conversations and portal availability for questions 
Evidence-Based and Safe The clinic uses best evidence to ensure optimal, 
safe care 
Coordinated Nurse Care Coordinators coordinates care with the 
entire team and network with specialists and 
hospital/ED staff as appropriate  
Informed, Empowered Patient 
and Family 
Communication with appropriate team members 
through telephone encounters, face-to-face 
meetings, group visits, group workshops, support 
groups to obtain the knowledge and confidence to 
be informed and empowered. 
Productive Interactions The communication itself is in the form of phone 
and portal encounters, face-to-face meetings, group 
visits, group workshops, support groups  
Prepared, Proactive Practice 
Team 
Interprofessional team-based care—the entire team 
participates in team building experiences to ensure 
that they work together to improve care and meet 
regularly to discuss patient care 
Outcomes  
Patient engagement Number of clinic no shows/same day cancellations, 
number of annual eye examinations, number of 
influenza immunizations 
Health care utilization Number of inpatient hospitalizations/emergency 
room visits, Number of hospital days 
Clinical indicators A1C, Systolic and diastolic blood pressure, weight 
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Health system in this study. The Health System is a tertiary care system that includes 
two hospitals, 29 clinic locations and three immediate care centers (Loyola University Health 
System, 2016). This health system is part of a larger Jesuit, Catholic Health System (Loyola 
University Health System, 2016). The family practice clinic, satellite clinic, and the outpatient 
clinic comparison sites are among the 29 clinic locations comprising this health system.  
The community. The community, as the place where the patient spends the most time, 
provides resources and policies to assist the patient in managing his/her own health care needs on 
a daily basis (MacColl Center, 2016b). The Health System can facilitate the use of community 
resources that influence the ability of the chronically ill patient to achieve optimal self-
management. Marshalling available community resources is critical to the achievement of self-
management.  
In addition, the community government adopts policies, laws, and procedures that have a 
large impact on the health of the community. For example, the decisions the community 
government makes on provided services, the allocation of funds, provision of police and fire 
departments, street maintenance (including signage and lighting, water and sewer systems, parks, 
pest control and garbage collection) all have an impact on the health of the community. Other 
services, like special transportation services for the handicapped and elderly, affect the ability of 
patients to access health care services. Consequently, how each community allocates their 
resources has a great effect on the health of the community. 
The community in this study. Both the comparison and the ICCCM patient populations 
reside in the same general community. The community included Chicago or one of the six collar 
counties surrounding Chicago (Loyola University Health System, 2013a). This low income, 
racially diverse population identified diabetes, hypertension, obesity and hypercholesterolemia as 
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among the top health problems in their health needs assessment (Loyola University Health 
System, 2013a). 
The Community and the Health System cannot function in a silo, but, rather they are 
indelibly and synergistically linked through underlying concepts. These four sub-concepts are 
Self-Management Support, Delivery System Design, Decision Support, and Clinical Information 
Systems. 
Self-management support. Self-Management Support means providing the support that 
patients need to manage their own chronic illness(es). It acknowledges the patient’s role in 
chronic care management - and the healthcare team provides the support to patients to empower 
them to manage their own health (MacColl Center, 2016f). To maximize health, chronically ill 
patients must learn how to live with their chronic illness(es) and cannot rely exclusively on the 
health system to meet their own health needs. These patients must also learn to successfully 
navigate both the community and the health system to effectively manage their own health. 
Therefore, the role of the health care team is not only to provide the support and education 
needed but also to marshal the services needed by patients to manage their own health. Self-
Management Support strategies “include assessment, goal-setting, action planning, problem-
solving and follow-up” (MacColl Center, 2016f). Self-Management Support places the patient at 
the center of the model by emphasizing the patient’s role in his or her own health (MacColl 
Center, 2016f).  
The self-management support concept is actualized in health care in that patients choose 
when to access health care services. The health care provider (physician or nurse practitioner) 
leads the team and refers the patient for services as needed. Patients are responsible for 
navigating the health care system.  
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Self-management support in this study. The nurse care coordinator identifies patients 
who need help with self-management. The care coordinator initiates a meeting and discusses 
care-coordination with the patient/care giver. Together with the patient and health care team, the 
care coordinator develops a mutually agreeable care plan. It is the care coordinator’s 
responsibility to follow-up with the patient to ensure the success of the care plan. 
Communication care strategies include individual face-to-face meetings, phone and portal 
communication, diabetes education classes, support groups, and group clinic appointments. This 
model empowers patients to enhance self-management skills and meet health goals (Burkhart, et 
al., 2019). 
Delivery system design. The Delivery System Design is the system structure designed to 
manage patient care. The Care Model Delivery System changes the Delivery System Design 
from one of reactive care to one that focuses on being proactive by maintaining optimal health 
(MacColl Center, 2016d). It incorporates all the components of the care system. This includes 
the defined roles of each team member, planned interactions with patients/families, the provision 
of culturally competent and literacy-competent care and the provision of coordinated care for 
complex, chronically ill patients that includes planned, regular follow-up care (MacColl Center, 
2016d). Since the IOM published the report Crossing the Quality Chasm: A New Health System 
for the 21
st
 Century (Institute of Medicine, 2001), it has been recognized that quality must be 
built into the core of the delivery system. A major goal of the delivery system is to make 
continual improvements in the delivery system based on the latest evidence, changes in health 
care, and analysis of their own data.  
Delivery system design in this study. The traditional ambulatory clinic Delivery System 
Design requires the patient to identify when he or she needs to seek health care services. The 
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patient makes the appointment and bears the responsibility of maintaining a relationship with the 
provider. The clinic staff often function alongside each other, each performing the tasks 
necessary for their job but rarely communicating as a team to identify and meet patient needs 
(Burkhart, et al., 2019).  
The ICCCM focuses on interprofessional collaborative care-coordination in an 
ambulatory primary care clinic. In this redesign, both the registered nurse and the nurse 
practitioner functioned as care coordinators and team leaders (personal communication Amber 
Garrett, Care Coordinator, 1/30/2017). Their care-coordinating responsibilities include 
developing and coordinating the plan of care, empowering both patients and families to 
participate in their own care, marshaling all available services, serving as the team leader to 
ensure everyone is working toward the same goals, and using the information system to monitor 
progress and proactively engaging with patients who are struggling to meet their care plan goals 
(I-Care-PATH meeting, 2014). In addition, an on-site dietitian and social worker complete the 
team and provide additional education and services for this highly complex group of patients 
(personal communication with Kimberly Koziol, Clinical Coordinator, 3/20/2017). 
Decision support. Decision Support is the health information health professionals use to 
assist in making clinical judgments regarding care. It provides both person- and population-
specific information that is linked with health knowledge to make health decisions to improve 
the quality of care provided. Clearly, the Decision Support system is very tightly linked with the 
Clinical Information System. In the Care Model, Decision Support focuses on engaging the 
patient/family through the most innovative evidence-based educational methods to help the 
patient identify his/her preference for care (MacColl Center, 2016c). From these preferences, the 
patient and the health care team collaborate to design individualized care plans for treatment. 
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Through effective decision support, care provided by specialists is integrated with that of 
primary care.  
Decision support in this study. Decision Support is operationalized with a software 
called Phytel (IBM Phytel), which is an administrative program that extracts EHR data to help 
guide population and individual care (IBM Phytel, 2016). Phytel reports identify patients with 
scheduled appointments who require appointment reminders and needed lab work prior to their 
appointments (IBM Phytel, 2016). These reports are also used for population health statistics and 
to identify patients who have not completed recommended follow-up tests (Burkhart, et al., 
2019).  
Clinical Information Systems. Clinical Information Systems (CIS) are the systems 
within the environment that collect and organize individual patient clinical health data as well as 
aggregated population data. Due to the vast amount of data that are required to manage 
individual and population needs in a timely, efficient and effective manner, these systems are for 
the most part electronic. The CIS provides the organizational method to document and manage 
patient clinical information, particularly for disease management. Disease management 
information includes identifying patients in need of more intensive health support, providing 
reminders for both staff and patients, monitoring outcomes of the care model, sharing 
information electronically, and assessing the overall performance and quality of the model 
(MacColl Center, 2016a).  
Clinical information systems in this study. All 29 clinics use EpicCare (Epic Systems, 
Verona, WI) and Phytel as the clinical information system. EpicCare is an electronic health 
record that houses the patient’s medical data for all 29 clinic sites and both hospitals within this 
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academic medical center. Phytel is a data management program for ambulatory care that pulls 
the data from Epic and organizes the data in a useful way for patient care (Burkhart, et al., 2019).  
As Wagner’s The Care Model graphic demonstrates (see Figure 1), the Community and 
the Health System cannot be completely separated from each other. Therefore, both the 
Community and the Health System together make up the core elements of The Care Model. 
Although the Community does impact the concept of Self-Management Support, as the green 
inner circle darkens, the Community impact on Delivery System Design, Decision Support, and 
Clinical Information Systems diminishes. The Community and the Health System cannot 
function in a silo, but, rather they are indelibly and synergistically linked through the underlying 
tiered concepts. 
Services. Services are helpful interventions provided to the patient and support system by 
the Community and Health System. The services provided to the chronically ill patient must be 
Patient-Centered, Timely and Efficient, Evidence Based and Safe, and Coordinated to be 
effective in producing both an informed, empowered patient and family and a prepared, 
proactive practice team (MacColl Center, 2002). These service attributes align with the IOM 
Report (2001).  
Patient-centered. Patient-centered care makes the patient the center of the team, putting 
the informed patient in control of his own goals of care. Through a patient-centered care plan, the 
health care team can provide the patient with needed support and encouragement by 
collaborating with the patient and his support system to establish health care goals, action plans, 
solutions to problems and appropriate follow-up as well as to facilitate the use of community 
resources to provide increased support for self-management.  
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According to Morgan and Yoder (2012), there are four key attributes which demonstrate 
patient-centered care. Patient-centered care must be holistic, individualized, respectful, and 
empowering (Morgan & Yoder, 2012).  
Patient-centered in this study. The Patient-Centered concept is applied to both usual care 
and the ambulatory care ICCCM redesign. In the standard care clinic, the patient makes an 
appointment to see the provider with a list of health concerns, which the provider respectfully 
addresses. The provider attempts to individualize the care to the needs and resources available to 
the patient. Patients are at the center making requests based on their recognition of their health 
care needs. Although the provider does bring up concerns and health maintenance suggestions, it 
is up to the patient to schedule follow-up appointments and manage his own health care for any 
problems that cannot be addressed at the time of the appointment. Although care is centered 
around the patient’s identified needs, the patient may be ill-equipped to accurately identify these 
needs. The care is respectful and individualized but it may or may not be holistic or empowering. 
Much will depend on the ability of the provider to address the whole patient and communicate in 
a manner that empowers the patient in a single 10-15 minute clinic visit (Burkhart, et al., 2019). 
The Patient-Centered concept is applied to the ICCCM in that when the patient is 
identified as needing care coordination, the appropriate care coordinator contacts the patient and 
sets up an initial meeting (I-Care-PATH meeting, 2014). In the initial meeting, the care 
coordinator provides information about the opportunities available through care-coordination (I-
Care-PATH meeting, 2014). Then, patients with complex health care needs in collaboration with 
the entire healthcare team set care goals demonstrating the PCC aspect of this innovation. In this 
case, the PCC intervention is a holistic approach to the patient and family/caregiver. The health 
care team works to understand patients from all aspects of their lives including physical, 
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psychosocial, cognitive, and spiritual. After understanding a patient’s health care needs and the 
many facets of these needs, the care coordinator and patient mutually develop goals and weave 
together the potential action plans to meet those goals. This process respects the needs, goals and 
desires of the patient. The resulting care plan includes a wide range of services; for example, 
multidisciplinary team visits, phone and portal support, support groups, and individualized team 
member visits. The support and education provided by the care coordinator and health care team 
empowers the patient and his/her family/caregiver to take control of the patient’s own health.  
Timely and efficient. Timely care is care that is provided promptly (Institute of 
Medicine, 2001). Eliminating long wait times for patients to get appointments and long wait 
times at the point of care is especially important for patients with chronic illnesses who need 
more frequent healthcare visits. Without timely care, patients will be forced to wait until their 
healthcare is unmanageable. If the patient is unable to engage with their primary healthcare team, 
they will wait until care needs are emergent, at which time they will access the emergency 
department and hospital to get their health care needs met. This will lead to increased care 
fragmentation as well as increased cost. Thus, health care, to be effective, must be timely. 
Efficient care eliminates healthcare waste by eliminating unnecessary repetition of 
services (Institute of Medicine, 2001). Providing efficient care is another method of ensuring that 
the patient’s care is not fragmented, but rather that care is holistic, with one health care team 
member coordinating the services of all healthcare providers. To provide efficient care, one 
provider must assume the responsibility for ensuring the care of the whole patient and 
coordinating specialty services. 
Timely and efficient in this study. Timely and Efficient care applies to both usual care 
and the ICCCM ambulatory care redesign. The standard care clinic providers have 10-15 minute 
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appointments allotted for each scheduled patient appointment. Although they attempt to provide 
timely, efficient, and holistic care for each patient, it is difficult to address all of the needs of 
complex patients with limited time and without the assistance of the full team. Furthermore, 
standard care relies on the patient to schedule needed appointments at appropriate intervals. 
In the ICCCM, the patient and caregiver have access to the care coordinator prior to or 
after the primary care provider (PCP) appointment as required and identified by either the PCP 
or care coordinator (I-Care-PATH meeting, 2014). This ensures that the patient’s healthcare 
needs are being met in a timely fashion. In addition, with the use of technology, the care 
coordinator reaches out to patients when decision support reports indicate a need for follow-up 
(I-Care-PATH meeting, 2014).  
In the ICCCM model of care, during their appointments, patients may see other team 
members during, before, or after the PCP appointment (I-Care-PATH meeting, 2014). Extending 
the visit helps to ensure that all individual patient needs can be met. In addition, rather than 
waiting for the patient to contact the clinic, the care coordinator reaches out to the patient to 
make sure their needs are being met (I-Care-PATH meeting, 2014). Patients are encouraged to 
contact their care coordinator with any problems they encounter (I-Care-PATH meeting, 2014). 
This relationship ensures that care needs can be met in a much more timely and efficient manner 
with the goal of minimizing urgent care, emergency care and hospitalizations. 
Evidence-based and safe. Evidence-based care is care that is based on the current best 
evidence from rigorous research findings combined with clinical expertise and patient values. 
Although the concept of evidence-based practice originated in medicine, it is currently 
considered an interdisciplinary approach to practice and is firmly based on the patient’s values, 
goals and preferences (Lilienfeld, Ritshcel, Lynn, Cautin, & Latzman, 2013).  
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Safe care means that the patient is free from unintended injury related to the care 
provided (Institute of Medicine, 2001). Standardizing care is an important component of 
providing safe care (Haas, Swan, & Haynes, 2014). Many of the errors that occur in healthcare 
are related to poor communication between healthcare providers.  
Evidence-based and safe in this study. The Evidence-Based and Safe concept was not 
evaluated or measured for this study. Since all 29 clinics follow the same policies, procedures 
and mission, an assumption of this study is that they provide the same degree of safe and 
evidence-based care.  
Coordinated. Coordinated care means organizing the care provided between health 
professionals and the patient so that patients receive appropriate and optimal health care services 
(Agency for Healthcare Research and Quality, 2014). Effective and efficient communication 
between the patient and all healthcare providers is an attribute of care-coordination. With optimal 
communication, waste and redundancy of care is minimized. Thus, coordinating healthcare is a 
multidimensional task that incorporates many of the concepts of The Care Model.   
Coordinated in this study. Coordination is operationalized differently in the standard care 
and in the ICCCM redesign. In standard care, the PCP bears the responsibility of effectively 
coordinating all the health care needs of their patients. In the ICCCM redesign, the care 
coordinator communicates with all team members and the patient. The nurse care coordinator 
develops an individualized plan of care based on physician recommendations, decision support 
recommendations, team feedback, and patient/family decisions (I-Care-PATH meeting, 2014). 
The care coordinator follows the plan and is responsible for providing transitional care and 
communicating with care providers outside the clinic (I-Care-PATH meeting, 2014). By utilizing 
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the full capacity of the registered nurse to coordinate the care of the complex patient, care is 
effectively coordinated.  
Productive interactions. Productive interactions are the methods that empower patients 
to produce their own health outcomes. In chronic care management, it is the patient and family 
who live with the chronic condition and only through their actions can the disease trajectory be 
altered. Interactions occur between the health care practice team and the patient and family in 
every health care model. To be productive interactions, the patient and family are placed 
squarely in the driver’s seat rather than being a bystander in their own health care.  
Productive interactions in this study. Productive interactions are operationalized in 
both usual care and in the ICCCM redesign. In standard care, productive interactions are 
operationalized in that the physician or APN answers the patient/care giver questions, 
coordinates the care, and educates the patient in the allotted 10-15-minute appointment. 
Additional needs are met through referrals to other clinics. In the ICCCM redesign, the nurse 
care coordinator uses motivational interviewing techniques to assist the patient/care giver in 
identifying their health goals and meeting them. These interactions are not limited to the clinic 
visit but rather extended by encouraging follow-up visits, phone visits and portal visits. While in 
the clinic, if social work, dietary or psychological needs are identified, the respective team 
member attempts to meet with the patient/caregiver at the time of the visit. However, if this is 
not possible, appointments with the appropriate team member can be made within the same 
clinic location (Burkhart, et al., 2019). 
 Prepared, proactive practice team. The Prepared, Proactive Practice Team means that 
every member of the team is actively engaged in assisting the patient and his/her support system 
to meet their health care goals. The team is prepared in that they understand the health care needs 
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of the patient and can apprise the patient of their health care management options. Proactive 
means that the healthcare team is focused on the prevention of future problems rather than being 
strictly reactionary. For example, a proactive team member uses the clinical information system 
to identify patients with increased care needs to reach out to and interact with these individuals.  
Team is critical to the success of the Care Model. Team means that each member is 
vested in working together toward the common goal of informing, educating and supporting the 
patient and family. Practice team includes all the members of the healthcare team working 
together to inform and empower patients and their families. The practice team includes lay 
caregivers, nursing staff, care managers, physicians, administrative staff as well as ancillary 
professionals like social workers, dietitians, psychologists, pharmacists, and physical and 
occupational therapists as needed to meet the individual patient’s needs.  
Prepared, proactive practice team in this study. Prepared, Proactive Practice Teams are 
operationalized differently in the standard clinic and in the ICCCM redesign. In the standard 
clinic, care is provided by the PCP or APN. The patient care tech “rooms” the patient and obtains 
basic health data measurements and information. The nurse and patient care tech provide any 
care needs ordered by the PCP or APN. The nurse also triages phone calls from patients daily. 
The Team huddles at the beginning of the clinic to discuss particular patient needs for the day 
but after the basic health data is obtained, the nurse and patient care technician provide only 
specifically ordered care.  
The Prepared, Proactive Practice Team is applied to the ICCCM in that standard practice 
is for the care coordinator to meet with the patient as well as the physician/APN. The care 
coordinator uses motivational interviewing to determine the patient’s progress and continued 
goals of care. The Team huddles at the beginning of the clinic to discuss patient needs for the 
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day. The care coordinator also organizes bimonthly team meetings with the nurses, social worker 
and dietitian to ensure a continuously improving model of care, as well as monthly team 
meetings with the physicians to discuss specific patient needs. The care coordinator also 
establishes the care plan with the patient/care giver and contacts the patient/care giver between 
clinic visits as needed to assure goal attainment (Burkhart, et al., 2019). 
 Informed, empowered patient and family. Informed and empowered patients and 
families mean that they understand the health intervention options available to them, and they 
have the confidence and health literacy to make individual health care decisions and meet the 
challenges of their own health care plan.  
 In the Care Model, the prepared, proactive practice team informs and empowers the 
patient and family to make lifestyle changes, utilize available resources within the environment 
and learn how to optimize their own health. A prepared, proactive practice team means that the 
interprofessional health care team optimizes the delivery system to make evidence-based 
decisions using the retrieved clinical information to help patients, together with their family, self-
manage their own health. The informed, empowered patient and family is informed and 
empowered by the prepared, proactive practice team to ensure that they have all the necessary 
tools and resources to self-manage their chronic illness and improve their disease trajectory and 
ultimately their health outcomes. In the Care Model, every construct is inextricably linked to 
ensure that all aspects of health care are united in the effort to ensure one goal—to empower the 
patient and family to achieve better outcomes. 
 Informed, empowered patient and family in this study. The Informed and Empowered 
Patient and Family is operationalized differently in standard care and in the ICCCM redesign. In 
the standard care workflow, patients with diabetes are asked to schedule quarterly appointments 
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with their PCP to assist them in their diabetes management and address any questions or health 
problems patients identify as well as addressing their diabetes control. Educational and education 
materials are provided within the scheduled appointment. 
The Informed and Empowered Patient and Family is applied to the ICCCM workflow in 
that the care coordinators contact patients not only prior to their appointments but also regularly 
based on a schedule developed between the patient and the care coordinator to ensure that all the 
patient's needs are being met. The care coordinator helps the patient and their support system 
identify and meet their healthcare goals. Through both telephone and face-to-face meetings, 
potential needs are identified. Then the PCP, care coordinator or other appropriate team member 
can further address these needs with the patient through education and support provided either 
through face-to-face or telephone communication. These interactions help inform and empower 
the patient and family. The health care goals and decisions made by the patient and his or her 
family in conjunction with the health care team provide the patient with Self-Management 
Support through care-coordination, assessment of health literacy and subsequent provision of 
educational needs and services. This workflow relies on nurse-led interprofessional collaborative 
practice. The nurse coordinates care and delegates leadership of patient care to the team member 
who can best address the care needs. On-going communication between both team members and 
the patient ensures coordinated care (Burkhart, et al., 2019). 
Thus, the ICCCM workflow creates the informed, empowered patient and family through 
productive interactions with the prepared, proactive practice team. As demonstrated, this 
interprofessional collaborative care-coordinated practice is a redesign of the standard ambulatory 
healthcare system.  
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Improved outcomes. Outcomes are the consequences of the Healthcare 
system/community care of health care services through productive interactions between the 
proactive healthcare team and the informed and empowered patient and family. Outcomes are 
measures of health that are used to determine if the disease trajectory has improved and if the 
model is delivering quality care. There are both short-term and long-term outcome measures. 
Short-term outcome measures are measures that change within a short time period, considered 
one to three years (W.K. Kellogg Foundation, 2004). Long-term outcome measures take a long 
time to identify in a population, from four to six years (W.K. Kellogg Foundation, 2004). For 
example, A1C levels can change every two to three months and are a good short-term measure of 
diabetes management. A long-term outcome measure for diabetic patients would be the number 
of patients experiencing a cardiac event, retinopathy or nephropathy. 
Improved outcomes in this study. This study measures short term outcomes. These 
include patient engagement (number of missed visits, annual influenza immunizations and 
annual dilated eye examinations), appropriate healthcare utilization (number of hospitalizations, 
emergency room visits and hospital days), and clinical indicators (percent of patients with Hgb 
A1C levels > 9.0; change and difference in Hgb A1C, weight, and systolic and diastolic blood 
pressure, systolic blood pressure < 140, diastolic blood pressure < 90).  
Figures 2, 3 and 4 provide the substructure of The Care Model describing how the 
Outcomes were measured. 
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Figure 2. The Care Model substructure A 
 
Figure 3. The Care Model substructure B 
 
 
47 
 
Figure 4. The Care Model substructure C 
 
Summary of Literature Review 
The literature will be described in the following areas: Home Health Care Team Model, 
Carondolet Model, Community Care Management Model, Transitional Care Models, Medicare-
Coordinated Care Demonstration Projects, Physician Group Demonstration Projects, Case 
Management, Primary Care Models, Patient Centered Medical Home Model, and 
Multidisciplinary Collaborative Models.  
Models of Care-Coordination Late 20
th
 Century 
Care-coordination models emerged in the later 20
th
 Century. The following sections will 
describe these early models: Home Health Care Team Model, the Carondelet Model, and the 
Community Care Management Model. 
Home Health Care Team Model. The Home Health Care Team Model was a physician-
led team approach including a physician, nurse practitioner (NP), and social worker (Zimmer, 
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Groth-Juncker, & McCusker, 1985). Interventions included home visits by each team member to 
develop an interdisciplinary care plan followed primarily by NP home visits but including other 
team member visits as needed, weekly team conferences, and 24-hour emergency phone service 
(Zimmer et al., 1985). A random control trial (RCT) of a population of 167 high-risk, chronically 
ill and often terminally ill patients found a significant improvement in caregiver satisfaction in 
the treatment group at both 3 months (p < 0.0001) and six months (p < 0.002) (Zimmer et al., 
1985). However, there was no statistically significant difference in healthcare utilization, which 
was attributed to the high rate of mortality in this population (Zimmer et al., 1985). 
Carondelet Model. The Carondelet Model followed a high-risk Medicare population 
with nurse-managed care-coordination throughout the patient’s lifespan (Ethridge & Lamb, 
1989; Ethridge, 1997). Continuous care through nurse-managed care-coordination was an 
effective means of increasing quality and decreasing costs (Ethridge & Lamb, 1989; Ethridge, 
1997). The focus of this model was to improve patient care for seniors and the medically 
disabled population by providing the full continuum of care (Ethridge & Lamb, 1989; Ethridge, 
1997).  
Carondelet Model description. This Carondelet Model used a risk assessment tool to 
identify, enroll and periodically match patients based on need and risk with both nursing and 
community services. The nurse care manager assisted in the development and selection of 
individualized educational and clinical interventions and coordinated these services at all levels 
of care (primary, secondary and tertiary) (Lamb & Zazworsky, 1997). In this model, the nurse 
case manager assumed the central role of coordinating all patient care to provide all needed 
services and ensure that no patient fell through the cracks of the healthcare system (Ethridge & 
Lamb, 1989; Ethridge, 1991).  
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Carondelet research findings. No specific statistical findings from Ethridge’s work have 
been published, and the specific number of patients who were case managed was not provided. 
The data provided is based on the discharge data set extracting the diagnosis related group for 
COPD and total hip replacements at the Carondelet hospital for fiscal years 1986-1988. 
Administrative data provided the total number and length of hospitalizations in the years 
following the case management intervention for COPD and total hip replacements.  
The literature does provide a description of Ethridge's methodology and information 
regarding the cost savings of this nurse managed care-coordinated approach. In their analysis, 
Ethridge and Lamb claimed that case-managed patients with chronic obstructive pulmonary 
disease (COPD) or total joint replacements had fewer readmissions, decreased length of hospital 
stay, and decreased use of emergency room services than non-case-managed patients (Ethridge 
& Lamb, 1989). It is unclear how they identified participants from the nurse managed care-
coordinated group verses standard care. However, they reported that the case-managed COPD 
group was hospitalized earlier with less acuity (4.4 vs. 5.5 in non-case-managed group) (Ethridge 
& Lamb, 1989). Subsequently these patients were able to be discharged on average 3.5 days 
sooner than the non-case-managed group (6-day length of stay (LOS) for case-managed vs. 9.5-
day LOS for non-case-managed group) (Ethridge & Lamb, 1989). In the total hip replacement 
group, despite higher acuity (4.9 vs. 4.4), these patients also had shorter LOS (8.1-day LOS in 
case-managed group vs. 10.2-day LOS in non-case-managed group) (Ethridge & Lamb, 1989). It 
appeared that the case managers were able to decrease LOS in this surgical group by impacting 
the end of the hospitalization rather than the beginning (Ethridge & Lamb, 1989). Based on this 
discrepancy, Ethridge and Lamb (1989) surmised that the effect of care-coordination is complex 
and needs to be individualized based on the type of conditions treated. Although this research 
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was not published, Ethridge and Lamb (1989) reported that their care-coordinated nursing model 
improved the cost and quality of individual health care.  
Community Care Management model. The Community Care Management model was 
an advanced practice nurse (APN)-led care-coordinated model of care utilizing intensive face-to-
face clinical management combined with close collaboration between the physician and the APN 
who was assigned to a specific physician practice (Quinn, Prybylo, & Pannone, 1999). High-risk 
patients were identified through a health risk assessment utilizing an acuity tool, which was also 
the basis for future care planning, patient education, health care team coordination and 
communication (Quinn et al., 1999).  
Research demonstrated that this model decreased hospital admissions and healthcare 
costs (Quinn et al., 1999). Quinn et al. (1999) found that patients (n= 174) had experienced a 
54% reduction in acute care admissions with a subsequent cost savings of $3,602 per patient (p < 
0.001) in the six months after initiating this care-coordinated intervention compared to six 
months prior. Although statistically significant, a highly problematic limitation of this study was 
the fact that over half (n = 114) of the patients had been identified during an acute care admission 
prior to beginning the intervention (Quinn et al., 1999). Therefore, medical costs prior to 
initiation of the intervention were likely overestimated skewing the results toward significant 
decreased spending in the post-intervention period (Quinn et al., 1999). Thus, regression to the 
mean was identified as a potential problem, questioning the validity of the findings (Quinn et al., 
1999).  
Transitional Care Models: 1990s to the Present 
 Beginning in 1990, a new model of care emerged, called Transitional Care. Transitional 
care differs from care-coordination in that it focuses the care during high-risk times, rather than 
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only with high-risk patients. This high-risk time is the 30-days immediately post-hospitalization. 
Transitional care models have become more popular due to the Medicare regulation both 
prohibiting reimbursement for 30-days post-discharge for certain diagnoses and adjusting 
payment for all-cause readmissions based on each hospitals’ risk adjusted readmission rate 
(CMS.gov, 4/18/2016).  
Transitional care is the care offered to patients when transitioning from one level of 
service/care provider to another and CMS has defined readmissions as occurring within 30-days 
of the initial hospital stay (James, November 12, 2013). Landmark research by Naylor (1994; 
2004), Coleman (2006), and Jack (2009) demonstrated the potential of care-coordination and 
discharge planning to effectively transition patients out of the hospital to minimize the costly 
problem of hospital readmissions. Although there are many transitional care models, two major 
models focus primarily on the time after discharge when the patient is transitioning back to 
ambulatory care. These two successful transitional care models, Naylor’s Transitional Care 
Model (TCM) and Coleman’s Care Transition Intervention model (CTI), were developed based 
on nurse-led care-coordination (Coleman, Parry, Chalmers, & Min, 2006; Naylor et al., 1994; 
Naylor et al., 1999; Naylor et al., 2004; Naylor et al., 2011b; Naylor et al., 2014). These models 
have demonstrated that nurse-led care-coordinated research or clinic-based transitional care 
models reduce hospital readmissions and are cost-effective. The final transitional care model 
discussed, Hewner’s Population-Based Care Transition model (PBCT) is based on the TCM 
intervention but uses population health technology to identify and enroll the patients at highest 
risk of readmission. The following sections describe each model in more detail. 
Naylor’s Transitional Care Model. The Naylor TCM uses APNs to provide care 
coordination from the day of hospital admission until one to three months post-discharge. During 
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the post-discharge phase, the APNs visit patients in their homes within 48 hours of discharge and 
then weekly to bimonthly, and maintain access to care through daily phone “office” hours. 
Although Naylor’s model population is hospitalized patients transitioning to home, the transition 
time period grew from two weeks (Naylor et al., 1994) to four weeks (Naylor et al., 1999) to two 
to three months (Naylor et al., 2004) post discharge.  
Naylor’s Transitional Care Model research results. Research of the Transitional Care 
Model consistently demonstrated that the model was effective in reducing both 30-day hospital 
readmissions and admissions over a longer length of time for a variety of populations. In their 
1999 random control study of 363 geriatric patients, they found a statistically significant 
decrease in readmissions at 24 weeks (p < .001) (Naylor et al., 1999). Naylor et al. (1999) also 
found the total number of days spent in the hospital post-index admission was significantly 
shorter at 24 weeks, with 270 hospital days for the intervention group (177 patients) and 760 
hospital days for the control group (186 patients) (p < 0.001). 
Naylor et al.’s 2004 RCT evaluated the effect of TCM on 239 older adults with heart 
failure and comorbidities. In this study, 38% of the control group and 37% of the intervention 
group had DM. This three-month TCM intervention demonstrated a statistically significant 
decrease in hospital admissions up to one year with 88.1% (104/118) admissions in the year after 
the index admission for the intervention group, compared to 133.9% (162/121) admissions for 
the control group patients (p = 0.047) (Naylor et al., 2004). This translated into a statistically 
significant decrease in healthcare costs of $6,152 on average per patient for the intervention 
group and $9,618 for the control group (p = 0.002) after removing the costs of the program 
(Naylor et al., 2004). Quality of life was significantly improved from baseline at only one 
timepoint: 12 weeks (p < 0.05) and patient satisfaction improved from baseline to both 2 and 6 
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weeks post-intervention (p < 0.001) which were the only two timepoints in which patient 
satisfaction was measured in the study (Naylor et al., 2004).  
Naylor et al.’s 2014 prospective comparative study of 202 cognitively impaired, 
community-dwelling older adults compared the TCM intervention to augmented standard care 
(ASC) and resource nurse care (RNC) (Naylor et al., 2014). ASC included cognitive screening 
while inpatient, and RNC consisted of trained RNs acting as resource nurses during 
hospitalization to provide care directly to the patient or to coach care of other nurses to the 
patient (Naylor et al., 2014). In their time-to-event data model, findings demonstrated that there 
was an accelerated time to readmission or death for both the ASC (1.75 (p=.05)) and the RNC 
(1.93 (p= .02)) in comparison to the TCM (Naylor et al., 2014). The TCM was an effective 
transitional care model with decreased hospitalizations for up to one year after the index 
admission and subsequent decreased cost.  
Naylor’s third-party TCM. Naylor (2011b) expanded the use of the TCM intervention to 
a commercial insurance group with the APNs hired by the insurance company; this revised 
model excluded patient visits in the hospital (Naylor et al., 2011b). A study with 105 participants 
(45 TCM, 60 standard care without TCM) demonstrated statistically significant decrease in 
hospital readmission at 3 months (p < 0.041) but no statistically significant difference in 
readmissions at 6 or 12 months (Naylor et al., 2011b). This demonstrates that either the first visit 
in the hospital is an important dimension to the intervention or the insurance company affected 
the quality of the intervention. More research is needed to clarify why this model was less 
successful than the initial model.  
Coleman’s Care Transitions Intervention (CTI) model. The CTI model focuses their 
intervention exclusively on the acute hospitalization phase followed by the first 28 days of post-
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hospital discharge. The CTI was developed based on discharge needs expressed during patient 
focus groups making it a more evidence-based, patient-centered approach (Parry, Coleman, 
Smith, Frank, & Kramer, 2003). In this model, nurses provide care coaching/coordination 
through one hospital visit followed by one home visit within 24-72 hours of discharge and three 
phone calls during the subsequent 28 days post-discharge (Coleman et al., 2006). The focus of 
these meetings is to empower the patient to take an active role in his/her own care by 
concentrating on patient medication self-management, maintaining the patient’s personal health 
record, and encouraging appropriate follow-up with active patient participation. Patients are 
encouraged to ask questions and learn to identify red flags early (Coleman et al., 2006). The goal 
of the CTI is to improve the patient’s self-care ability, so that the patient can coordinate his/her 
own care (Coleman et al., 2006).  
The CTI significantly decreases readmissions. In a quasi-experimental study of the CTI 
model, a population of 158 elderly adults with at least one of nine chronic conditions receiving 
CTI care was compared to 1,235 control subjects who received standard care (Coleman et al., 
2004). Findings indicated that the percent of rehospitalizations significantly decreased in the 
intervention group for all time periods:—30-day (0.52 Odds Ratio (OR) with confidence interval 
(CI) 0.28–0.96; p = 0.04), 90-day (0.43 OR, CI 0.25–0.72; p = 0.002), and 180-day (0.57 OR, CI 
0.36–0.92; p = 0.02) (Coleman et al., 2004). However, the percent of emergency department 
visits or observation visits was only significantly reduced at 90 days (0.61 OR, CI 0.39–0.95; p = 
0.03) (Coleman et al., 2004).  
In a random control trial of 750 elderly patients with at least one of eleven chronic 
conditions, Coleman et al. (2006) found the CTI intervention group had significantly fewer all-
cause readmissions at 30 days (0.59 OR, CI 0.31–1.00; p = .048) and 90 days (0.64 OR, CI 0.42–
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0.99; p = .04) with no significant difference at 180 days (0.80 OR, CI 0.54–1.19; p = 0.28). 
However, when they looked at readmissions for the same diagnosis as the initial admission, the 
adjusted intervention group had statistically significant fewer admissions at both 90 days (0.50 
OR, CI 0.26–0.96; p = .04) and 180 days (0.55 OR, CI 0.30–0.99; p = .046) with no significant 
difference at 30 days (p = 0.18) (Coleman et al., 2006). Research indicated that the Coleman 
model decreased all-cause readmissions for the first 90 days but only had an impact on 
readmissions for the same initial diagnosis post-hospitalization after 30 days. 
Hewner’s Population-Based Care Transition (PBCT) model. Hewner’s model relied 
on a nurse-developed informatics algorithm to identify the population at highest risk of hospital 
readmission in a regional managed care organization. The complexity algorithm provided the 
means to stratify patients based on their chronic disease complexity hierarchy into four groups: 
complex chronic, major chronic, minor chronic and no chronic conditions (Hewner, 2014).  
PBCT services were provided based on the hierarchy of needs with the complex chronic 
population receiving full integrative services, the major chronic receiving care-coordination 
services, minor chronic receiving linkage services only and the population without chronic 
conditions receiving health promotion services only (Hewner, Seo, Gothard, & Johnson, 2014; 
Hewner, 2014). Hewner (2014) indicated that as patients were placed in higher complexity 
groups, the previous interventions from the lower complexity groups were added to the 
intervention in higher complexity groups. Therefore, although all four groups received health 
promotion services, only the major chronic condition group and the complex chronic condition 
group received care-coordination services (Hewner, 2014).  
In this model, the PBCT makes the initial call to the patient, identifies their risk and 
refers the patient based on the intensity of services needed (Hewner, 2014). For example, if the 
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patient needs ongoing home health care that has not been previously arranged, the nurse arranged 
for follow-up by the visiting nurse or APN (Hewner, 2014). If the primary problem is complex 
medication regimens, the nurse care coordinator refers the patient to the pharmacist for 
reconciliation and education (Hewner, 2014). Upon discharge from pharmacy services, the 
pharmacist evaluates and refers the patient to the nurse care coordinator or other services based 
on need (Hewner, 2014). In this model, transitional care management nurses made one to four 
calls and one to four home visits to the patient after discharge with those complex patients who 
required more follow-up being referred to other enhanced programs (Hewner, 2014).  
  Hewner et al. (2014) found in their pre-/post-study of 27,890 Medicare patients that the 
inpatient hospitalization rate decreased from 497/1000 high-risk patients (complex chronic 
condition and major chronic conditions groups) in 2008 to 449/1000 in 2009. This was 
equivalent to 2,055 prevented hospitalizations in the two high-risk groups. Hewner (2014) 
equated decreased admissions in the chronic disease groups to a 2009 decrease of $54 per 
member per month cost (from the 2008 cost) with a total reduction of $16,923,708 in one year. 
Unfortunately, Hewner et al. (2014) were unable to interpret the results for 30-, 60-, and 90-day 
readmissions as the hospital did not code this information (Hewner et al., 2014).  
 Systematic reviews of transitional care models. Several systematic reviews were 
conducted to evaluate transitional care models and the interventions associated with each model 
(Hansen, Young, Hinami, Leung, & Williams, 2011; Kansagara et al., 2016; Verhaegh et al., 
2014). 
In a systematic review of interventions to reduce hospital readmissions, Hansen et al. 
(2011) found that most of the 43 hospital-based interventional studies reviewed (60.3%) were 
unable to account for admissions to other institutions and estimated that this failure could miss 
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about 20% of hospitalizations indicating a potentially significant error in the evidence provided. 
They found that bundled interventions like the TCM and CTI tended to be the most successful 
interventions (Hansen et al., 2011). There were only seven single intervention RCT studies, with 
only one reaching statistical significance (Intervention = early discharge planning) (Absolute 
Risk Reduction 11.0%, p < .05) (Hansen et al., 2011). They surmised that studies that used 
bundled interventions might have a cumulative effect since single interventions like discharge 
planning, discharge education, and discharge phone calls alone were generally unsuccessful 
(Hansen et al., 2011). Furthermore, Hansen et al. (2011) did find that when interventions were 
bundled together with other interventions as in CTI and TCM, the combination of multi-faceted 
interventions like care-coordination did prove successful.  
Another systematic review of transitional care studies demonstrated mixed results 
(Verhaegh et al., 2014). Verhaegh et al (2014), evaluated 26 random control trials of transitional 
care interventions and found that less than half (10) evaluated short-term 30-day readmissions 
with more focusing on longer admission periods: 18 studies included intermediate (31-180 days) 
and 7 long-term (181-365 days) admission rates. Furthermore, most of the interventions that had 
a positive effect on readmission and admission rates in all three time periods provided care-
coordination (Verhaegh et al., 2014). These studies focused on heart failure, COPD, asthma or 
general internal medicine or surgical patient populations (Verhaegh et al., 2014). They also 
found that the most successful studies included high intensity transitional care in elderly 
populations (age > 60) (Verhaegh et al., 2014).  
Kansagara et al.’s (2016) systematic review of previous systematic reviews of transitional 
care interventions found that interventions that included discharge planning from the hospital to 
post-hospital timeframe, that were flexible and individualized were most successful. However, 
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they also found the strength of the evidence low due to the heterogeneity of the interventions, 
populations, clinical settings, and implementation strategies (Kansagara et al., 2016). They did 
find that the most robust interventions, including nurse-provided discharge planning and care 
coordination, provided the greatest benefit in reduced readmissions (Kansagara et al., 2016). This 
demonstrates that transitional care with nurse-led care coordination is effective in decreasing 
hospital readmissions and admissions for up to one year post-discharge.  
Care Coordination Models in the 21
st
 Century 
 This section will review the research on care coordination models from the 21
st
 century 
including the Medicare-Coordinated Care Demonstration Projects, the Physician Group 
Demonstration Project, and case management and nursing care-coordination.  
Medicare-coordinated care demonstration projects. The Balanced Budget Act of 1997 
mandated the Secretary of Health and Human Services to conduct large random control trials on 
care-coordination in the chronically ill Medicare fee-for-service population (CMS.gov, 2017). 
The purpose was to determine if care-coordination could improve quality of care without 
increasing cost (CMS.gov, 2017). Therefore, in 2001, the government funded 15 Medicare-
Coordinated Care Demonstration (MCCD) sites providing care-coordination services with the 
goal of finding an economically feasible solution to America’s highly fragmented decentralized 
system that rewards providers for delivering care but not for coordinating care (Nelson, 2012b).  
However, findings from these demonstration projects did not show savings to offset costs 
(Nelson, 2012a; Nelson, 2012b). In fact, among the 15 MCCD random control trials funded, 
CMS found only two demonstrated a significant change on the number of hospitalizations (p < 
.05) and no significant reduction on overall general Medicare expenses, excluding the cost of the 
care-coordination project itself (Peikes, Chen, Schore, & Brown, 2009). Of the two with 
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significant effects on hospitalizations, Mercy had 0.168 fewer hospitalizations per person per 
year (17% less than the control group mean, p = .02) and Charlestown had 0.118 more per person 
hospitalizations per year (19% more than the control group, p = .04) (Peikes et al., 2009). In 
addition, two programs, Health Quality Partners and Mercy Medical Center, demonstrated a 
substantial, albeit not significant, decrease in treatment group expenditures compared to the 
control group (Peikes et al., 2009).  
In addition to the MCCD, CMS conducted five other large-scale demonstration projects 
on coordinated care (Nelson, 2012a). All of these demonstration projects primarily involved 
care- coordination telephonic interventions with fewer face-to-face interventions. In their 
analysis of all six CMS demonstration projects, the CBO found that most of the 34 programs that 
participated in disease management or care-coordination projects were unable to decrease costs 
and increase quality (Nelson, 2012a).  
Findings revealed that although these programs were not budget-neutral, hospital 
admissions were decreased when there was an established face-to-face relationship between the 
patient and the care manager or the care manager collaborated face-to-face with physicians 
(Nelson, 2012a). Increased in-person interaction between the care manager and patients lowered 
hospital admissions by 7% (average) (p = 0.01) and reduced regular Medicare spending by 3% 
(average) (p = 0.10) (Nelson, 2012a). For those programs that included care managers who had 
increased direct interactions with physicians, hospital admissions fell by an average of 7% (p = 
0.09) with regular Medicare spending decreased on average by 6% (p = 0.01) (Nelson, 2012a). 
However, programs that emphasized telephone interaction rather than in-person interaction with 
the patient did not have a significant effect on Medicare spending or hospital admissions 
(Nelson, 2012a).  
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In response to the original findings, several MCCD sites either modified their model to 
include localized care-coordination or continued a focus on localized care-coordination 
interventions to improve outcomes. 
Washington University’s MCCD model. Washington University did demonstrate both 
decreased hospitalizations and cost savings after redesigning the intervention (Peikes, Peterson, 
Brown, Graff, & Lynch, 2012). After the first four years, Washington University replaced long-
distance care managers with local care managers (Peikes et al., 2012). This change meant more 
in-person contact, stronger patient/care manager relationships, and more aggressive transitional 
care with inpatient care manager visits as well as closer follow-up with primary care providers 
(Peikes et al., 2012). In a study comparing patients pre-redesign (N=2,144) to post-redesign 
(N=2,166), hospitalizations were reduced by 11.7% and spending by 9.6%, albeit not statistically 
significant (90% CI = -$250 to $119) (Peikes et al., 2012). However, this savings offset the care 
management fees (Peikes et al., 2012). Finally, when they evaluated only the patients at the 
highest risk for hospitalizations, they found that the results were more dramatic with 17.0% 
fewer hospitalizations and decreased monthly Medicare spending by 14.8% with a total savings 
of 9.7% or $286 per patient per month after deducting the cost of the care management 
intervention (Peikes et al., 2012).  
The change in method of care-coordination from off-site to in-person, face-to-face visits 
in combination with telephone visits increased the opportunity to build trusting relationships 
(Peikes et al., 2012). By maintaining close communication with the primary clinic and in-person 
visits with the patient, this study demonstrated the potential of care-coordination services to 
decrease hospitalizations and Medicare expenses in both the general population and a high-risk 
population (Peikes et al., 2012).  
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Mercy Medical Center MCCD model. This model used care coordination as a method of 
changing patient behavior and providing coordination across all providers rather than focusing 
only on physician practice (Burwell, 2014). Nurse care coordinators (NCC) met with patients 
and their caregivers face-to-face initially and monthly for at least the first year with intermittent 
phone communication as needed. This built a trusting relationship and promoted adherence to 
treatment plans (Burwell, 2014). NCCs provided education about chronic conditions and 
preventive care and served as the communication hub for the patient and providers (Burwell, 
2014). 
In a RCT of 1,392 patients (696 randomized to control and 696 randomized to treatment 
by the outside evaluator Mathematica), Mercy reduced hospitalizations by 9.8% (p = 0.07) while 
increasing costs by 10.3% (program fees included) (p = 0.08) (Burwell, 2014). The high-risk 
participants (n = 1050) (those with congestive heart failure, coronary artery disease or COPD, 
and a hospitalization in the year prior to participation) demonstrated a 14.4% reduction in 
hospitalizations (p = 0.02) (Burwell, 2014). However, this high-risk group had a 3.5% increase in 
cost (program fees included) (p = 0.62) (Burwell, 2014). Neither the full cohort nor the high-risk 
group had an impact on quality of care measures (immunization rates or recommended 
monitoring for disease-specific care like glucose testing) other than podiatry visits. There was a 
statistically significant increase in podiatry visits for patients with diabetes (Schore, Peikes, 
Peterson, Gerolamo, & Brown, 2011). However, disease-specific quality measures were 
underpowered and may not have been able to detect a difference in quality (Schore et al., 2011). 
There was no difference in two-year survival after enrollment (Burwell, 2014). Consequently, 
although this model significantly reduced hospital admissions in the highest risk group, it did not 
demonstrate significant cost reduction in any group (Burwell, 2014). 
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Health Quality Partners (HQP) MCCD model. The Health Quality Partners, under the 
Healthcare Cost and Utilization Project (HCUP), had a nurse-led care-coordination model similar 
to the Mercy Medical Center Model, in which the aim was to change patient behavior rather than 
physician practice (Burwell, 2014). Nurses initially worked on building a relationship with the 
patient and caregiver followed by improving self-management (Burwell, 2014). In the first year 
of the demonstration project, the nurse case manager met both monthly with patients and 
caregivers and contacted patients by phone (Burwell, 2014). Finally, NCM served as the 
“communication hub” for all members of the team (Burwell, 2014).  
Due to early success, HQP was afforded several extensions to their RCT (Burwell, 2014). 
HQP had demonstrated a 17 % reduction in hospitalizations with no additional Medicare costs 
between 2002-2012 (Burwell, 2014). However, after the extension for high-risk patients from 
2011–2014, the intervention no longer had an effect on hospitalizations, ED visits or cost 
reduction (Peterson, Zurovac, Mutti, Stepanczuk, & Brown, 2015). In fact, total Medicare 
expenditures increased by 16% (Peterson et al., 2015). Post hoc analysis revealed that the most 
likely explanation for this phenomenon was improvements in usual care since both transitional 
care was being offered by affiliated hospitals and patient centered medical homes were being 
established (Peterson et al., 2015). In the post hoc analysis, Peterson et al. (2015) found that 
there was no change in hospitalization rates pre-extension to post-extension but that the usual 
care hospitalization rate was 34% lower (p = 0.009) in the post-extension compared to the pre-
extension. There was no difference in ED visits between the pre- and post- extension period for 
the control group, and the treatment group’s ED visit rate increased significantly from pre- to 
post- extension (p < 0.001), which does not support the theory that usual care improved during 
this time period (Peterson et al., 2015). It is possible that changes afforded by the latest evidence 
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in medical research and new medications had also improved standard care since the initiation of 
HQP’s RCT in 2001 (Peterson et al., 2015). For these reasons, Peterson et al. (2015) indicated 
that the current HQP program was unlikely to sustain success in the current changing healthcare 
environment.  
MCCD quality measures. The Medicare-Coordinated Care Demonstration sites (Mercy 
Medical Center and Health Quality Partners Models) did also measure some diabetes-related 
quality-of-care variables including influenza immunizations, eye exams and frequency of A1C 
blood tests (Schore et al., 2011). They found that for Health Quality Partners care-coordination 
model had a statistically significant (p < 0.1) improvement in influenza and pneumococcal 
vaccinations but no effect on eye examinations or frequency of A1C blood tests (Schore et al., 
2011). Mercy Medical Center's care-coordination project had no effect on any of these three 
quality-of-care measures but did have a statistically significant improvement in podiatry 
examinations (p < 0.1) (Schore et al., 2011).  
Physician Group Demonstration Project: Value-based payment. The Physician 
Group Demonstration Project was a legislative mandate designed to determine if value-based 
payments could save Medicare funds while increasing process and outcome quality measures 
(Kautter et al., 2012; Nelson, 2012b). The Physician Group Demonstration Project included 10 
Physician Group Practices of varying sizes from 292 physicians to 1,291 physicians (Kautter et 
al., 2012; Nelson, 2012b). Physicians received bonus payments if they could demonstrate that 
Medicare expenses were at least 2% below the expected target (based on risk) with any 
additional expenses for other providers, hospitalizations, etc., included in Medicare expenses 
(Kautter et al., 2012; Nelson, 2012b). Although each group was given much autonomy to 
determine how to add value and save cost, and many different interventions were provided, all 
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ten physician groups provided nurse-led care-coordination in some capacity generally in the form 
of disease management services or care-coordination for certain high-risk patient groups (e.g. 
CHF, diabetes) (Kautter et al., 2012; Nelson, 2012c).  
The Physician Group Project also measured quality measures including hgb A1C > 9.0%, 
Blood pressure < 140/90, eye exams and influenza vaccinations (Kautter et al., 2012; Nelson, 
2012b). The Physician Group Project sites were rewarded financially for meeting these along 
with a number of other quality goals (Kautter et al., 2012; Nelson, 2012b). Data was provided for 
annual eye examinations which indicated a statistically significant improvement over the 5 years 
(Difference in difference 1.52%, p < 0.01) but did not reach significance in the first two years 
even at the 1% level (difference in difference 0.4%) (Kautter et al., 2012; Department of Health 
& Human Services, 2009). However, more data is reported at the end of the study (year 5) and 
there was significant variability in the sites when they evaluated each site individually. Seven of 
the sites showed eye examination rates with a statistically significant difference between the 
control clinic and the intervention clinic but two significantly improved in the control group (p < 
0.001) and 5 improved in the intervention clinic (p < 0.01 in 4 sites and p < 0.001 in 1 site) 
(Kautter et al., 2012).  
Unfortunately, for A1C ≤ 9, blood pressure < 140/90, and influenza examinations, the 
data for the control sites was not reported since it was not included in Medicare claims data, and, 
therefore, only the annual percent changes at each intervention site for these variables were 
included. However, since each of the ten sites had complete autonomy in identifying strategies 
for quality and savings, it was not possible to evaluate the individual contribution of nursing 
care-coordination (Kautter et al., 2012).  
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The Physician Group Demonstration Project had reimbursement tied to 10 quality 
measures including annual eye examinations, annual influenza immunizations for those with 
diabetes over age 50, b/p < 140/90, and A1C ≤ 9 (Department of Health and Human Services, 
2009). Although they found an increase in the overall percent of patients achieving these quality 
measures over the 5 years with results per site generally positive, the results were not always 
positive despite linking reimbursement to the quality measures. Since the control groups were 
reporting only on measures that could be electronically retrieved from the billing data, it was not 
always possible to determine whether these results were statistically significant in comparison to 
standard care. Finally, findings must be viewed cautiously as the control sites were not aware 
their data was being analyzed and the intervention sites were not only aware but were receiving 
financial incentives for improvement (Department of Health and Human Services, 2009).  
Case management. The Case Management Society of America defines case 
management as “a collaborative process of assessment, planning, facilitation and advocacy for 
options and services to meet an individual’s health needs through communication and available 
resources to promote quality cost-effective outcomes” (Case Management Society of America 
(CMSA), 2015). According to the Medical Surgical Nursing Certification Board (MSNCB) 
(2018), care-coordination and transition management are umbrella terms for care practice roles 
that provide "individualized patient-centered assessment and care planning across settings, 
providers and levels of care." This role includes many different titles including "care coordinator, 
care manager, nurse navigator and case manager" as well as others (Medical Surgical Nursing 
Certification Board, 2018). According to a review by Joo and Huber (2018), the key ingredient to 
case management is care-coordination (Joo & Huber, 2018). Case managers are members of the 
care-coordination team who often provide the one-on-one services of care-coordination, liaison 
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with other team members, and self-care promotion activities with the individual patient and 
family. According to a study by Park and Huber (2009), 93.3% of case managers in the US are 
registered nurses (Park & Huber, 2009). 
 Current models of case management (CM) have begun to focus on preventing 
hospitalizations, rather than focusing on preventing 30-day readmissions. These models 
identified high-risk patient populations to improve health and healthcare quality. Case 
management models focus on monitoring and addressing patients' needs across the life span.  
Case management models improve blood sugar control. Research indicates that these 
nurse case management models improved glucose management in the Type 2 diabetes population 
(Mullen & Kelley, 2006). In their retrospective study, Mullen and Kelley extracted medical 
record data from a previously unpublished CM intervention study of 52 adult patients (29-80) 
with diabetes who had completed the case management intervention with an A1C ≤ 7.0. The 
unpublished results of this CM intervention by Serwer, Escobedo, Kelley and Shimeall as cited 
by Mullen and Kelley (2006) found a mean decrease in A1C of 2.6% (from 10.4% to 7.8% 
during the program). The length of this case management program was unclear but case 
management involved an initial assessment in a multidisciplinary clinic followed by nurse case 
manager weekly calls for 12 weeks, monthly calls for 3 months and then quarterly calls. Based 
on health status, the nurse case manager could decide to return the patient to weekly supervision 
at any time. These patients also attended a diabetes education class and attended the diabetes care 
clinic which included a foot exam, dietitian-provided education, pharmacist review of 
medication for those with more than 5 medications, and a primary care provider visit with 
continued follow-up.  
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 From this CM program, Mullen and Kelley (2006) evaluated 19 patients’ medical records 
who started the CM intervention with a baseline A1C ≥ 8.0% and had successfully finished the 
diabetes CM program with an A1C value of ≤ 7.0%. They found not only the expected 
significant changes in the A1C value between the beginning of the study and completion of the 
study (specific length of time unspecified) (p < .001) but also a sustained change between the 
beginning of the study and six months following completion (p < .001) (Mullen & Kelley, 2006). 
However, only 19 patients of the potential 53 eligible patients had complete data for all data 
points and therefore a major limitation is the rejection of data from over half the patients who did 
not have complete data in this retrospective study. No description of the differences between 
these two groups is provided. The implication of this study was that case management not only 
improved A1C outcomes but this improvement was maintained after a six-month period without 
continued case management services. 
 Watts and Sood (2016) evaluated a registered nurse case manager program in the 
Veterans Health Administration type 2 diabetes population. They did a quality improvement 
retrospective study of 15,636 patients' computerized record system and evaluated pre- and post- 
data (Watts & Sood, 2016). In this study, the nurse case managers were also certified diabetes 
educators and they evaluated all patients with type 2 diabetes who had an initial nurse case 
manager and at least one follow-up visit over a 10-year period (Watts & Sood, 2016). These case 
managers appeared to work independently within VA patient aligned care team clinics with 
patients with A1C levels > 9% (Watts & Sood, 2016). Patients participated in the quality 
improvement intervention until their blood glucose was stable when they returned to their PCP 
for further management (Watts & Sood, 2016). Patients were followed for 14-26 months and 
using t-tests to compare pre- and post-data demonstrated a significant A1C reduction of 2.1%  
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(p <0.001; CI 1.9885-2.1301) (Watts & Sood, 2016). This study demonstrated the effectiveness 
of nurse case management on diabetes control for patients with uncontrolled type 2 diabetes. 
 C. B. Taylor et al. (2003) compared usual care to nurse CM in which the nurses used 
evidence-based algorithms to titrate medications and provide recommendations for care. Case 
management included an initial 90-minute consultation, weekly group class for 4 weeks and 
phone calls at 4, 5, 8, 12, 16, 20, 28, 36 and 44 weeks with additional calls scheduled as needed 
(C. B. Taylor et al., 2003). Usual care was care provided by their primary care physician along 
with a folder of information on diabetes (C. B. Taylor et al., 2003). Taylor et al. (2003) studied a 
population of 127 patients with Type 2 diabetes and a baseline A1C > 10% who had either 
hyperlipidemia, hypertension or cardiovascular disease (C. B. Taylor et al., 2003). In their RCT, 
they found that more patients in the intervention group (43%) achieved an A1C ≤ 7.5%, (p < 
0.03) with a mean improvement in A1C of 1.14% drop in the intervention group compared to 
0.35% increase in the control group (p = 0.01) (C. B. Taylor et al., 2003). This indicated that 
case management was significantly more effective in improving diabetes control for patients than 
usual care. 
 In 2006, Shojania et al. published a meta-regression analysis of 50 RCTs, 3 quasi-
randomized trials and 13 controlled before and after trials to evaluate the effectiveness of 11 
quality improvement strategies in Type 2 diabetes management on A1C. When they compared 
the mean post-intervention difference in A1C for all 26 studies, they found a -0.42% difference 
(95% CI, -0.29% to -0.54%) (Shojania et al., 2006). Additionally, when they separated the 
studies based on intervention strategies, they found two quality improvement strategies had 
greater statistically significant A1C reductions: a change in the care team and the provision of 
RN case management services (Shojania et al., 2006).  
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The change in the care team was employed by 26 studies with a total average A1C 
reduction of 0.67%; 95% CI, 0.43% to 0.91% (Shojania et al., 2006).  
The change in care team intervention included the following four categories: 
1. addition of a new team member of a discipline other than medicine 
2. addition of more than one new team member or description of multidisciplinary 
3. role of nurse or pharmacist adjusted  
4. description of "shared care" between specialist and PCP (Shojania et al., 2006).  
Teams that included members of other disciplines demonstrated statistically significant 
decreases in A1C post intervention (Shojania et al., 2006). Comparing the 16 studies using 
multidisciplinary team interventions to the 10 studies of team care without multidisciplinary 
team interventions, A1Cs were reduced on average by 0.37% more (p < .001) (Shojania et al., 
2006). This indicates that RN case management and a multi-disciplinary team approach were the 
most effective quality improvement strategies in improving diabetes control for patients with 
diabetes. 
Use of RN case management services was employed by 26 studies with a total average 
A1C reduction of 0.52%; 95% CI 0.31% to 0.73% (Shojania et al., 2006). When comparing the 
26 studies with case management with the 24 studies that did not incorporate case management 
into the intervention, there was an average A1C reduction of 0.22% more (95% CI 0.00% to 
0.44; p = 0.04) (Shojania et al., 2006). Further analysis described case management interventions 
based on four elements: (a) the professional background of the case manager, (b) the relationship 
between the clinic and the case manager, (c) the type of patient contact the case manager 
engaged in, and (d) whether the case manager could make medication adjustments or not 
(Shojania et al., 2006). They found that in the 11 studies where case managers could adjust 
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medications, A1Cs were reduced by 0.96% (mean) (95% CI, 0.52% to 1.41%) compared to 
0.41% (95% CI, 0.20% to 0.62%) in the 15 trials that did not permit case managers to adjust 
medications (Shojania et al., 2006). From their meta-regression, they concluded that although 
most of the 11 quality improvement interventions produced some improvement in A1C, the most 
effective strategies on A1Cs were multidisciplinary team-based care and case management in 
which the case manager used algorithms to adjust medication (Shojania et al., 2006).  
Egginton et al. (2012) performed a systematic review and meta-analysis of care 
management in a diabetes population in the United States, which included 52 studies. In their 
meta-analyses of the 17 studies of diabetes care management interventions that provided 
complete A1C measures, there was a significant difference in A1C means pre- and post- 
intervention (-0.22%; p = 0.02) (Egginton et al., 2012). However due to the significant 
heterogeneity in the studies (including sample characteristics, treatment variations, and the 
quality of the study design), Egginton et al. (2012) were unable to identify a specific intervention 
or team characteristic that was more significant in improving A1C measures.  
Case management effect on other diabetes health outcomes. Results of the effect of CM 
on other health outcomes in the diabetes population is mixed. Gabbay et al. (2006) used a nurse 
CM intervention with the nurse fully integrated in the primary care clinic. In their random 
control trial of 332 patients with type 2 DM (150 intervention and 182 control randomized by 
odd/even numbers), they found that nurse CM improved both health process and health outcome 
measures (Gabbay et al., 2006). Although only the per cent change was reported, they claimed 
statistically significant improved process measures of completed annual ophthalmological exams 
(68% in IG vs. 26% CG), foot exams (64% IG vs. 47% CG), microalbuminuria screening (72% 
IG vs. 34% CG), dietitian visits (53% IG vs. 3% CG), certified diabetes educator visits (70% IG 
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vs. 3% CG), pneumonia vaccinations (50% IG vs. 6% CG), and smoking cessation counseling 
(96% IG vs. 76% CG) (Gabbay et al., 2006). They found significantly improved systolic blood 
pressure (mean systolic blood pressure decreased 9 mm HG (from 137 to 128) at 6 months and 8 
mm (from 137 to129) HG at 12 months, p < 0.001), and diastolic blood pressure (mean decrease 
of 5 mm HG at 6 and 12 months (from 77 to 72), p < 0.001) (Gabbay et al., 2006).  
Gary et al. (2009) used a combined NCM/community health worker (CHW) intervention 
compared to usual care with an added lay educator reminder call for preventive health care 
screening visits. In an RCT study with a sample of 542 low-income urban African American 
adult Type 2 diabetes patients (488 completed the 24-month study, 235 intervention, 253 
control), findings indicated that the NCM/CHW intervention was associated with a statistically 
significant reduction in ER visits (Gary et al., 2009). Specifically, at 24 months there was a 23% 
reduction in ER visits, (adjusted rate ratio (RR), 0.77; 95% CI, 0.59–1.00, p ≤ 0.05%) which 
increased to 34% when comparing those with the most NCM/CHW visits to those with usual 
care (95% CI, 0.43-1.00, p ≤ 0.05%). However, although hospitalizations also decreased, the 
decrease was not significant (Gary et al., 2009). Furthermore, this rate reduction in ER visits was 
greatest when there were more NCM/CHW visits (RD, 31.0% decrease; adjusted RR, 0.66; 95% 
CI, 0.43 to 1.00; adjusted rate reduction 34%; p ≤ 0.05%) (Gary et al., 2009). They also found a 
significant decline in A1C in those with a higher number of CHW/NCM visits vs. the usual care 
group (A1C -0.68%, p = .03), but this did not remain significant after adjustment for baseline 
A1C values, age and amount of time between baseline and final data point (Gary et al., 2009). 
This study demonstrated that the number of touches provided by care management might 
significantly decrease both A1C and ER visits. 
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 Ishani et al. (2011) compared CM provided by a nurse who used an algorithm protocol to 
adjust medication with usual care. In their RCT (randomized based on computerized 
randomization in blocks of six) of 556 patients (278 intervention, 278 control) with Type 2 
diabetes with at least one baseline value above goal (blood pressure > 140/90; LDL cholesterol > 
100 or A1C > 9), findings indicated that the CM group was significantly more likely to achieve 
all three target measures after one year (61 (29%) vs 28 (10.1%) p < 0.01) (Ishani et al., 2011). 
This was also true for individual measures of blood pressure (40.6% intervention group vs. 
15.9% control, p < 0.01) and A1C (40.5% vs 24.6%, p = 0.047) (Ishani et al., 2011). Findings 
supported the use of nurse case management in improving cardiac risk factors in patients with 
diabetes, particularly when the case manager could adjust medications per algorithms (Ishani et 
al., 2011).  
In a population of patients with both Type 2 diabetes and hypertension, Edelman et al. 
(2015) evaluated telephonic nurse CM with focused bimonthly calls (IG) vs. bimonthly calls 
unrelated to diabetes or hypertension (CG) with inconclusive results. In their RCT of 377 
patients with hypertension and diabetes with A1Cs > 7.5% at baseline, eligible patients were 
stratified by clinic and baseline blood pressure control and randomized on a 1:1 ratio to the 
intervention group (n= 193) or the control group (n=184) (Edelman et al., 2015). No difference 
in A1C or blood pressure was found between the two groups despite the fact that this 
intervention had been used to improve blood pressure effectively in an academic center 
(Edelman et al., 2015). However in this study, both groups improved A1C with no improvement 
in systolic blood pressure (Edelman et al., 2015). From these insignificant results, Edelman et al. 
(2015) surmised one of four possible explanations: (a) that the intervention might not translate 
well into a fee-for-service community setting; (b) that the intervention despite literature to the 
73 
 
contrary might not be efficacious; (c) that there was regression to the mean in the usual care 
group; or (d) that the study was underpowered for the effect size. 
 Micklethwaite, Brownson, O’Toole, and Kilpatrick (2012) evaluated a care team program 
(RN/RD team), which was a hospital-based program reaching out to the communities and clinics. 
The care team provided diabetes initial assessments to an underserved population followed by 
case management with face-to-face visits every six to eight weeks as well as patient education, 
and support in the participants’ individual clinic (Micklethwaite, Brownson, O’Toole, & 
Kilpatrick, 2012). This was a pre-/post-study of a subset of 81 participants who had used hospital 
services prior to enrollment (Micklethwaite et al., 2012). The primary outcome was cost 
effectiveness, and Micklethwaite et al. (2012) found that the total cost savings for the program 
was $551/patient per year due to decreased hospital facility use primarily for inpatient but also 
for emergency department and outpatient hospital use. Although they measured pre-/post-BMI, 
blood pressure, cholesterol and A1C for all 81 patients, only A1C significantly decreased from 
8.31 to 7.54 (-0.77, p = 0.0036) (Micklethwaite et al., 2012).  
 AHRQ’s comparative effectiveness review of case management. In 2013 AHRQ 
published a comparative effectiveness review of case management as a strategy for chronic 
illness management. They found that the interventions provided by case managers were based on 
the target population and varied greatly making these studies more difficult to compare (Hickam 
et al., 2013). Consequently, they separated the case management research based on population 
(Hickam et al., 2013). For Type 2 diabetes populations, they found that although case 
management did improve glucose management, it did not improve either lipid or BMI/weight 
management or reduce mortality or hospital utilization (Hickam et al., 2013).  
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 Nurse case management and cost of care. Xing, Goehring and Mancuso (2015) 
evaluated a NCM intervention that included an initial comprehensive assessment, development 
of an individualized action plan, initial face-to-face meeting with both the patient, and PCP to 
refine the action plan—followed by phone or face-to-face meetings with the patient at least 
monthly and updated health action plans every six weeks. In their retrospective comparative 
effectiveness study of high-risk functionally limited Medicaid patients from 2007-2012, they 
used a nearest neighbor propensity score matching for factors including age, race, ethnicity, sex, 
medical risk score etc. to match the 907 CM patients with 907 usual care patients (propensity 
scores < 0.10 after matching) (Xing, Goehring, & Mancuso, 2015). They found that inpatient 
hospital costs were significantly decreased (-$318, p = .01) in the intervention group (Xing et al., 
2015). However, although the case managed group had decreased medical costs of $248 per 
member per month adjusted for program costs, the difference was not significant (p = .09) (Xing 
et al., 2015).  
Nurse care coordination. Snaterse et al., in their 2016 meta-analysis of nursing care- 
coordination (NCC) random control studies in a population with cardiovascular disease, found 
18 random control trials from 1994-2013 that met inclusion criteria with sample sizes that ranged 
from 138 to 2142 participants. In their meta-analysis, they found that NCC significantly lowered 
systolic B/P 2.96 mm Hg, (95% CI 1.53–4.40 mm Hg), LDL cholesterol 0.23 mmol/L, (95% CI 
0.10–0.36 mmol/L), and improved smoking cessation rates by 25% (risk ratio 1.25; 95% CI 
1.08–1.43) (Snaterse et al., 2016). In the nine studies that evaluated weight loss, only one 
demonstrated a statistically significant weight loss of 1 kg (p = 0.007) (Snaterse et al., 2016).  
Snaterse et al. (2016) found it difficult to compare studies as there was no shared 
definition of nurse care-coordination. They also noted that the interventions were often broadly 
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structured over varied time frames making it difficult to pinpoint either the specific elements of 
the intervention or the necessary time frame of these interventions to accurately and fairly 
compare the effect of nurse care-coordination (Snaterse et al., 2016).  
One conclusion is that the effectiveness of care-coordination may differ based on the 
health system. Therefore, it is important to conduct research at each institution to determine if 
that model, or a modification of a care-coordination model, is needed to improve quality, cost 
and satisfaction of health care. This is consistent with the IOM study Best Care at Lower Cost: 
The Path to Continuously Learning Health Care in America in that each health system must be a 
learning community (Committee on Learning Health Care Systems in America & Institute of 
Medicine, 2013; Interprofessional Education Collaborative, 2016). 
Nurse care management. Holtrop et al., (2017) used a matched-pair cluster RCT in 10 
primary care practices in midwestern US to evaluate both patients with DM2 and obesity. Five of 
the clinics were randomly selected to participate in this care management intervention in which a 
nurse joined the clinic and provided care management to all patients with either obesity or 
diabetes type II with A1C> 9% (Holtrop et al., 2017). All patients who participated in the clinics 
and met eligibility criteria were included in the study. Data was extracted from the EHR for the 
year of participation (Holtrop et al., 2017). Patients in the five intervention clinics were matched 
to a similar patient in one of the other 5 control clinics (Holtrop et al., 2017). These patients were 
matched on baseline A1C, LDL levels, systolic blood pressure levels, disease status and initial 
enrollment date (within 3 months) (Holtrop et al., 2017). Since there was some imbalance in the 
two groups despite matching, differences were statistically controlled (Holtrop et al., 2017). 
Findings indicated that in the diabetes group (n=443 pairs), A1C significantly improved to <7% 
(95% CI, 3%-20%) (Holtrop et al., 2017). However, the care management intervention had no 
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effect on weight, systolic blood pressure or LDL cholesterol in type 2 diabetes (Holtrop et al., 
2017). Interestingly, in the obese nondiabetic group (n=253 pairs), the adjusted difference in 
difference in weight was statistically significant with a 3.6% weight decrease (from baseline) 
(95% CI, -5.5, -1.7) (Holtrop et al., 2017).  
Kearns (2017) found no statistically significant difference in any healthcare utilization 
(emergency room visits, hospitalizations (number or length of inpatient stay), urgent care visits 
or readmission rate) in his 3- year randomized cluster trial of a primary care redesign study 
intervention. His study, based on Wagner's Care Model, added certified diabetes educators 
(either nurse or pharmacist) to 5 of 10 randomly selected PCP clinics to manage care for patients 
with diabetes within the clinic (Kearns, 2017). The patients in both the control (9, 988) and 
intervention group (9,708) were located initially through an electronic search of the EHR for all 
patients with any diabetes ICD-coded diagnosis or anyone referred for diabetes education 
(Kearns, 2017). The clinics were randomly selected for either care management or usual care and 
the patients were randomized by the clinic to which they belonged (Kearns, 2017). Each care 
manager (n=3) had an assigned medical assistant, both of whom were embedded in the five 
clinics as team members providing team continuity (Kearns, 2017). Usual care clinics personnel 
were scheduled for the other clinics as needed and did not work exclusively with any particular 
PCP or clinic (Kearns, 2017). Kearns (2017) found no significant change in any healthcare 
utilization after 1 or 2 years of the intervention. However, he stated that the benefits of care 
management may not be in resource utilization but in improving the quality of patient care 
(Kearns, 2017). 
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Collaborative Practice Models 
 The IOM, now the National Academy of Medicine, identified collaboration as a key 
element to improving quality (Institute of Medicine, 2001). This section will focus on the 
research surrounding collaborative practice as a method of achieving improved patient 
engagement, improved healthcare utilization, and clinical outcomes. There is very limited 
research on collaborative care models within the US. However, since it is unlikely that findings 
from other countries with significantly different healthcare systems can be extrapolated to the US 
health system, the data from Belgium's Interdisciplinary Diabetes Care Teams (Borgermans et 
al., 2009), Canada's interdisciplinary nurse navigator intervention (Dajczman et al., 2013), 
Canada's IMPACT clinic (Tracy, Bell, Nickell, Charles, & Upshur, 2013) or Canada's adaptation 
of the TEAMcare model (Johnson et al., 2014) were not included in this literature review. 
 TEAMcare model. This western Washington healthcare redesign program was a 12-
month collaborative care model with physician-supervised nurse care management incorporating 
elements of both the Chronic Care Model and previous studies implementing collaborative care 
for patients with depression (McGregor, Lin, & Katon, 2011). The team included the TEAMcare 
nurse care manager (TCM), primary care provider (PCP), PCP’s care team, and TEAMcare 
consultants (physicians, psychiatrists, and psychologist) (McGregor et al., 2011). TCMs were 
integrated in the clinic they served and received two days of training on motivational 
interviewing, behavioral activation, depression management strategies, and diabetes and heart 
disease management (McGregor et al., 2011). TEAMcare psychiatrists assisted the PCP in 
determining the best antidepressant regimen for each patient in the intervention group 
(McGregor et al., 2011). Initially the TCM saw patients weekly to develop the relationship and 
ensure patient goal progression by providing patient self-management education and support, 
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care-coordination and continuity (W. Katon et al., 2012; W. J. Katon et al., 2010; McGregor et 
al., 2011). Weekly visits were gradually decreased so that by the end of the year, the mean 
number of face-to-face TCM visits was 10 and phone visits was also 10 with the majority of 
face-to-face clinic visits occurring in the first six months (McGregor et al., 2011). TCMs had set 
protocol parameters to transition to maintenance care or relapse prevention based on the patient‘s 
progress to goals (McGregor et al., 2011). In addition, the TCM participated in weekly caseload 
reviews with the consultants who supervised care (McGregor et al., 2011).     
In an RCT (intervention group = 106 and control group = 108), TEAMcare was tested in 
14 Group Health primary care clinics in Washington recruiting a population of 214 patients with 
either poorly-controlled DM2 (A1C ≥ 8.5%) or coronary heart disease (CHD) (systolic B/P > 
140 mm/HG or LDL cholesterol >130 mg/dl) and a depression score ≥ 10 on the patient health 
questionnaire-9 (PHQ-9) (W. J. Katon et al., 2010; McGregor et al., 2011). Findings indicate that 
at 12 months, the intervention group demonstrated statistically significant improvement in the 
outcome composite measure that included the difference in A1C, LDL cholesterol, systolic blood 
pressure and SCL-20 depression score (p < 0.001) (W. J. Katon et al., 2010). However, this 
difference in A1C, LDL cholesterol and systolic blood pressure was not sustained at 24 months 
despite the TCM focus on diabetes and CHD (W. Katon et al., 2012).  
Lin et al.'s (2014) post hoc analysis of the TEAMcare data found that clinical benefits of 
TEAMcare occurred early in the intervention and were most favorable for those with poor 
control of the outcome at baseline. Since Katon et al.’s (2012) inclusion criteria mandated only 
one of three baseline criteria: A1C ≥ 8.5% or systolic B/P > 140 mm/HG or LDL cholesterol 
>130 mg/dl, Lin et al. (2014) divided the groups into “more vs. less favorable control” for each 
of these 3 baseline values (Lin et al., 2014). Despite being underpowered, they found that in the 
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less favorable A1C control group, the A1C remained significantly decreased at 18 months (-0.86, 
p = 0.028) with an insignificant decrease from baseline at 24 months (Lin et al., 2014). This 
indicated that the benefits of a 12-month TEAMcare program for diabetes could last for at least 
an additional 6 months (Lin et al., 2014). They also found that the improvement in systolic B/P 
was for the most part sustained for the 24 months (although not statistically significant) (Lin et 
al., 2014). However, in the groups with more favorable control, there was no difference in 
medical control for A1C or systolic blood pressure (Lin et al., 2014). This indicated that the 
benefit of collaborative care coordination would likely be greatest with patients in less favorable 
control and could last beyond the length of the intervention. 
Buena Salud program. This was an insurance-sponsored 'enhanced primary care model'. 
The multi-disciplinary team added two nurses, two outreach workers and a case manager (all 
bilingual) to the primary care team (Goff et al., 2017). It is unclear whether these team members 
were integrated into the clinic or whether they worked outside the clinic (Goff et al., 2017) . 
Most patients who participated in the self-management program were referred by their PCP 
(Goff et al., 2017). No information on the workflow was provided other than that the team 
members used patient monitoring tools, concentrated on patients with chronic conditions and 
worked to develop trusting relationships with this Hispanic population (Goff et al., 2017). This 
study of the intervention was a retrospective medical record review of 72 patients in the 
intervention and 247 in the matched group (Goff et al., 2017). All patients had type 2 diabetes 
and the match was based on the date the intervention patient started the study with up to 3 
patients matched to each intervention patient (Goff et al., 2017). There were differences in the 
groups in that the control group was older (54 vs 50) with a lower baseline A1C and were less 
likely to have anxiety or depression and more likely to be HIV infected (Goff et al., 2017). 
80 
 
Findings indicated an increase in diastolic blood pressure for the intervention group of 2.6 (95% 
CI = 0.8 – 4.3; p = 0.004) and no significant difference in A1C, systolic blood pressure, 
emergency room visits or hospitalizations (Goff et al., 2017).  
ImPACT model. This VA team model augmented the PACT teams at the VA (Wu, 
Slightam, Wong, Asch, & Zulman, 2018). PACT teams included the PCP, nurse, clinical 
associate and administrative assistant (Wu et al., 2018). The ImPACT model included a nurse 
practitioner, social worker, recreation therapist, administrative coordinator and a supervising 
physician who were co-located in the same clinic to enhance communication and teamwork (Wu 
et al., 2018). These members had weekly meetings to discuss high acuity patients and worked 
with patients for a complete assessment of physical, mental, emotional, and social health (Wu et 
al., 2018). They assisted with goal setting, coordinating care, managing chronic conditions and 
provided transitional care (Wu et al., 2018). They provided 24 hour phone service (Wu et al., 
2018).  
They randomly selected 150 participants for the ImPACT model with standard care being 
the PACT model which the remaining 433 patients received (Wu et al., 2018). Two years after 
starting the ImPACT Model, Wu et al. (2018) evaluated the ImPACT model patients both two 
years pre- and two years post- ImPACT model and compared the ImPACT model patients with 
the RCT patients receiving usual VA care (PACT model). They evaluated continuity of care by 
the number of PCP visits and found a significant increase in both the post data and in the 
ImPACT group over the usual care group (p <0.001) (Wu et al., 2018). They also evaluated 
telephone encounters and missed visits as variables of care access (Wu et al., 2018). Similarly, 
they found significant increases in telephone encounters for the ImPACT group post-intervention 
over the usual care group (p <0.001) but no significant difference in missed visits (Wu et al., 
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2018). They used personal health record (PHR) registration and advanced directive (AD) 
discussion/completion to measure patient engagement and found significant improvement in AD 
discussion or completion (p <0.001) (Wu et al., 2018). Wu et al. (2018) did not report on 
healthcare utilization. Findings indicated that the ImPACT model enhancement to the PACT 
medical home interdisciplinary model improved care continuity, portal registration and AD 
discussion or completion with no improvement in missed visits (Wu et al., 2018).  
Gaps in the Research 
Care-coordination does improve A1C, but it does not improve weight, LDL cholesterol, 
or healthcare utilization in the diabetes population. Care-coordination is most successful in 
higher risk populations. Less is known about how care-coordination works or the essential 
elements of the care-coordination intervention other than, as Hansen et al. (2011) pointed out, it 
appears this intervention is more successful when individual interventions are bundled together.  
Much less research has been done on collaborative care and what the essential elements 
of a successful collaboration look like. In analyzing the literature on care-coordination and 
collaboration, several gaps were identified. The following section will summarize these gaps. 
Gap 1: Little is known about how collaborative care should be integrated into 
healthcare redesign in primary care. Although it is clear that care-coordination and team care 
are effective in improving A1C outcomes in the Type 2 diabetes population, little research has 
been done on what is the best model of care to collaborate and deliver care-coordination. More 
research is needed to evaluate the effectiveness of care-coordination and case management 
within the primary care setting. Primary care provides the on-going relationship and has the 
potential to optimize health and prevent complications. Primary care research is needed to 
identify optimal team membership, the best model of care delivery within the team, and how to 
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measure team effectiveness in terms of patients and patient care outcomes (Haas, Vlasses, & 
Havey, 2016).  
Most of the research on system redesign incorporating interprofessional collaboration and 
care-coordination in primary care has been done in other countries with very different health 
systems or in a large U.S.-managed care system rather than in the general population within the 
primary care clinic.  
Gap 2: Few studies provided a well-defined description of the care-coordination 
intervention. As Popejoy et al. (2015) point out, it is difficult to identify or measure care-
coordination as there is not a well-defined ontology of this concept. Consequently, further 
research to identify and define the specifics of care-coordination interventions especially in 
primary care settings is essential if the goal is to quantify the impact of these interventions 
(Popejoy et al., 2015). Most studies, including the PCMH research, bundled care-coordination 
with other strategies, making an evaluation of the benefits of care-coordination in isolation 
difficult. Consequently, care-coordination interventions need to be very specifically defined so 
that interventions are equivalent and future meta-analyses can be successfully performed. Studies 
that evaluate detailed care-coordination strategies for patient engagement, health-care utilization, 
and health outcomes including patient reported outcomes are needed. Identifying a system of 
specifically quantifying interventions to ensure compatibility is essential to making the data more 
homogeneous and thus easier to interpret.  
Gap 3: Optimal dose of care-coordination. The appropriate dose of care-coordination 
for each patient population needs to be evaluated. Many studies of care-coordination extend the 
intervention over different lengths of time and there have been no identified studies of what is 
the best dose of nurse visits either in the home or in the clinic as well as phone visits to achieve 
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optimal outcomes at the lowest cost. In fact, it is also not clear what the timing of visit and phone 
interventions should be (Meisinger et al., 2013).  
Gap 4: Length of care-coordination intervention. No studies have identified the 
optimal length of time to continue intensive care-coordination services to achieve optimal long-
term results. Mullen and Kelley (2006) found that care-coordination had an effect for a full six 
months after the intervention. It is possible that after an initial exposure to intense care-
coordination, many patients may reap the benefits for some time. It is unclear how much time 
care-coordination is needed.  
Gap 5: Research focused on the effect of care-coordination on patient-reported 
outcomes. Little to no research indicated the effect of care-coordination on patient-reported 
outcomes. This limits the ability to evaluate patient-centered care. As Egginton et al. (2012) 
point out, research that focuses on issues that are important to patients like quality of life, 
symptom improvement, decreased complications, or increased life expectancy—rather than 
surrogate measures like lab values—is needed if patient-centered care is a goal in health system 
redesign.  
Gap 6: Team-based care models. There is little research describing what constitutes an 
effective team or what the make-up of that team should be to achieve the best care.  
Gap 7: Theory-based research. Most studies lacked a theoretical framework. A theory 
would help guide research.  
Gap 8: Electronic health records. If the U.S. healthcare system is truly to become a 
system of learning as the IOM suggests, then a focus for each health system must be to use the 
multitude of data already generated by their unique patient population and patient encounters to 
improve the effectiveness of the care each health system provides (Committee on the Learning 
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Health Care System in America & Institute of Medicine, 2013). As both Burkhart et al. (2016) 
and McMillan et al. (2013) pointed out, there are vast differences in how patients respond based 
on the patients’ culture, history, and the clinic environment itself. However, few studies were 
found that demonstrate how a health system has learned from its own health care data.  
Research gaps addressed. This study will focus on the following gaps (1, 2, 6, 7 and 8) 
indicated above. First it will evaluate a nurse-led, team-based care-coordination model within a 
primary care clinic rather than a hospital or specialty care model (Gaps 1 and 6). Second, by 
specifically defining the model and following a well-researched theory, later comparisons of 
team-based, nurse-led care-coordination for high-risk diabetic patients will be possible (Gaps 2, 
and 7). Finally, it will provide a strategy for using secondary patient data from the EHR to 
improve primary care offered to patients within a health system (Gap 8).  
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CHAPTER THREE 
METHOD 
The purpose of this research study was to compare the effectiveness of a new model of 
care in ambulatory primary care practice, a nurse-led interprofessional care-coordinated 
collaborative team approach (ICCCM) with standard ambulatory primary care practice. This 
study was part of the Interprofessional-Collaborative Redesign and Evaluation for Population 
Access to Health (I-Care-PATH), funded by the Health Resources and Services Administration 
(HRSA #UD7HP26040, PI-Vlasses). Nurse-led interprofessional collaborative practice teams 
were developed within a family practice clinic to provide optimal healthcare to residents of a 
low-income, diverse community as well as to provide interprofessional learning opportunities to 
students in healthcare professions.  
This chapter presents the study design, sampling criteria, variables studied and data 
collection methods used for this comparative effectiveness research study. The overall aim of 
this research study was to measure the effectiveness of a nurse-led interprofessional team in 
primary care on (a) patient engagement, (b) health care utilization, and (c) clinical indicators of 
high-risk patients with Type 2 diabetes in a low-income, diverse urban setting. Effectiveness was 
measured pre/post within the ICCCM site and in comparison to similar patients who received 
standard primary care in the same health system. To address this overall aim, the following 
hypotheses were addressed: 
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 H1a: Adult patients with Type 2 diabetes had better patient engagement (number of 
missed visits (no show encounters/same day cancellations), annual influenza 
immunizations, and annual eye examinations) after one year's participation in the ICCCM 
model in comparison to one year prior to participation in the ICCCM model. 
 H1b: Adult patients with Type 2 diabetes, who received care at the ICCCM (intervention) 
site, had better patient engagement (number of missed visits (no show encounters/same 
day cancellations), annual influenza immunizations, and annual eye examinations) after 
one year than a sample of matched patients with Type 2 diabetes who received standard 
primary care within the same health system over that same year. 
 H2a: Adult patients with Type 2 diabetes had better health care utilization (fewer 
hospitalizations, fewer hospital days, and fewer emergency room visits) after one year's 
participation in the ICCCM model in comparison to one year prior to participation in the 
ICCCM model. 
 H2b: Adult patients with Type 2 diabetes who received care at the ICCCM (intervention) 
site had better health care utilization (fewer hospitalizations, fewer hospital days, and 
fewer emergency room visits) after one year than a sample of matched patients with Type 
2 diabetes who received standard primary care within the same health system over that 
same year. 
 H3a: Adult patients with Type 2 diabetes had better clinical indicators (percent of 
patients with Hgb A1C levels > 9.0; change and difference in Hgb A1C, weight, and 
systolic and diastolic blood pressure, systolic blood pressure < 140, diastolic blood 
pressure < 90) after one year's participation in the ICCCM model in comparison to one 
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year prior to participation in the ICCCM model. 
 H3b: Adult patients with Type 2 diabetes who received care at the ICCCM (intervention) 
site will have better clinical indicators (percent of patients with Hgb A1C levels > 9.0; 
change in Hgb A1C, weight, and systolic and diastolic blood pressure, systolic blood 
pressure < 140, diastolic blood pressure < 90) for one year than a sample of matched 
patients with Type 2 diabetes who received standard primary care within the same health 
system over that same year. 
Study Design 
 This study used a retrospective, longitudinal, matched design employing secondary data. 
It was retrospective in that the data were extracted from the EHR from June 2013 through June 
2016. The data were longitudinal in that the data points were extracted at three different time 
points from June 2013 to June 2016. It was a matched comparison in that participants in the 
treatment group were matched using propensity scores to control for confounding variables of 
age, gender, race, insurance, baseline A1C, and comorbidities. It was a study using secondary 
data in that the data were already collected for another purpose and then were extracted based on 
specified data extraction rules (see Table 3, Data Extraction Rules for Sample #3 and Table 4, 
Dependent Variable Data Extraction Rules). The research design framework is presented in 
Figure 4, which describes the treatment group that received the ICCCM model of care and the 
standard model of care. Figures 5 and 6 provide the design schematic and the design notation. 
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Figure 5. Research design schematic 
Treatment Group: 
 
 
Comparison Group: 
 
 
  Time 2                                             Time1                                                                          Time 3 
Figure 6. Research design notation 
 
 
 
 
 
Human Subjects Protection 
 Data were extracted by a research analyst in the health system into tables based on the 
data extraction rules (See Data Extraction Tables 3 and 4). The data were stored on a protected 
server provided by the Institutional Review Board (IRB). The health system Institutional Review 
Board approved this study through expedited review in August of 2017 and reapproved this 
study in August of 2018. 
Sample 
Consistent with Wagner’s The Care Model, the sample will be described in terms of the 
community, health system and individual participants.  
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Community. The community served is a large Midwestern city and its surrounding 
counties. In 2013, the community in which the ICCCM clinic was located had an estimated 
median household income of $41,794 and a median resident age of 35.1 years (City-Data, 2016). 
For community citizens aged 25 and over, 76.7% had at least a high school education and 15.5% 
had a bachelor’s degree or higher (City-Data, 2016). Approximately 75% were black and 53.4% 
were female (City-Data, 2016). The community in which the satellite clinic was located, had an 
estimated median household income of $57,823 and a median resident age of 40.3 years (City-
Data, 2017). For community citizens age 25 and over, 85.8% had at least a high school education 
with 25.8% having a bachelor’s degree or higher (City-Data, 2017). Approximately 65.5% were 
white, 27.1% were Hispanic, and only 1.9% were black with 52.6% being female (City-Data, 
2017).   
The community in which each of the other clinics are located are all within the large 
Midwestern city or the surrounding counties. These clinics vary in median household income, 
median resident age, educational level, race and sex. Consequently, rather than matching clinics, 
participants were propensity matched (See Matched Sample). 
Diabetes, hypertension, obesity and hypercholesterolemia were among the top health 
problems identified by respondents on the health needs assessment survey (Loyola University 
Health System, 2013a). This report also demonstrated that there are substantial disparities in 
unemployment rates, educational levels and socioeconomic status as well as health status in this 
population (Loyola University Health System, 2013a). The respondents surveyed identified the 
following barriers to health: decreased access to preventive and specialty care, coordination of 
healthcare, nutritional education, healthy food desserts, few safe places to play, and economic 
instability (Loyola University Health System, 2013a). 
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 Health system. This health system provided primary care to a six-county metropolitan 
area in the Midwest (Loyola University Health System, 2013b). This large Jesuit academic 
medical center had 29 clinic locations throughout this metropolitan area. Of these clinics, 15 
were primary care clinics. 
ICCCM clinic sites. The ICCCM clinic was a family practice medicine clinic with one 
satellite clinic in a large Midwestern collar county community. These primary practice clinics 
provided care to patients of all ages by 13 family medicine physicians, one internal medicine 
physician, and two nurse practitioners (personal communication, Sandra Brehm, Director & 
Clinic Manager, 5/4/2017). These two clinics provided primary care to patients in high-need 
geographic community areas.  
Patient Sample 
The initial intervention sample was a convenience sample of patients with Type 2 
diabetes from both intervention clinics who participated in the I-CARE-PATH model of care. 
The comparison group was comprised of propensity score matched patients with Type 2 diabetes 
from one of the 13 comparison primary care clinics within this academic medical center. 
Inclusion criteria for the ICCCM intervention were adult (> 18) patients with type II 
diabetes who were active patients of one of the two intervention clinics who had been identified 
by the nurse care coordinators. The nurse care coordinators identified eligible patients by 
searching the Phytel database, a population management software tool, for all patients with Type 
2 diabetes in these two clinics whose last A1C was between 8–10. Patients with an A1C greater 
than 10 were eligible to participate in the ICCCM only if they expressed a desire to manage their 
diabetes or were recommended by their primary care physician. In addition, primary care 
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physicians identified patients that they felt would benefit from care coordination (called a “gut 
check”).  
Intervention participants for this study included the ICCCM patients. These were 
identified as patients assigned and actively followed by care coordinators, with a start date (T1) 
identified by the care-coordination entry into the problem list. An additional inclusion criterion 
was a diagnosis of type 2 diabetes for over one year prior to the T1 date; that is, prior to the T2 
date.   
Exclusion criteria for the intervention group were those patients with Type 2 diabetes 
who either did not have care-coordination entered into the problem list, were newly diagnosed 
with type 2 diabetes at T2 or after T2, expired prior to T3, dropped from the study prior to T3, or 
were pregnant the year prior to or during the care-coordination intervention (June 2013–June 
2016). If care coordination was not entered in the problem list, no T1 date could be identified so 
these intervention patients were excluded. Pregnancy was an exclusion since A1C levels can be 
inaccurate due to the increased red blood cell turnover pregnant women experience, therefore 
patients who are pregnant rely more on glucose testing than A1C levels (American Diabetes 
Association [ADA], 2016). All patients provided from the available care coordinators list who 
met inclusion and exclusion criteria were included in the intervention group in this study 
(n=204). 
Matched patients had to meet the same inclusion/exclusion criteria. However, they also 
had to be seen by either a family practice or internal medicine primary care physician within one 
of the 13 comparison clinics during the same period of time as their matched intervention 
counterpart (June 2014-June 2016). Therefore, matched patients were also excluded if they did 
not have a primary care physician within the health care system for the period from T1 to T3, 
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had expired prior to the T3 date, or were newly diagnosed or diagnosed after the matched T1 
date. Potential match's medical records (n = 371) were reviewed to ensure that they had a 
primary care physician contact within 6 months of T1 and T3 and to ensure that they were not 
pregnant during this time (see matched control sample Chapter 4). Potential matches were not 
excluded if they had missing data elements. 
Matched Sample 
Each participant was propensity-score-matched to a comparison participant to optimize 
the sample while ensuring a representative sample (Lanehart et al., 2012; Lanza, Moore, & 
Butera, 2013). A determination of the best possible match for each of the Type 2 diabetic 
intervention patients was made by statistically evaluating gender, race, ethnicity, language, age 
(Xing et al., 2015), insurance coverage (Medicare, Medicaid, private insurance payer, 
uninsured/self-pay as primary payer of services) (Jack et al., 2009), baseline A1C, and 
comorbidities based on the Charlson Comorbidity index diagnoses (D’Hoore, Sicotte, & Tilquin, 
1993; Xing et al., 2015). In addition, it was determined that an estimate of the number of years 
since diagnosed with diabetes could be extracted from the administrative data, therefore this was 
also included in the match. Race and insurance coverage were matched to control for 
socioeconomic status. The insurance coverage match used the categories of Medicare, Medicaid, 
private insurance payer, uninsured/self-pay as primary payer of services (Jack et al., 2009). Since 
it is easier to achieve a greater reduction in A1Cs that are higher at baseline making regression to 
the mean a study limitation, baseline A1Cs were matched (The California Medi-Cal Type 2 
Diabetes Study Group, 2004). Since the severity of chronic conditions increases over time, age 
was matched. Comorbidity was matched using the Charlson Comorbidity Index diagnoses using 
ICD-9 codes (D’Hoore et al., 1993) individually (rather than the index number). Specifically, 
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patients were matched for the following ICD-9 code diagnoses: cancer, metastases, dementia, 
cerebrovascular disease, diabetes with chronic complications, HIV, peptic ulcer disease, 
rheumatic disease, renal disease, liver disease either mild or moderate/severe, myocardial 
infarction, hemiplegia or paraplegia, chronic pulmonary disease and peripheral vascular disease 
using the algorithms described by Quan, et al. in 2005. Although only 4 patients in the 
intervention group required a translator, language was matched based on English verses non-
English speaking as the primary language.  
Data Sources 
Data for this study were collected at all clinics and entered in the electronic medical 
record by the patient care tech (PCT), medical assistant (MA), licensed practical nurse (LPN), 
registered nurse (RN), and/or physician or administrative desk staff (service representative). 
EpicCare (Epic Systems, Verona, WI) is a common electronic health record system that began in 
the ambulatory clinic setting of this academic medical center in 2004. All of the clinics had been 
using Epic successfully since 2004 to document all patient care services provided and for 
decision support purposes. Epic is a robust electronic health record relational database used for 
data entry at the point of service. Epic manages clinical data (entered at the point of care by the 
appropriate provider), financial administrative data (entered by administrative personnel), and 
healthcare encounter information (entered by both administrative personnel and service 
associates). Data from the Epic EHR is downloaded daily into Clarity (Clarity Software, United 
Kingdom), a business management software tool, and Phytel (IBM Phytel, United States),  a 
population management software tool. The care coordinators used Phytel to extract patient 
information related to primary care. Phytel provided the data (care history, relevant lab data, and 
care needs based on protocols; e.g., screenings) that the care coordinator used for decision 
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support. The Epic data were further downloaded into the data warehouse where it was extracted 
by the data analyst using data extraction rules (See Data Extraction Tables 3 and 4). 
Research Study Variables 
 In this study, the intervention, or ICCCM, was the independent variable while the 
dependent variables were the patient engagement indicators (missed visits (no show 
encounters/same day cancellations), influenza immunizations, and annual eye examinations); 
healthcare utilization indicators (number and length of hospitalizations, number of emergency 
room visits); and the clinical indicators (Hgb A1C, weight, systolic and diastolic blood pressure). 
Each will be defined below. 
Independent variable: ICCCM intervention. The ICCCM was a primary care, nurse-
led interprofessional collaborative care-coordinated team model of care. Key characteristics 
included location of team members in the same clinic for convenient, daily communication; an 
equal voice in decisions for all team members; and the opportunity for all team members to help 
plan and improve the model. Three interprofessional collaborative practice teams were created, 
and each team included a nurse care coordinator, social worker, dietitian, and primary care 
physician. Since each clinic housed all employed team members including the primary care 
physician, each patient had all his/her care needs met at one time in the same clinic and team 
members communicated concerns daily with other team members. The patient population 
targeted was patients with Type 2 diabetes with high A1C levels (≥ 8.0 and < 10). Patients who 
met criteria were assigned a team.  
Model development. A number of steps were taken to develop the interprofessional 
collaborative teams within this primary care clinic. These incremental steps were documented as 
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they occurred in the I-CARE-PATH meeting minutes. The following is a description of those 
steps taken in designing the intervention (Burkhart, et al., 2019).  
Step 1. Develop a leadership team. This team included key leadership members from the 
schools, the clinic and the health system. Key members of this team were the health system 
upper management, Principle Investigator of the grant, Dean, and attorneys. This leadership team 
created the infrastructure and policy to link the health system and school initiatives. Key 
activities of the leadership team included contract negotiation and developing job descriptions. 
Step 2. Create transformational teams including key members of the school, clinic, 
information technology department, and health system. This transformational team facilitated the 
system redesign by providing process evaluation and redesign, general oversight of the care 
redesign in the clinics, troubleshooting problems, and identifying opportunities to integrate the 
processes between the health system and the University schools/programs. 
Step 3. Create interprofessional teams at the two clinics. Members of this team included 
providers and staff at the clinics, registered nurses, social worker, dietitian, physician, 
psychologist, licensed practical nurses, medical assistants, patient care technicians, desk staff, 
office manager, and clinic coordinator. The key activities of this team included participating in 
interprofessional training and providing feedback to further develop training materials. 
Step 4. Identify the patient population to be care-coordinated. A phase-in system was 
used that began with the identification of Type 2 diabetic patients with A1Cs either between 8-10 
or those with A1Cs > 10 who were motivated to manage their diabetes. A population 
management software linked to the electronic health record was used to identify current patients 
meeting the A1C criteria. In addition, patients who might benefit from care-coordination were 
identified by their clinic primary care provider. This was called the “gut-check.” 
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Step 5. Create patient panels for each interprofessional team (registered nurse care 
coordinator (RNCC), nurse practitioner care coordinator (NPCC), physician, social worker (SW), 
and dietitian (RD)). These interprofessional teams met monthly. 
Step 6. Develop and establish multiple patient communication strategies. These 
communication strategies included telephone encounters, face-to-face meetings, group visits and 
group workshops. Telephone encounters were used to establish or strengthen relationships, 
coordinate care, and foster patient accountability and empowerment. Specifically, telephone 
encounters were used for touching base, following up on medication changes or, prescription 
refills, and ordering supplies.  
Face-to-face meetings occurred during clinic visits to maximize the time the patient was 
in the clinic. These meetings were individualized based on patient needs and could include the 
social worker, dietitian and/or care coordinator as needed. Similarly, group visits made use of the 
time the patient was in the clinic. At these clinic visits, based on patient needs, a team member 
might join the physician during the visit or schedule a visit immediately after the physician clinic 
visit. 
Group workshops were provided as outreach workshops for groups of patients to provide 
diabetes education, meal planning, and smoking cessation support. Patients could sign up for a 
single specific workshop or for a class series. Finally, support groups were offered to help 
empower patients to support each other in integrating healthy behaviors into their lives.  
Step 7. Develop and follow a process for patient outreach for care-coordination. This 
included developing and following a process for initial contact/recruitment, on-going contact and 
discharge from care-coordination. Communication and care plans were individualized based on 
patient needs. This workflow included a process for adding patients to the care-coordination 
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worklist, removing patients from the care-coordination worklist, and telephone scripts for 
telephone communication. 
Step 8. Establish monthly multidisciplinary care-coordination team meetings including 
the care coordinator, physician, social worker and dietitian. These teams met to review patient 
care plans for a select group of patients (approximately five each for both the RNCC and the 
NPCC). The RNCC and NPCC selected the patients to be discussed based on patient selection 
guidelines. The care coordinator maintained a multi-team meeting spreadsheet with the latest 
patient data (last and next appointments, last A1C, last lipid profile, statin dose/name as 
applicable, last microalbumin, names and doses of angiotensin-converting enzyme inhibitor 
(ACE) and angiotensin II receptor blockers (ARB), as well as any other important lab values). 
The Better Outcomes for Older adults Through Safe Transitions (Boost) tool was used to guide 
these monthly care-coordination meetings, as the tool incorporates medical, social and 
environmental determinants of health associated with hospital readmission (Society of Hospital 
Medicine, 2016). These include needs associated with medications, psychological issues, 
principal diagnosis of diabetes and other chronic conditions, physical limitations, health literacy, 
support system, prior hospitalizations, and palliative care (Society of Hospital Medicine, 2016). 
These meetings provided an opportunity for the healthcare team to review and optimize patient 
care plans, which were discussed and aligned with the patient’s health goals at the subsequent 
appointment. The team discussed each case and concurrently documented care planning during 
these meetings. An EHR screen was developed by the nurse informaticist to guide meeting 
workflow and document assessments and care plans. In addition, a timekeeper ensured that time 
was used wisely with six minutes per patient allotted for the discussion.  
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Step 9. Establish daily communication patterns within the team. At the beginning of each 
day, each physician met with the team member who “roomed” the patient (LPN, PCT, or medical 
assistant) to review the plan of the day for all scheduled patients. This was the morning “huddle.” 
If a care-coordinated patient was scheduled for that day, the care coordinator also met with the 
patient. Sometimes the care coordinator joined the physician during the visit, and sometimes the 
care coordinator met with the patient after the physician visit, depending on workflow. If the 
patient needed to meet with the dietitian or social worker, every attempt was made to incorporate 
that meeting during or immediately after the physician visit.  
The daily nurse workflow was redesigned to integrate care-coordination. The following 
items describe the care coordinators’ (CC) workflow redesign.  
 Checked email and calendar.  
 Responded to phone messages and triaged calls from patients.  
 EPIC communication occurred continuously throughout the day including: 
o responded hourly to in-basket messages  
o responded to patient emails  
o refilled patient medications  
o entered referrals 
 Checked MDs’ folders throughout the day for authorizations, faxes.  
 Checked physician team members’ hospital discharged patients from the EPIC 
inpatient lists. 
 Called back care-coordinated patients only. 
 Checked Team PCP schedule for future pre-visit lab work.  
 Care-coordination (CC) activities: 
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o Checked Team PCPs clinic schedule for any visits by care-coordinated patients.  
 Informed PCPs' RN that the CC would like to speak to care-coordinated 
patients before or after the clinic visit.  
 Requested impromptu care-coordination meetings as needed.  
o Weekly face-to-face care-coordination visits. 
 Each CC had approximately two face-to-face patient visits per week.  
 Each visit was approximately 1 hour. 
o Prepared for the multidisciplinary team meeting with each Team PCP.  
o Participated in Multidisciplinary Team meetings. 
o Attended care-coordination-related meetings  
o Followed up with care-coordinated patients. 
o Contacted new care-coordination patients. 
 Updated care-coordination documentation in EPIC and Phytel.  
 Checked calendar/agenda for following day. 
 Prepared monthly care-coordination dashboards. 
Step 10. Provide community outreach and collaboration with community partners. 
Relationships were built with schools and community centers to offer wellness programs. 
Specific initiatives included coordination of health fairs at pre-schools and high school, active 
participation in the community consortium charged with changing the environment for 
sustainable health outcomes for the township, and offering health wellness programs through the 
local community center. 
Step 11. Established a workgroup to troubleshoot issues and learn from the health system 
redesign. This team was called C
2
 and included the care coordinators, social worker, and 
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dietitian. They met every two weeks to troubleshoot problems, proactively identify strategies to 
support interprofessional collaborative practice and streamline workflow. In addition, this team 
developed initial designs for marketing, patient education materials, and welcome packages. This 
team helped create the organizational culture of support and collegiality. 
Step 12. Ensured that the EHR supports, captures and measures outcomes of the new 
health system redesign. Documentation that aligned with the health care redesign model 
followed the new model’s workflow so that providers could easily document and capture data 
which could later be used for decision support (Haas et al., 2016). The EHR supported the 
provider workflow.  
The nurse informaticist met regularly with the healthcare team to discuss workflow and 
optimize documentation needs. Documentation flowsheets included: 
 outreach encounter documentation 
 telephone encounter documentation 
 monthly meeting documentation 
 care coordinator-led team meetings utilizing the 8 Ps of the BOOST tool to accurately 
include the social determinants of health 
 asynchronous encounter documentation to capture email data from the portal system 
In addition, the nurse informaticist served on institutional committees in which she 
helped to ensure that documentation was designed to support future care-coordination efforts and 
extract summary reports that reflected the work of care-coordination. 
 Team training in interprofessional practice to enhance productive interactions. Team 
training was provided that focused on Interprofessional Education (IPE) competencies including 
values, roles, communication, and teamwork (Interprofessional Education Collaborative, 2016). 
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Each competency was addressed through didactic on-line modules, case analysis, and simulation. 
Care coordinators also attended motivational interviewing training. In addition, new team 
members received four (PCT/MA) to six and a half (nurses) hours of EPIC training (personal 
communication Mary Lou Knytych, EHR Inpatient Trainer, June 27, 2017). 
Dependent variables. Dependent variables are listed below, along with their conceptual 
definition, and data collection methods. These definitions and data extraction rules are 
summarized in Table 4. 
Patient engagement. Patient engagement is the concept of how interested and activated a 
patient is to maintain his/her own health. The underlying assumption is that those who are more 
engaged in their healthcare will show up to appointments, take recommended healthcare advice 
(influenza immunizations) and schedule preventive care. In this study, patient engagement was 
operationalized using the following variables.  
Missed appointments (no show visits and same-day cancellations). A missed (no show 
and same-day cancellation) visit at this health care facility was defined as a visit that was not 
completed because the patient did not show up or call to reschedule on the day of the scheduled 
visit.  
Same-day cancellations were scheduled encounters that were canceled on the same 
calendar date as the scheduled appointment.  
Both no show visits and same-day cancellations were operationalized as the total number 
of missed visits from the Epic Encounters Database. Per protocol, these data were entered into 
the Epic Encounter Database by the service representative on the day of the scheduled visit. All 
service representatives were trained to follow Epic protocol by the healthcare institution. 
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Influenza immunization. Influenza immunizations were provided to prevent patients from 
contracting influenza. At the time of this study, the Centers for Disease Control recommended 
Influenza immunizations for all patients with diabetes who did not have a life-threatening allergy 
to the vaccine itself or any of the vaccine ingredients (Centers for Disease Control and 
Prevention [CDC], 2016a). Since this was an annual immunization, this variable was 
operationalized as a dichotomous variable (received or not received) for each time period (T2-
T1, T1-T3). Vaccinations provided by the clinic or within the health system automatically 
populated the EHR. If the vaccination was administered outside the health system, the patient 
provided written or oral verification. If the patient provided oral verification without a written 
report, the patient's estimated exam date was documented.  
Dilated retinal eye examination. An annual dilated retinal eye examination was 
recommended for patients with Type 2 diabetes. This variable was operationalized as a 
dichotomous variable (received or not received) for each time period (T2-T1, T1-T3). Eye 
examinations provided within the health system automatically populated the EHR. If the exam 
occurred outside the health system, the administering clinic submitted a written report to the 
primary care clinic. If the patient provided oral verification without a written report, the patient’s 
estimated exam date was documented. 
Health care utilization. Health care utilization was a measure of how many high cost 
visits (emergency room and hospital) were being provided to each patient. Health care utilization 
was operationalized as count measures of the total number of hospital visits, emergency room 
visits, and total number of hospital days between each time-point.  
Emergency department visits. These were any visits to the emergency room that did not 
result in any hospital encounter status. It was operationalized as a visit from the Epic encounter 
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database and was initiated when the patient checked into the emergency department by the 
service representative.  
Hospitalizations. Hospitalizations were any overnight stay in the hospital that were 
classified as inpatient, inpatient hospice, or observation. Observation stays could include 
overnight stays, which were expected to be less than two midnight stays but occasionally did last 
longer than two midnights. Consequently, observation status visits were counted in the total 
number of hospital visits. Short-term outpatient stays (outpatient-in-a-bed) were generally < 8 
hours and usually reserved for patients who need post-procedure monitoring. Short-term 
outpatient visits (outpatient-in-a-bed) were excluded. Rehabilitation visits were also excluded, 
they were not acute care visits. 
Hospitalizations were operationalized when the provider entered the order for the type of 
stay, which generated a Hospital Account Record (HAR). Each visit has a distinct HAR.  
To ensure the number of visits was not exaggerated, the highest level of care visit was 
counted. If an encounter for the emergency department occurred on the same calendar day as an 
encounter for a hospital stay, only the hospitalization was counted.  
It was also possible that patients were admitted to the sister community hospital and 
transferred to the academic tertiary care hospital, which would result in two HARs for billing 
purposes. To ensure that these transfers were not extracted as two visits, if a hospital or 
emergency department visit discharge date equaled the academic medical centers admission ED 
or hospital observation or inpatient date, only the highest level of care HAR was counted. 
However, the total number of days from admission to the sister community hospital to discharge 
from the academic hospital was counted. 
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Every encounter the patient had with a clinician in the healthcare system is logged in 
Epic under an encounter number. No hospitalizations or emergency department visits to this 
health care system were missed in the data extraction. However, encounter information was only 
available from the EHR if these visits occurred at this academic medical center’s facilities or its 
sister community hospital’s facilities. Therefore, it was possible that some patients had visits 
outside these facilities. It was assumed that since the patients had been matched, an equal 
number of patients in both groups would be seeking outside services. This was a validity concern 
but was consistent with the manner that healthcare utilization had been addressed in the literature 
since it was not yet possible to obtain this information from all healthcare facilities throughout 
the nation. 
Clinical indicators. Clinical indicators were quantitative health measures that were 
included in the National Committee for Quality Assurance’s (NCQA) Healthcare Effectiveness 
Data and Information Set (HEDIS). The clinical indicators that were extracted for this study 
included glycosylated hemoglobin or Hgb A1C, weight, and systolic and diastolic blood 
pressure.  
Glycosylated hemoglobin/A1C. Glycosylated hemoglobin or A1C is a test that measures 
the amount of glucose that has adhered to the hemoglobin protein molecule of the red blood cell. 
Once adhered, it remains for approximately 120 days or the life of the red blood cell. 
Glycosylated hemoglobin provides a measure of average plasma blood glucose concentration for 
the previous three months. At both the ICCCM and all the primary standard care clinics, 
venipuncture for this test was performed either by a trained phlebotomist or an RN. This variable 
was operationalized as a lab value. To ensure reliability, both the ICCCM clinic and the standard 
care clinics used the same lab testing method for glycosylated hemoglobin or A1C. The A1C test 
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was performed using a Bio-Rad Variant II Turbo analyzer employing high performance liquid 
chromatography. This method complied with both accreditation requirements of the College of 
American Pathologists and the Clinical Laboratory Improvement Amendments of 1988 (Personal 
communication with Dr. Stephen Kahn, Professor and Vice Chair, Clinical Services, Pathology, 
5/19/16.) It was therefore a valid measure of Hgb A1C. The normal lab value for this test was 
4.0–6.0%.  
Weight. Weight is the force of an object—in this case, the patient’s body due to gravity. It 
was measured in pounds at each clinic visit (both the ICCCM and the primary standard care 
clinics) using an upright standard digital scale, which was calibrated at least annually and as 
needed. At all clinics, weights were obtained by the LPN, MA, or PCT. Although actual weights 
were encouraged, if a patient refused to be weighed at a clinic visit, either verbal weights were 
entered, or no weight was entered. In both instances, the type of weight was documented as 
verbal or declined. To ensure validity, only actual weights were included in this study. In 
addition, since weight is dependent on fluid balance, no weights from emergency room, urgent 
care, or hospital visits were used. Per protocol, weights were documented in Epic by the clinician 
obtaining the weight at the point of service. Finally, to ensure reliability, weights were obtained 
in all clinics using an upright digital scale that was calibrated annually and as needed.   
Systolic and diastolic blood pressure. Systolic blood pressure is the measure of the 
arterial pressure during left ventricular contraction or the pressure exerted by the blood on the 
arterial wall when the heart beats. Diastolic blood pressure is the pressure exerted by the 
circulating blood on the arterial wall between heart beats when the heart is at rest. Both systolic 
and diastolic blood pressure measurements were recorded in the EHR nursing flowsheet by the 
person performing the measure at the point of care. Since blood pressure could be measured 
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several times in each visit, over several visits, and while hospitalized or in the emergency 
department, an algorithm was developed to identify how to determine what blood pressure 
measures were used and how to average those measures (Burkhart et al., 2016). For more 
information on this dependent variable and the data extraction rules see the dependent variable 
data extraction rules in Table 4.  
Blood pressure was measured using either a manual cuff or an automated blood pressure 
machine by the PCT/MA/LPN at each visit for all the clinics. Blood pressures were entered into 
the electronic nursing flowsheet at the point of care. PCTs/MAs and LPNs were required to have 
demonstrated proficiency in measuring blood pressure prior to performing this skill. In addition, 
in some instances, RNs, physicians, or advanced practice nurses might measure the patient’s 
blood pressure.  
To support validity for this study, if more than one blood pressure was recorded for a 
clinic visit, only the last blood pressure value was extracted, as patients may have elevated blood 
pressures due to stress or exercise immediately prior to the visit. To ensure reliability, the 
automatic blood pressure machines were checked by the biomedical department annually and as 
needed. Manual blood pressure cuffs were replaced and verified with a second cuff as needed. 
Data Extraction 
Data were extracted exclusively from the data warehouse. The data warehouse received 
data from the Clarity download of the Epic EHR. Table 3 describes the data extraction rules to 
identify the ICCCM and matched samples.  
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Table 3. Extraction Rules for Sample 
Data Extraction Rules Phase 1: Sample Identified 
ICCCM Sample Data Extraction Rules 
Identified by Care coordinator from Phytel 
lists of patients (obtained from clinic) 
 Extract date patient entered into problem 
list by care coordinator–this date = 
timepoint 1 (T1) 
 Assign each patient with unique ICCCM 
identification number 
T1 data: Data documented at first visit closest 
to T1 (within 6 months prior to or after T1) 
 
 Gender  
 Race 
 Ethnicity 
 Age 
 Language 
 Financial class (Medicare, Medicaid, 
private insurance payer, uninsured/self-
pay as primary payer of services) 
 A1C  
 Comorbidities: the following diagnoses 
pulled from the ICD-9 codes: cancer, 
metastases, dementia, cerebrovascular 
disease, diabetes with chronic 
complications, HIV, peptic ulcer disease, 
rheumatic disease, renal disease, liver 
disease either mild or moderate/severe, 
myocardial infarction, hemiplegia or 
paraplegia, chronic pulmonary disease and 
peripheral vascular disease  
Identify Timepoint 2 (T2) For each ICCCM patient, T2 = One year prior 
to T1 date. 
Identify Timepoint 3 (T3) For each ICCCM patient, T3 date = one year 
after T1 date. 
Matched Sample (matching as appropriate for 
closest match while optimizing sample size 
i.e. propensity scoring) 
 Extract all patients in General Medicine or 
family practice clinics with Type 2 
diabetes documented in administrative 
ICD-9 codes who were active patients 
between June 2013 -June 2016 (“Match-1 
sample” dataset) 
 For each Match-1 sample, extract sex, 
race, age, insurance, baseline A1C, 
Charlson Comorbidity diagnoses from the 
administrative data set ICD-9 codes: 
cancer, metastases, dementia, 
cerebrovascular disease, diabetes with 
chronic complications, HIV, peptic ulcer 
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disease, rheumatic disease, renal disease, 
liver disease either mild or 
moderate/severe, myocardial infarction, 
hemiplegia or paraplegia, chronic 
pulmonary disease and peripheral vascular 
disease 
 Assign each matched patient with unique 
identification number 
 
First the population who received ICCCM was identified from the clinic care 
coordinator’s lists. The date that care coordination was added to each patient's problem list was 
extracted as T1. T2 and T3 were automatically one calendar year prior to T1 and one calendar 
year after T1 respectively. For clinical indicators, the variable closest to the T1, T2 and T3 dates 
were extracted. If no value was available within six months of the T1, T2 or T3 date, no data 
were extracted. To ensure at least one full year’s data after the intervention began, all the patients 
had to have a T1 date after June 1, 2014 when the intervention began but prior to February 1 of 
2016 as the ICCCM model was changed in February 2017.  
For each patient in the ICCCM group, the values for Hgb A1C; weight; systolic and 
diastolic blood pressure were extracted as described in the dependent variable data extraction 
rules table for each of the three time points (see dependent variable data extraction rules, Table 
4). All influenza vaccinations; eye examinations; number of missed visits (no shows (NS) and 
same-day cancellations); hospital days and visits and emergency department visits were recorded 
that occurred between T2 (one year prior to the intervention) and T3 (one year post intervention). 
The data was then verified with the EHR and quality control checks of the data were performed 
prior to matching. These checks include descriptive statistics and frequency distributions of key 
variables to ensure that the ranges of the variables were plausible.  
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Table 4. Dependent Variable Data Extraction Rules Table  
Variable Definition Data Extraction for each 
ICCCM participant 
Data Extraction for each 
Matched participant 
Patient Engagement 
Missed 
Visits (No 
Show 
(NS) 
Visits + 
Same Day 
Cancellati
ons) 
 
Counted 
separately 
for T2-T1 
and T1 to 
T3 
 Did not come 
to scheduled 
appointment 
 Did not call to 
cancel or 
reschedule 
 Patient cancels 
on same day of 
appointment or 
comes late to 
scheduled 
appointment 
and cannot be 
seen so the 
appointment 
must be 
cancelled 
 Appointment 
date = 
Cancellation 
date 
 Extract all canceled 
clinic visits and NS 
visits between T2 and 
T1 (NS 1) 
 Extract all canceled 
clinic visits and NS 
visits between T1 and 
T3 (NS 2) 
 For NS1 and NS2, count 
all visits in which the 
appointment date = 
cancellation date or the 
visit is a NS (Count 1 
NS1, Count 1 NS2) 
 Label as #NS Pre 
ICCCM visits (T2-T1) 
& #NS Post-ICCCM 
visits (T1-T3) 
 
 Extract all canceled 
clinic visits and NS 
visits between T1 and 
T3 (NS 3) 
 For NS 3, count all visits 
in which the 
appointment date = 
cancellation date or this 
visit is a NS (Count 1 
NS3) 
 Label as #NS Match 
visits (T1-T3) 
 
Influenza 
immuniza-
tions 
Influenza 
immunization 
injection 
 For T2-T1, extract date 
of influenza 
immunization 
 For T1-T3, extract date 
of influenza 
immunization 
 For each time period, if 
date is blank, assign 0 to 
influenza immunization 
 For each time period, if 
date is not blank, assign 
1 to influenza 
immunization 
 For T1-T3, extract date 
of influenza 
immunization 
 For T1-T3 time period, 
if date is blank, assign 0 
to influenza 
immunization 
 For T1-T3 time period, 
if date is not blank, 
assign 1 to influenza 
immunization 
Dilated 
eye 
examina-
tions 
Dilated eye 
examination from 
ophthalmology 
For each time period (T2-
T1, & T1-T3) separately: 
 Extract date of all 
dilated 
eye/ophthalmologist 
examination 
 For each time period, if 
For T1-T3: 
 Extract date of all 
dilated 
eye/ophthalmologist 
examination 
 If date is blank, assign 0 
to dilated eye 
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date is blank, assign 0 to 
dilated eye examination  
 For each time period, if 
date is not blank, assign 
1 to dilated eye 
examination  
examination  
 If date is not blank, 
assign 1 to dilated eye 
examination 
    
Healthcare Utilization 
Hospitali-
zations- 
Number of 
hospitali-
zations & 
Number of 
days 
hospital-
ized 
 Overnight 
stays in the 
hospital with 
inpatient, 
inpatient 
hospice or 
observation 
status at 
academic 
medical center 
or at affiliated 
community 
hospital 
 Excludes 
Outpatient-in-
a-bed, and 
rehab 
encounters 
 If patient 
transfers from 
affiliated 
hospital to 
academic 
hospital, count 
as 1 visit 
For each time period (T2-
T1, & T1-T3) separately: 
 Count all Inpatient, or 
Inpatient Hospice and 
Observation HARs from 
both academic and 
affiliated community 
hospital (HAR count) 
 If affiliated community 
hospital discharge date 
from inpatient, inpatient 
hospice, observation or 
emergency department = 
admission date to 
academic hospital, count 
as 1 HAR only (add 1 to 
HAR count) 
 To determine # of 
hospital days, subtract 
date of discharge from 
date of admission and 
add 1 for each inpatient, 
observation, and 
inpatient hospice visit 
For T1-T3: 
 Count all Inpatient or 
Inpatient Hospice and 
Observation HARs from 
both academic and 
affiliated community 
hospital (HAR count) 
 If affiliated community 
hospital discharge date 
from inpatient, inpatient 
hospice, observation or 
emergency department = 
admission date to 
academic hospital, count 
as 1 HAR only (add 1 to 
HAR count) 
 To determine # of 
hospital days, subtract 
date of discharge from 
date of admission and 
add 1 for each inpatient, 
observation, and 
inpatient hospice visit 
Emerg. 
Depart-
ment (ED) 
Visit 
Any visit to the 
ED in which 
patient checks in, 
is billed as ED 
visit and visit did 
not result in a 
hospital admission 
For each time period (T2-
T1, & T1-T3) separately: 
 Count all Emergency 
Department (ED) visit 
HARs (ED count) 
 If ED visit from 
affiliated community 
hospital was transferred 
to ED at academic 
hospital, count as only 
one ED visit—
Discharge date ED 
For T1-T3: 
 Count all Emergency 
Department (ED) visit 
HARs (ED count) 
 If ED visit from 
affiliated community 
hospital was transferred 
to ED at academic 
hospital, count as only 
one ED visit—
Discharge date ED 
community hospital = 
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community hospital = 
admission ED date 
academic medical center 
= 1 ED visit  
 If ED visit from 
community hospital was 
transferred to ED at 
academic hospital 
resulting in an inpatient 
or observation visit in 
academic hospital, do 
not count ED visit—
Discharge date ED 
community hospital = 
inpatient/observation 
admission date 
academic medical center 
= 0 ED visit, 1HAR visit 
admission ED date 
academic medical center 
= 1 ED visit  
 If ED visit from 
community hospital was 
transferred to ED at 
academic hospital 
resulting in an inpatient 
or observation visit in 
academic hospital, do 
not count ED visit—
Discharge date ED 
community hospital = 
inpatient/observation 
admission date academic 
medical center = 0 ED 
visit, 1 HAR visit 
    
Clinical Indicators 
Hgb A1C Test that measures 
the amount of 
glucose that has 
adhered to the 
hemoglobin 
protein molecule 
of the red blood 
cell. 
For each T1, T2 and T3 
date:   
 Extract date of and 
value of A1C closest to 
each date  
 If no A1C exists within 
6 months of each date, 
leave data point blank 
For each T1 and T3 date:   
 Extract date of and value 
of A1C closest to each 
date  
 If no A1C exists within 
6 months of each date, 
leave data point blank 
Weight Force an object 
(the patient’s 
body) exerts due to 
gravity 
For each ICCCM participant 
extract T1, T2 and T3 
weight:   
 Extract weight closest to 
each date (T1, T2 and 
T3) and the date of 
weight  
 If weight extracted is 
verbal weight, do not 
extract and extract next 
closest actual weight 
and date of weight 
 If weight is from 
hospital or ED visit, do 
not extract 
 If no weight exists 
within 6 months of each 
For each Match participant 
extract T1 and T3 weight:   
 Extract weight closest to 
each date (T1 and T3) 
and the date of weight  
 If weight extracted is 
verbal weight, do not 
extract and extract next 
closest actual weight and 
date of weight 
 If weight is from 
hospital or ED visit, do 
not extract 
 If no weight exists 
within 6 months of each 
date, leave data point 
blank 
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date, leave data point 
blank 
Systolic 
blood 
pressure 
Measure of the 
arterial pressure 
during left 
ventricular 
contraction or the 
pressure exerted 
by the blood on the 
arterial wall when 
the heart beats 
For each ICCCM participant 
extract T1, T2 and T3 B/P:   
 Extract systolic B/P 
taken closest to each 
date and the date taken  
 Delete blood pressure 
measures from urgent 
care, outpatient surgery, 
ED, or hospital visits 
 If more than one blood 
pressure is measured on 
the same date, the last 
systolic B/P taken will 
be used 
 If no B/P exists within 6 
months of each date, 
leave data point blank 
For each matched 
participant extract T1 and 
T3 B/P:   
 Extract systolic B/P 
taken closest to each 
date and the date taken  
 Delete blood pressure 
measures from urgent 
care, outpatient surgery, 
ED, or hospital visits 
 If more than one blood 
pressure is measured on 
the same date, the last 
systolic B/P taken will 
be used 
 If no B/P exists within 6 
months of each date, 
leave data point blank 
Diastolic 
blood 
pressure 
Pressure exerted 
by the circulating 
blood on the 
arterial wall 
between heart 
beats when the 
heart is at rest. 
For each T1, T2 and T3 
date:   
 Extract diastolic B/P 
taken closest to each 
date and the date taken  
 Delete blood pressure 
measures from urgent 
care, outpatient surgery, 
ED or hospital visits 
 If more than one blood 
pressure is measured on 
the same date, the last 
diastolic B/P taken will 
be used 
 If no B/P exists within 6 
months of each date, 
leave data point blank 
 For each T1 and T3 date:   
 Extract diastolic B/P 
taken closest to each 
date and the date taken  
 Delete blood pressure 
measures from urgent 
care, outpatient surgery, 
ED or hospital visits 
 If more than one blood 
pressure is measured on 
the same date, the last 
diastolic B/P taken will 
be used 
 If no B/P exists within 6 
months of each date, 
leave data point blank 
 
After the data for the ICCCM participants had been verified, a series of data extractions 
were conducted to identify a matched participant for each ICCCM participant. First to identify 
the matched population, all patients who had Type 2 diabetes in their diagnostic codes were 
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extracted (Match–1 sample). Then, from this sample, patients who had a visit within six months 
of all the ICCCM participants T1 range were included (Match–2 sample). For the Match-2 
sample, the gender, race, ethnicity, language, age, insurance, A1C at matched date (baseline 
A1C), date of diabetes diagnosis, and comorbidities were extracted. From the Match–2 sample, 
the closest three propensity matched score participants were identified and ranked. The 
propensity match was based on gender, race, ethnicity, language, age, insurance, A1C at T1, date 
of diabetes diagnosis and comorbidity between the ICCCM participant and the patient from a 
comparison primary care clinic within the same health system. The EHR of the top three 
potential matches was searched to determine if all inclusion/exclusion criteria had been met. The 
closest match who met all inclusion/exclusion criteria was identified as the match for the 
corresponding intervention patient. If no suitable match could be found, the intervention patient 
was deleted from the data for the matched portion of the study, resulting in a loss of 33 
participants for the Hypotheses 1b, 2b, and 3b. As shown in Table 5, the 33 patients were 
demographically similar to the 171 intervention patients who had matches except that they were 
more likely to be non-English speaking. 
Table 5. ICCCM Intervention Sample/33 Unmatched Patients' Demographics    
 Intervention 
patient population 
33 patients who 
were unable to be 
matched 
Chi Square 
Significance 
 Total 
Number 
Percent Total 
Number 
Percent  
Age     0.62 
<55 55 27.0 11 33.3  
55-65 71 34.8 11 33.3  
>65 45 22.1 11 33.3  
Gender     0.72 
  Female 99 57.9 18 54.5  
  Male 72 42.1 15 45.5  
Race     0.69 
  African- 108 63.2 20 60.6  
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  American 
  White 46 26.9 8 24.2  
  Other 17 9.9 5 15.2  
Language     0.03 
  English 161 94.2 27 81.8  
  Non- 
  English 
10 5.8 6 18.2  
Insurance     0.63 
  Private 102 59.6 21 63.6  
  Medicare 48 28.1 11 33.3  
  Medicaid 18 10.5 1 3.0  
Uninsured/   
Other 
3 1.8 0 0  
 
Next, for each of the corresponding matched patients, the values for Hgb A1C; weight; 
systolic and diastolic blood pressure; influenza vaccination; eye examination; number of no 
shows and same-day cancellations; hospital admission and discharge dates and emergency 
department visits were extracted (similarly to their matched counterpart) as described in the 
dependent variable data extraction rules table for both time-points (see Table 4). These data were 
downloaded into an Excel spreadsheet and imported into REDCap (Harris et al., 2009) and from 
REDCap into SPSS (IBM SPSS Statistics for Windows, Version 25.0, 2017, SPSS, Armonk, 
NY).  
Data Cleaning 
To ensure data integrity, all participants' data were compared to the EHR data to 
determine accuracy of the data extraction. Next data cleaning was conducted by analyzing 
frequency distributions of all variables and descriptive statistics. When outliers were identified, 
these variables were reverified with the EHR. 
Missing Data 
If there were no data for any of the three time points for any participant in the ICCCM 
group, that participant was excluded for that variable. Missing data were identified using 
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descriptive statistics. Missing data were not replaced, but rather, the participant was excluded 
from that data variable statistic. 
Power 
For this study, based on a quality improvement project, it was estimated that a total of 
130 patients participated in ICCCM at the main clinic and its satellite clinic between October 
2014 and June 2015. A power analysis using G*Power for a two-tailed, two group t-test, with a 
beta of 0.2 and alpha of 0.05 demonstrated that the smallest effect size that this study could 
detect was 0.35 if all 130 patients in the ICCCM group were successfully matched to another 
control group primary care clinic patient (Faul, Erdfelder, Buchner, & Lang, 2009). This would 
be for 260 patients or 130 in each group.  
 Based on the literature, this sample size would have enough power to answer the research 
questions. A review of the data on hemoglobin A1Cs indicated that this was not unlikely for this 
variable. Afzali, Karnon, Gray, and Beilby (2012) estimated a need for 84 participants to detect 
an absolute difference of 0.5% in mean A1C. This was based on a standard deviation of 1.44% 
with an alpha of 5% and 80% power (Afzali, Karnon, Gray, & Beilby, 2012). Shojania et al.’s 
meta-regression demonstrated a mean reduction in A1C as high as 0.67% for interventions that 
included team-based care and 0.52% for interventions that included case management (2006).  
Clark, Snyder, Meek, Stutz, and Parkin (2001) found in their pre-/post-analysis of a team 
system intervention that the percentage of patients receiving the dilated eye examination at the 
end of one year increased from 53.9% to 80.3% for an effect size of 0.264, requiring 176 
participants. The percent of patients achieving a blood pressure of < 140/90 increased from 
38.9% to 66.8% for an effect size of 0.279, requiring 156 total participants (Clark, et al., 2001). 
Gabbay et al. (2006) found that the difference in the percent of patients receiving the pneumonia 
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vaccination increased from 6% in the control group to 50% in the nurse case management 
intervention group for an effect size of 0.44, requiring 57 total participants. Using McNemar’s 
test for the dichotomous study variables, the sample size required to detect a difference for a 
two-tailed test was 56 participants (28 in each group) with an effect size of 0.26. Consequently, 
the study was determined to be well powered for the dichotomous variables. However, no 
published information regarding the effect size needed for no show and same day cancellation 
visits was found.  
Data Analyses 
Data were reviewed upon entry into REDCap to ensure that the data matched with the 
data pulled in from the excel spreadsheet.  
Descriptive statistics of the matching variables (gender, race, age, ethnicity, language, 
insurance, baseline A1C, length of time with DM, Charlson comorbidities previously listed, (see 
Table 3)) were presented to ensure that the patients were indeed well matched. Propensity 
diagnostics (standard mean differences) were evaluated to ensure the groups were similar at 
baseline (T1).  
For all the dichotomous variables, McNemar's nonparametric test was used. However, 
since the propensity match demonstrated imbalance in baseline A1C and renal disease, 
generalized estimating equations were run to statistically control for those two variables.  
Assumptions of normality, homogeneity of variance and, independence were assessed for 
the continuous variables to ensure that parametric statistical methods could be used. Since these 
assumptions were violated for all continuous variables, nonparametric statistics were used. Since 
the continuous healthcare utilization variables and missed visits had a Poisson distribution, they 
violated a normal distribution; therefore, a Wilcoxon signed ranked test was used to evaluate the 
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healthcare utilization and missed visit count variables. Since the intervention patients were from 
a family practice clinic and in some cases were related to each other (spouses, or parent/child), 
the assumption of independence was also violated; therefore, the Wilcoxon signed rank test was 
also used for these variables. Again, since the propensity match demonstrated imbalance in 
baseline A1C and renal disease, mixed models, general linear models with a binomial probability 
distribution and a logit link function were run to statistically control for those two variables. 
However, since the general linear mixed model is a parametric test, the Wilcoxon signed rank 
test was also run to ensure there was no discrepancy in the results. The only continuous variable 
in which significance was affected by the baseline A1C and renal disease was missed visits. 
Therefore, missed visits in the ICCCM/propensity matched group were categorized into no 
missed visits or 1 or more missed visits and a generalized estimating equation test was run to 
statistically control for the covariates.   
The data analysis table below (see Table 6) provides the hypotheses being tested, the 
variable definitions, and the statistical test planned. 
Table 6. Data Analysis 
Hypothesis Variable Definitions Statistical Test 
Informed, empowered patient and family/patient engagement 
1) After participating in the 
ICCCM for one year, Type 2 
diabetic participants will have 
significantly increased patient 
engagement as demonstrated 
by fewer Missed (No Show 
visits and same day 
cancellation) visits than prior 
to participation. 
Pre-ICCCM # No show/same 
day cancellations per 
participant between T1 & T2 
  
Post-ICCCM # Missed visits 
per participant between T1 & 
T3 
 
Change scores calculated for 
pre and post ICCCM 
timepoints 
 
Wilcoxon Signed Rank Test 
2) After participating in 
ICCCM for one year,  
Type 2 diabetic participants 
will have increased patient 
engagement as demonstrated 
Post-ICCCM: # Missed visits 
between T1 & T3 in ICCCM  
 
Post-Match: # Missed visits 
between T1 & T3 in Match 
General linear mixed model 
with binomial probability 
distribution and logit link 
function to control for variables 
with >0.2 standardized mean 
118 
 
by significantly fewer missed 
(No Show visits and same day 
cancellation) visits than 
matched participants receiving 
standard care. 
 difference in propensity match 
and Wilcoxon Signed Rank 
Test – due to discrepant results, 
variable was dichotomized into 
missed visits = none or ≥ 1 and 
Generalized estimating 
equation (GEE) was used to 
statistically control for 
unbalanced propensity matched 
covariates  
3) After participating in the 
ICCCM model of care for one 
year, Type 2 diabetic 
participants will have a 
significantly greater number 
of received influenza 
immunizations than prior to 
participation. 
Influenza immunizations is a 
dichotomous variable – either 
received or not received for 
the year 
 
Pre-ICCCM: # ICCCM 
participants who received 
influenza immunizations 
between T1 & T2 
  
Post-ICCCM: # ICCCM 
participants who received 
influenza immunizations 
between T1 & T3 
McNemar’s test 
4) After participating in 
ICCCM for one year, Type 2 
diabetic participants will have 
a significantly greater increase 
in the number of received 
influenza immunizations than 
matched participants receiving 
standard care. 
Influenza immunizations is a 
dichotomous variable – either 
received or not received for 
the year 
Post-ICCCM change: # 
ICCCM participants receiving 
influenza immunization 
between T1 & T3 
 
Post-Match change: # 
Matched participants receiving 
influenza immunization 
between T1 & T3 
Generalized estimating 
equation (GEE) to 
statistically control for 
unbalanced propensity 
matched covariates  
5) After participating in the 
ICCCM model of care for one 
year, Type 2 diabetic 
participants will have a 
significantly greater number 
of received dilated eye 
examinations than prior to 
participation. 
Dilated eye examination is a 
dichotomous variable – either 
received or not received for 
the year  
 
Pre-ICCCM: # ICCCM 
participants who received 
dilated eye examinations 
McNemar's test 
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between T1 & T2 
  
Post-ICCCM: # ICCCM 
participants who received 
dilated eye examinations 
between T1 & T3 
6) After participating in the 
ICCCM model of care for one 
year, Type 2 diabetic 
participants will have a 
significantly greater increase 
in the number of received eye 
examinations than matched 
participants receiving standard 
care. 
Dilated eye examination is a 
dichotomous variable – either 
received or not received for 
the year  
 
Post-ICCCM: # ICCCM 
participants who received 
dilated eye examinations 
between T1 & T3 
 
Post-Match: # matched 
participants who received 
dilated eye examinations 
between T1 & T3 
Generalized estimating 
equation (GEE) to 
statistically control for 
unbalanced propensity 
matched covariates  
Productive Interactions/ Healthcare Utilization 
7) After participating in 
ICCCM for one year, Type 2 
diabetic participants will have 
significantly fewer 
hospitalizations than prior to 
participation. 
 
Pre-ICCCM # hospitalizations 
per participant between T1 & 
T2 
  
Post-ICCCM # 
hospitalizations per participant 
between T1 & T3 
Change scores calculated for 
pre and post ICCCM 
timepoints 
 
Wilcoxon Signed Rank test 
8) After participating in 
ICCCM for one year, Type 2 
diabetic participants will have 
significantly fewer 
hospitalizations than matched 
participants receiving standard 
care. 
Post-ICCCM Visits: # 
hospitalizations between T1 & 
T3 
  
Post-Match Visits: # 
hospitalizations between T1 & 
T3 
General linear mixed model 
with binomial probability 
distribution and logit link 
function to control for 
variables with >0.2 
standardized mean difference 
in propensity match and 
Wilcoxon Signed Rank Test 
9) After participating in 
ICCCM for one year, Type 2 
diabetic participants will have 
significantly fewer emergency 
department visits than prior to 
participation. 
Pre-ICCCM Visits: # 
emergency department visits 
per participant between T1 & 
T2 
  
Post-ICCCM Visits: # 
emergency department visits 
per participant between T1 & 
T3 
Change scores calculated for 
pre and post ICCCM 
timepoints 
 
Wilcoxon Signed Rank test 
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10) After participating in 
ICCCM for one year, Type 2 
diabetic participants will have 
significantly fewer emergency 
department visits than 
matched participants receiving 
standard care. 
Post-ICCCM Visits: # 
emergency department visits 
between T1 & T3 
  
Post-Match Visits: # 
emergency department visits 
between T1 & T3 
General linear mixed model 
with binomial probability 
distribution and logit link 
function to control for 
variables with >0.2 
standardized mean difference 
in propensity match and 
Wilcoxon Signed Rank Test 
11) After participating in 
ICCCM for one year, Type 2 
diabetic participants will have 
significantly fewer hospital 
days than prior to 
participation. 
Pre-ICCCM Visits: # hospital 
days per participant between 
T1 & T2 
  
Post-ICCCM Visits: # hospital 
days per participant between 
T1 & T3 
Change scores calculated for 
pre and post ICCCM 
timepoints 
 
Wilcoxon Signed Rank Test 
12) After participating in 
ICCCM for one year, Type 2 
diabetic participants will have 
significantly fewer hospital 
days than matched participants 
who receive standard care. 
Post-ICCCM Visits: # hospital 
days between T1 & T3 
  
Post-Match Visits: # hospital 
days between T1 & T3 
General linear mixed model 
with binomial probability 
distribution and logit link 
function to control for 
variables with >0.2 
standardized mean difference 
in propensity match and 
Wilcoxon Signed Rank Test 
Outcome Measures 
13) After participating in 
ICCCM for one year, Type 2 
diabetic participants will have 
significantly lower A1C levels 
than prior to participation. 
 
Change: 
Pre ICCCM A1C T1 
Post ICCCM A1C T3 
 
Difference: 
Pre-ICCCM A1C difference 
per participant: A1CT2 – 
A1CT1 
  
Post-ICCCM A1C difference 
per participant: A1CT1 – 
A1CT3 
Change scores will be 
calculated for pre and post 
ICCCM timepoints 
 
Wilcoxon Signed Rank Test 
14) After participating in 
ICCCM for one year, a 
significantly lower number of 
patients will have A1C levels 
> 9.0 than prior to 
participation. 
Pre-ICCCM: Number of 
patients with A1C > 9.0 from 
T2-T1  
  
Post-ICCCM: Number of 
patients with A1C > 9.0 from 
T1-T3 
McNemar's test 
15) After participating in 
ICCCM for one year, Type 2 
Post-ICCCM A1C change per 
participant: 
General linear mixed model 
with binomial probability 
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diabetic participants will have 
a significantly greater 
decrease in A1C than matched 
participants receiving standard 
care. 
A1CT1 – A1CT3 
  
Post-Match A1C change per 
participant: 
A1CT1 – A1CT3 
distribution and logit link 
function to control for 
variables with >0.2 
standardized mean difference 
in propensity match & 
Wilcoxon Signed Rank Test 
16) After participating in 
ICCCM for one year, Type 2 
diabetic participants will have 
a significantly lower number 
of patients with A1C > 9.0 
than matched participants 
receiving standard care. 
Post-ICCCM: Number of 
patients with A1C > 9.0 (T1-
T3) 
 
Post-Match: Number of 
patients with A1C > 9.0 (T1-
T3) 
 
Generalized estimating 
equation (GEE) to 
statistically control for 
unbalanced propensity 
matched covariates 
Population subset: Only participants in either ICCCM or Match group with BMI’s >25 or weight 
> 185 lb at T1 will be included. 
17) After participating in 
ICCCM for one year, Type 2 
diabetic participants with a 
BMI > 25 or weight > 185 lb 
at T1 will have a significantly 
greater weight decrease than 
prior to participation. 
Change: 
Pre ICCCM weight T1 
Post ICCCM weight T3 
 
Difference: 
Pre-ICCCM: Weight (Wt) 
change per participant - WtT2 
– WtT1 
  
Post-ICCCM: Wt change per 
participant - 
WtT1 – WtT3 
 
Change scores will be 
calculated for pre and post 
ICCCM timepoints 
 
Wilcoxon Signed Rank Test 
18) After participating in 
ICCCM for one year, Type 2 
diabetic participants with a 
BMI > 25 or a weight >185 lb 
at T1 will have a significantly 
greater weight decrease than 
matched participants receiving 
standard care. 
Post-ICCCM: Weight change 
per participant – WtT1 – 
WtT3 
  
Post-Match: Weight change 
per participant - WtT1 – WtT3 
General linear mixed model 
with binomial probability 
distribution and logit link 
function to control for 
variables with >0.2 
standardized mean difference 
in propensity match and 
Wilcoxon Signed Rank Test 
Population subset: Only patients with hypertension coded in administrative data set will be 
included in this subset. 
19) After participating in 
ICCCM for one year, Type 2 
diabetic participants with 
hypertension will have a 
significantly greater 
percentage of participants with 
Pre-ICCCM: Percent of 
participants with Systolic B/P 
< 140  
  
Post-ICCCM: Percent of 
participants with Systolic B/P 
McNemar's test 
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systolic blood pressure < 140 
than prior to participation. 
< 140 
20) After participating in 
ICCCM for one year, Type 2 
diabetic participants with 
hypertension will have a 
significantly greater 
percentage of participants with 
systolic blood pressure < 140 
than matched participants 
receiving standard care. 
Post-ICCCM: Percent of 
participants with Systolic B/P 
< 140 
 
Post-Match: Percent of 
participants with Systolic B/P 
< 140 
Generalized estimating 
equation (GEE) to 
statistically control for 
unbalanced propensity 
matched covariates 
21) After participating in 
ICCCM for one year, Type 2 
diabetic participants with 
hypertension will have a 
significantly greater decrease 
in systolic blood pressure than 
prior to participation. 
Change: 
Pre ICCCM systolic b/p T1 
Post ICCCM systolic b/p T3 
 
Difference: 
Pre-ICCCM: Systolic b/p 
change per participant – Sys 
b/p T2 – Sys b/p T1 
  
Post-ICCCM: Systolic b/p 
change per participant – Sys 
b/p T1 – Sys b/p T3 
Change/difference scores 
will be calculated for pre and 
post ICCCM timepoints  
 
Wilcoxon Signed Rank Test 
22) After participating in 
ICCCM for one year, Type 2 
diabetic participants with 
hypertension will have a 
significantly greater decrease 
in systolic blood pressure than 
matched participants receiving 
standard care. 
Post-ICCCM: Systolic b/p 
change per participant – Sys 
b/p T1 – Sys b/p T3 
  
Post-Match: Systolic b/p 
change per participant – Sys 
b/p T1 – Sys b/p T3 
General linear mixed model 
with binomial probability 
distribution and logit link 
function to control for 
variables with >0.2 
standardized mean difference 
in propensity match and 
Wilcoxon Signed Rank Test 
23) After participating in 
ICCCM for one year, Type 2 
diabetic participants with 
hypertension will have a 
significantly greater 
percentage of participants with 
diastolic blood pressure < 90 
than prior to participation. 
Pre-ICCCM: Percent of 
participants with Diastolic B/P 
< 90  
  
Post-ICCCM: Percent of 
participants with Diastolic B/P 
< 90 
McNemar's test 
24) After participating in 
ICCCM for one year, Type 2 
diabetic participants with 
hypertension will have a 
significantly greater 
percentage of participants with 
Post-ICCCM: Percent of 
participants with Diastolic B/P 
< 90 
 
Post-Match: Percent of 
participants with Diastolic B/P 
Generalized estimating 
equation (GEE) to 
statistically control for 
unbalanced propensity 
matched covariates 
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diastolic blood pressure < 90 
than matched participants 
receiving standard care. 
< 90 
25) After participating in 
ICCCM for one year, Type 2 
diabetic participants with 
hypertension will have a 
significantly greater decrease 
in diastolic blood pressure 
than prior to participation. 
Change: 
Pre ICCCM diastolic b/p T1 
Post ICCCM diastolic b/p T3 
 
Difference: 
Pre-ICCCM: Diastolic b/p 
change per participant – Dias 
b/p T2 – Dias b/p T1 
  
Post-ICCCM: Diastolic b/p 
change per participant – Dias 
b/p T1 – Dias b/p T3 
Change/difference scores 
will be calculated for pre and 
post ICCCM timepoints  
 
Wilcoxon Signed Rank Test 
26)  After participating in 
ICCCM for one year, Type 2 
diabetic participants with 
hypertension will have a 
significantly greater decrease 
in diastolic blood pressure 
than matched participants 
receiving standard care 
Post-ICCCM: Diastolic b/p 
change per participant – Dias 
b/p T1 – Dias b/p T3 
  
Post-Match: Diastolic b/p 
change per participant – Dias 
b/p T1 – Dias b/p T3 
General linear mixed model 
with binomial probability 
distribution and logit link 
function to control for 
variables with >0.2 
standardized mean difference 
in propensity match and 
Wilcoxon Signed Rank Test 
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CHAPTER FOUR 
  RESULTS 
 The study aim is to determine whether a nurse-led interprofessional collaborative care-
coordination model (ICCCM) will demonstrate improved patient engagement, use of fewer 
emergency and hospital encounters, and have better clinical outcomes both prior to the 
intervention and in comparison to a matched cohort.    
Study Sample 
The following sections will describe the intervention sample, the matched control sample, 
and the propensity match. 
Intervention Sample 
The ICCCM intervention pre/post sample consisted of 204 patients with type II diabetes 
from two intervention clinics for one year and who had been primary care patients for one year 
prior to the intervention redesign. As shown in Table 6, the majority of patients were English 
speaking, insured African American females who were under 55. In addition, 11 patients were 
deleted from the sample as they were not patients for a full year prior to the intervention so pre/ 
post analysis was not possible. Although these 11 patients were less likely to have private 
insurance and more likely to have Medicaid coverage, Chi square test results revealed that none 
of the differences between these two groups were statistically significant (Table 7).  
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Table 7. ICCCM Intervention Sample/11 Disqualified Patients' Demographics 
for Pre-/Post-Analysis 
   
 Intervention 
patient population 
11 patients without 
data year prior to 
intervention 
Chi Square 
Significance 
 Total 
Number 
Percent Total 
Number 
Percent  
Age     .960 
<55 94 46.1 5 45.5  
55-65 67 32.8 4 36.4  
>65 43 21.1 2 18.2  
Gender     0.681 
  Female 117 57.4% 7 63.6%  
  Male 87 42.6% 4 36.4%  
Race     0.373 
  African- 
  American 
128 62.7% 7 63.6%  
  White 54 26.5% 2 18.2%  
  Other 22 10.8% 2 18.2%  
Language     0.422 
  English 188 92.2% 9 81.8%  
  Non- 
  English 
15 7.4% 2 18.2%  
Insurance     0.427 
  Private 123 60.3% 5 45.5%  
  Medicare 59 28.9% 3 27.3%  
  Medicaid 19 9.3% 3 27.3%  
Uninsured/   
Other 
3 1.5% 0 0  
 
Matched Control Sample 
For each of the 204 patients who qualified and completed one year of the intervention, a 
propensity score match using nearest neighbor match without replacement was performed 
(Lanza, Moore, & Butera, 2013). Potential matches of patients with type 2 diabetes were 
extracted from the other 13 primary care clinics within this health system. Matched variables 
included age, race, gender, ethnicity, language, financial class, comorbidities based on the 
Charlson comorbidity index, years with diabetes, and baseline A1C. Each of the intervention 
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participants was matched to three potential matches, who were ranked 1-3 with 1 being the 
closest match possible and 3 being the third closest possible match. One intervention patient had 
no potential matches. A chart review was conducted to ensure all matched participants met 
inclusion/exclusion criteria (potential matches n=609). If the best (first) match qualified, the 
other two were deleted and not evaluated (no chart review conducted). Of the 609 potential 
matches, 171 qualified, 242 were not evaluated as a better match qualified and 196 were 
disqualified based on inclusion/exclusion criteria. The reasons for disqualification were not 
having a primary care physician within the health system (n=75), being a primary care patient of 
one of the two intervention clinics (n=51), being diagnosed after T1 (n=43), having no 
encounters during the two year timespan for data collection (n=20), expired during data 
collection T3 (n=3), were pregnant (n=2), or newly diagnosed during data collection (n=2). 
Propensity match. The following table (Table 8) demonstrates the standard mean 
difference between the ICCCM group and the matched control group. 
Table 8. Propensity Match Characteristics for Both ICCCM and Matched Group 
 Number 
in 
ICCCM 
Percent 
ICCCM 
Number 
in Match 
(Control 
Group) 
Percent 
Match 
(Control 
Group) 
Standard 
mean 
difference 
Age      
< 55 58 33.9 58 33.9 0 
55-65 64 37.4 59 34.5 0.06 
>65 49 28.7 54 31.6 0.06 
Race      
AA 108 63.2 113 66.1 0.06 
White 46 26.7 49 28.7 0.04 
Gender      
Female 99 57.9 100 58.5 0.01 
Male 72 42.1 71 41.5 0.01 
Ethnicity      
Hispanic 29 16.9 22 12.9 0.12 
Non-Hispanic 141 82.5 146 85.4 0.08 
127 
 
Language      
English 161 94.2 163 94.8 0.05 
Non-English 10 5.8 8 4.7 0.05 
Financial Class     
Insurance 102 59.6 108 63.2 0.07 
Medicaid 18 10.5 13 7.6 0.10 
Medicare 48 28.1 48 27.9 0 
Other 3 1.8 2 1.2 0.05 
Comorbidity      
cancer 16 9.4 17 9.9 0.02 
COPD 44 25.7 46 26.9 0.03 
CVD 38 22.2 39 22.8 0.01 
Dementia 4 2.3 7 4.1 0.10 
DM End 
organ Disease 
130 76 124 72.5 0.08 
HIV 0 0 0 0 n/a 
Mild liver 
disease 
45 26.3 50 29.2 0.07 
Severe liver 
disease 
2 1.2 3 1.8 0.05 
Metastases 1 0.6 1 0.6 0 
MI 19 11.1 13 7.6 0.12 
Plegia 10 5.8 7 4.1 0.08 
PVD 39 22.8 44 25.7 0.07 
Renal 38 22.2 22 12.9 0.25 
Rheumatic 6 3.5 6 3.5 0 
Peptic Ulcer 10 5.8 10 5.8 0 
Years w DM      
< 6.5 52 30.4 60 35.1 0.10 
6.5 - 8.5 89 52 99 57.9 0.12 
> 8.5 30 17.5 12 7 0.32 
 ICCCM 
Mean 
ICCCM 
Variance 
Match 
Mean 
Match 
Variance 
Standard 
Difference 
Baseline A1C 9.13 3.34 7.88 3.44 0.68 
 
The baseline matching characteristics used for the propensity match were compared to 
determine the adequacy of the match. An adequate match has a standard mean difference 
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between the two groups of less than 0.2 (Austin, 2009; Lanza, Moore, & Butera, 2013). As Table 
8 demonstrates, there are 3 characteristics that were not able to be matched adequately –the 
number of years since diagnosed with diabetes, Baseline A1C, and renal disease diagnosis. The 
number of years since diagnosed with diabetes was based on the first-time diabetes was coded at 
this healthcare system. Given that this value often coincided with the date the patient initiated 
care at this health system, it is unlikely that the time period accurately reflects the date of 
diabetes diagnosis. Therefore, this variable was eliminated from the match. However, the other 
two characteristics indicate the match is not from the same population; therefore, it was 
necessary to control statistically for the differences in these variables using a mixed models 
analysis. 
 Table 8 also demonstrates the actual number and percent of patient demographics in the 
intervention group compared to the propensity matched group. As recommended by Austin 
(2009, 2007), standardized differences were used to evaluate the match balance since unlike t-
tests, standardized differences are not affected by sample size. All the demographic 
characteristics were included in the propensity match. It is not recommended to run significance 
tests for these characteristics but rather standardized differences are recommended as they are 
neither a characteristic of a hypothetical population nor affected by the sample size (Austin, 
2007; Imai, King, & Stuart, 2008). 
Data Analysis per Hypothesis 
 The following describes the results per hypothesis.  
Data Analysis: Hypothesis 1a 
 H1a: Adult patients with Type 2 diabetes had better patient engagement (number of 
missed (no show encounters/same day cancellations), annual influenza immunizations, 
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and annual eye examinations) after one year's participation in the ICCCM model in 
comparison to one year prior to participation in the ICCCM model. 
Missed (no show/same day cancellation) visits. The data maintained a very right 
skewed poisson distribution. Consequently, a parametric statistical test could not be used to test 
this hypothesis. Since the Wilcoxon signed ranks test looks at the rank or the difference in 
medians rather than standard deviations, it is robust to outliers. Therefore, the Wilcoxon signed 
rank test, a nonparametric test, was used. Three assumptions were met to ensure that this test 
could be used (Laerd Statistics, 2015b). The first assumption met was that the dependent 
variable, missed (no show visits/same day cancellations) visits, was measured at an interval or 
ratio level (Laerd Statistics, 2015b). The second assumption met was that the independent 
variable (the intervention) was measured for two related groups, in this case pre and post 
intervention (Laerd Statistics, 2015b). The final assumption was that the differences in the 
distribution of these two groups were normally distributed (Laerd Statistics, 2015b). When 
looking at the differences distribution, this proved to be true for the total number of missed (no 
show visits/same day cancellations) visits even though the data itself was not normally 
distributed.   
Table 9. Difference in the Number of Missed Office Visits Pre- and Post-ICCCM 
 N  
Post Total Missed Office Visit - Pre 
Total Missed Office Visit 
Post < Pre Missed Office Visit  
65 
Post > Pre Missed Office Visit  
73 
 
Z score 
 
Significance 
Post = Pre Missed Office Visit  
66 
 
-1.090 
 
p = 0.28 
 
As shown in Table 9, there was no statistically significant difference between the number of 
missed appointments one year prior to participating in the ICCCM and one year after 
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participating in the ICCCM. Therefore, the ICCCM study failed to reject the null hypothesis: 
there was no difference in missed appointments pre and post ICCCM intervention. 
Influenza immunizations. McNemar's test was used to determine if this hypothesis was 
accepted or rejected. The following assumptions were met for performing McNemar's test: 1) 
there is one dichotomous dependent variable (received flu shot) from a related group (both from 
the same group pre and post intervention) and 2) the participants in each group are mutually 
exclusive; in this case no one both received the flu shot and did not receive the flu shot (Laerd 
Statistics, 2015a).   
Table 10. Difference in Receiving Annual Influenza Immunization Pre- and Post-ICCCM  
 Post (T1-T3) influenza immunization Total N 
Pre (T2-T1) influenza 
immunization 
 
No (%) 
 
Yes (%) 
 
204 
No 89(43.6%) 32 (15.7%) Significance 
Yes 30(14.7%) 53 (26.0%) p = 0.90 
 
As shown in Table 10, although there was a slight increase in influenza immunization 
post intervention, there was no statistically significant difference between the groups (p = 0.90). 
Consequently, the ICCCM study failed to reject the null hypothesis for influenza immunizations: 
there was no difference in receiving an influenza immunization pre and post ICCCM 
intervention. 
Dilated eye examinations. Since all the assumptions of McNemar's test were met, 
McNemar's test was also used for the statistical analysis of dilated eye examinations. 
Table 11. Difference in the Number of Eye Examinations Pre- and Post-ICCCM 
 Post (T1-T3) eye examination  
Pre(T2-T1) eye examination No (%) Yes (%) Total N: 204 
No 75 (36.8%) 37 (18.1%) Significance 
Yes 32 (15.7%) 60 (29.4%) p = 0.63 
 
As shown in Table 11, although there was an increase in eye examinations post intervention, the 
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difference was not statistically significant (p = 0.63). Consequently, the ICCCM study failed to 
reject the null hypothesis for dilated eye examinations: there was no difference in receiving a 
dilated eye examination pre and post ICCCM intervention. 
Data Analysis: Hypothesis 1b 
 H1b: Adult patients with Type 2 diabetes, who received care at the ICCCM (intervention) 
site, had better patient engagement (number of missed (no show encounters/same day 
cancellations), annual influenza immunizations, and annual eye examinations) after one 
year than a sample of matched patients with Type 2 diabetes who received standard 
primary care within the same health system over that same year. 
A generalized estimating equation with a binary logistic function was used for the 
categorical variables of influenza immunizations and eye examinations to statistically control for 
the covariates of renal disease and baseline A1C. This generalized estimating equation was also 
used for missed visits after this variable was dichotomized. Then, based on the output from the 
generalized estimating equation, an adjusted odds ratio was calculated (Table 12). All matched 
pairs were included in the sample (n=171) for all three dichotomized variables. 
Table 12. Odds Ratio of Patient Engagement Variables in ICCCM Group vs. Matched Group 
Adjusted for BL A1C and Renal Disease  
Variable  Unadjusted 
Mean 
Adjusted 
Mean 
Odds Ratio 95% Adjusted 
Confidence Interval 
Lower Upper 
Missed 
Appointments 
ICCCM 
 Group 
0.36 0.34
b 
0.753 
 
-.739 .170 
Matched 
Group 
0.46 0.41
b 
1(Reference) 
Influenza 
Immunization 
ICCCM  
Group 
0.40
a
 0.43
b
 0.693 -.798 .064 
Matched 
Group 
0.51
a
 0.53
b
 1(Reference) 
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Dilated eye 
examination 
ICCCM  
Group 
0.47 0.57
b 
0.552 -1.058 -.133 
Matched 
Group  
0.64 0.71
b 
1(Reference) 
a Significant at p = 0.033  bBaseline A1C Covariate fixed at 8.5006 
Missed (No Show/Same Day Cancellation) Visits. The Wilcoxon signed rank test was 
used for missed visits since missed visits had a Poisson distribution and did not meet the 
normality assumption of a parametric test (Table 13). However, since the Wilcoxon signed rank 
test cannot adjust for covariates, a general linear model with regular linear regression with 
normally distributed outcome was run despite not meeting the assumptions of a parametric test. 
This was necessary to determine if baseline A1C and/or renal disease had a significant effect on 
the outcome. This general linear model was a multivariable adjusted model to assess if the 
baseline A1C and/or renal disease made a difference. Using this model, it was determined that 
the statistical significance changed due to these covariates indicating that these variables 
attenuated the effect of the outcome of missed visits (Table 14). Therefore, missed visits was 
transformed to a categorical variable with either no missed visits or 1 or more missed visits and a 
generalized estimated equation as previously described was used to analyze this categorical 
variable.  
Table 13. Difference in the number of Missed Office Visits Between ICCCM and Matched 
Group 
 N  
Post Total Missed Office Visit - Pre 
Total Missed Office Visit 
ICCCM < Control  
58 
ICCCM > Control  
81 
 
Z score 
 
Significance 
ICCCM = Control  
32 
 
-2.266 
 
p = 0.02 
 
As shown in Table 13, there was a statistically significant difference between the number 
of missed appointments with the matched control group having a statistically significant 
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decreased number of missed visits than the ICCCM group (p = .02). Therefore, based on this 
data, the null hypothesis was rejected. Surprisingly, the matched control had a statistically 
significant fewer missed visits compared to the ICCCM group. However, since it was not 
possible to control for the Baseline A1C or renal disease, this data was also run as a mixed model 
despite being a Poisson distribution, which did not meet the assumptions of normality of the 
mixed model.  
Table 14. Missed Visits Controlling for Renal Disease and Baseline A1C
* 
 Covariates 
added to 
model 
Group Mean t-
statistic 
Significance 
 
 
Number of 
Missed 
Visits 
none ICCCM 1.94  2.101 0.04 
Control 1.42 
Renal 
disease 
ICCCM 2.22 1.732 0.08 
Control 1.79 
Baseline 
A1C 
ICCCM 1.85  1.334 0.18 
Control 1.50 
Renal 
disease & 
BL A1C 
ICCCM 2.13  0.995 0.32 
Control 1.87 
*Baseline A1C controlled at 8.5006 
As shown in Table 14, when adjusted for either baseline A1C and/or renal disease, 
missed visits were no longer statistically significant demonstrating that the null hypothesis was 
no longer able to be rejected. Since the mixed model assumptions had not been met, to accurately 
determine the statistical significance of missed visits while controlling for baseline A1C and 
renal disease, this data was dichotomized. 
As shown in Table 12, these results demonstrate that after adjusting for the covariates of 
renal disease and controlling baseline A1C at 8.5006, the odds of the intervention group having 
no missed visits (no show/same day cancellations) was 0.753 times lower than that of the control 
group. Although these data show the control group with fewer missed visits, this difference was 
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not statistically significant X
2
 (1, N = 171) = 1.503, p=0.22, CI [-0.739, 0.170]. Therefore, the 
ICCCM study failed to reject the null hypothesis: there was no difference between the number of 
missed (no show/same day cancellation) visits in the intervention group compared to the 
propensity matched group. 
Influenza immunizations. As shown in Table 12, after adjusting for the covariates of 
renal disease and controlling baseline A1C at 8.5006, the odds of the intervention group 
receiving their annual influenza immunization was 0.693 times lower than the control group. 
However, this difference was not statistically significant: X
2
 (1, N = 171) =2.792, p =0.10, 95% 
CI [-0.798, 0.064]. Therefore, the ICCCM study failed to reject the null hypothesis: there was no 
difference between the number of annual influenza immunizations in the intervention group 
compared to the propensity matched group.    
Dilated eye examinations. As shown in Table 12, after controlling for covariates with 
the baseline A1C controlled at 8.5006, the odds of the intervention group receiving their annual 
eye examination was 0.552 times lower than the control group. This difference was statistically 
significant - X
2
 (1, N = 342) =6.378, p =0.01, 95% CI [-1.058, -0.133] in that the patients in the 
ICCCM clinic were less likely to have an annual eye examination. Therefore, the ICCCM study 
rejected the null hypothesis, and the matched control group was more likely to have an annual 
eye examination. 
Data Analysis: Hypothesis 2a 
 H2a: Adult patients with Type 2 diabetes had better health care utilization (fewer 
hospitalizations, fewer hospital days, and fewer emergency room visits) after one year's 
participation in the ICCCM model in comparison to one year prior to participation in the 
ICCCM model. 
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As expected, all three variables, number of hospitalizations, emergency room visits and 
number of hospital days maintained a very right skewed poisson distribution. Consequently, a 
parametric statistical test could not be used to evaluate the data. Therefore, the Wilcoxon signed 
rank test, a nonparametric test was used. As previously explained, all three assumptions were 
met to ensure that this test could be used (Laerd Statistics, 2015b).   
Number of hospitalizations. As shown in Table 15, the difference in the number of 
hospitalizations pre- and post- ICCCM was evaluated using the Wilcoxon signed test. 
Table 15. Difference in the Number of Hospitalizations Pre- and Post-ICCCM 
 N(%) Post Hospitalizations – Pre 
Hospitalizations Post < Pre 33(16.2%) 
Post > Pre 31(15.2%) Z Significance 
Post = Pre 140(68.6%) -0.177  p = 0.86 
 
Although there was a slight decrease in number of hospitalizations post intervention, this 
difference was not significant, z = -0.177, p = 0.86. Therefore, the ICCCM study failed to reject 
the null hypothesis: there was no difference in the number of hospital visits pre and post 
intervention. 
Number of emergency room visits. As shown in Table 16, the difference in the number 
of emergency room visits pre- and post- ICCCM was evaluated using the Wilcoxon signed test. 
Table 16. Difference in Number of Emergency Room (ER) Visits Pre- and Post-ICCCM 
 N(%)  
Post ER visit - Pre ER visit Post ER visit < Pre ER visit 27(13.2%) 
Post ER visit > Pre ER visit 40(19.6%) Z Significance  
Post ER visit = Pre ER visit 137(67.2%) -1.108 p = 0.27 
 
Although more patients sought treatment in the emergency room after the intervention 
than before, there was no statistically significant difference between the two groups (p = 0.27). 
Therefore, the ICCCM study failed to reject the null hypothesis: there was no difference in the 
number of emergency room visits pre and post intervention. 
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Number of days hospitalized. As shown in Table 17, the difference in the number of 
days hospitalized pre- and post- ICCCM was evaluated using the Wilcoxon signed test. 
Table 17. Difference in Number of Hospital Days Pre- and Post-ICCCM Implementation 
 N(%) Wilcoxon sign Test 
Posthosp days < Prehosp days  
34(16.7%) 
Posthosp days > Prehosp days  
35(17.2%) 
 
Z 
 
Significance 
 
Posthosp days = Prehosp days  
135(66.2%) 
 
-0.473 
 
p = 0.64 
 
The difference in the number of days hospitalized pre and post ICCCM participation was 
not statistically significant (p = 0.64). Therefore, the ICCCM study failed to reject the null 
hypothesis: there was no difference in the number of hospital days pre and post intervention. 
Data Analysis: Hypothesis 2b 
 H2b: Adult patients with Type 2 diabetes who received care at the ICCCM (intervention) 
site had better health care utilization (fewer hospitalizations, fewer hospital days, and 
fewer emergency room visits) after one year than a sample of matched patients with Type 
2 diabetes who received standard primary care within the same health system over that 
same year. 
All three healthcare utilization variables demonstrated significant outliers in the Poisson 
distribution, violating the assumptions for the use of parametric statistics. Therefore, the 
Wilcoxon Signed Rank test was used to determine the effect of the ICCCM model on the 
intervention group when compared to a propensity matched group of patients for the healthcare 
utilization variables. As previously described, a general linear model was also run to control for 
the covariates for baseline A1C and renal disease despite not meeting all of the assumptions, 
since the Wilcoxon Signed Rank test does not provide a method of controlling for variables (see 
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Table 18). Neither the direction nor the significance of the results differed between the general 
linear model and Wilcoxon Signed Test for the three utilization outcome variables. 
Consequently, the decision was made to use the Wilcoxon Signed Rank test for these variables. 
Table 18. Healthcare Utilization Controlling for Renal Disease and Baseline A1C
* 
 Group Mean t-
statistic 
Significance 
Number of 
Hospitalizations 
ICCCM 0.77 -1.191 0.24 
Control 0.62 
Number of 
Emergency 
Room Visits 
ICCCM 0.40 0.341 0.73 
Control 0.37 
Number of 
Hospital Days 
ICCCM 3. 86 -0.850 0.40 
Control 3. 28  
*Baseline A1C controlled at 8.5006 
Number of hospitalizations. As shown in Table 19, although three more participants in 
the intervention group had more hospitalizations than the matched control group, this difference 
between the two groups was not statistically significant (p = 0.59). Consequently, the ICCCM 
study failed to reject the null hypothesis: there was no difference in the number of 
hospitalizations between the intervention group and propensity matched group. 
Emergency room visits. As shown in Table 19, although nine more ICCCM participants 
had more emergency room visits than the matched control group, this difference between these 
two groups was not statistically significant (p = 0.24). Consequently, the ICCCM study failed to 
reject the null hypothesis: there was no difference in the number of emergency room visits 
between the ICCCM group and propensity matched group. 
Number of days hospitalized. As shown in Table 19, although five more ICCCM 
participants had a greater number of hospital days then the propensity matched control group, 
this difference was not statistically significant (p = 0.48). Consequently, the ICCCM study failed 
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to reject the null hypothesis: there was no difference in the number of hospital days between the 
intervention group and the propensity matched control group. 
Table 19. Difference in Healthcare Utilization in ICCCM Intervention Group and Matched 
Group 
 N(%) ICCCM hospitalizations - Matched 
hospitalizations 
 
ICCCM hospitalizations < Matched 
hospitalizations 
 
29(17.0%) 
ICCCM hospitalizations > Matched 
hospitalizations 
 
32(18.7%) 
 
Z 
 
Significance 
ICCCM hospitalizations = Matched 
hospitalizations 
 
110(64.3%) 
 
-0.536 
 
p = 0.59 
ICCCM ER visits < Matched ER 
visits 
 
28(16.4%) 
ICCCM ER visits – Matched ER 
visits 
 
ICCCM ER visits > Matched ER 
visits 
 
37(21.6%) 
 
Z 
 
Significance 
ICCCM ER visits = Matched ER 
visits 
 
106(62.0%) 
 
-1.168 
 
p = 0.24 
ICCCM hosp days < Matched hosp 
days 
 
29(17.0%) 
ICCCM hosp days – Matched hosp 
days 
 
ICCCM hosp days > Matched hosp 
days 
 
34(19.9%) 
 
Z 
 
Significance 
ICCCM hosp days = Matched hosp 
days 
 
108(63.2%) 
 
-0.703 
 
p = 0.48 
 
Data Analysis: Hypothesis 3a 
 H3a: Adult patients with Type 2 diabetes had better clinical indicators (percent of 
patients with Hgb A1C levels > 9.0; change in Hgb A1C, weight, and systolic and 
diastolic blood pressure, systolic blood pressure < 140, diastolic blood pressure < 90) 
after one year's participation in the ICCCM model in comparison to one year prior to 
participation in the ICCCM model. 
Clinical Indicators. The clinical indicator data were continuous data, which assumed a 
normal distribution. However, since the ICCCM group were from a family practice clinic, there 
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were patients who were related and living in the same household (i.e. spouses, or parent/child). 
Therefore, it could not be assured that these patients met the parametric assumption of 
independence (Field, 2009). Consequently, since the assumptions of a parametric test were 
violated, nonparametric tests for all clinical indicators were used. After verifying assumptions, 
McNemar's test was used to analyze all categorical variables (i.e. A1C > 9, systolic blood 
pressure < 140, diastolic blood pressure < 90), and the Wilcoxon signed rank test was used for all 
continuous variables (change in absolute numeric value pre and post ICCCM) (Laerd Statistics, 
2015a; Laerd Statistics, 2015b).   
A1C. The A1C was measured as both dichotomized with A1C > 9.00 or ≤ 9.00 and as a 
continuous variable. Both the change in A1C from just prior to the ICCCM to one year of 
participation and the difference between the A1C one year prior to the ICCCM and one year after 
the initiation of the ICCCM intervention were analyzed. 
Categorical analysis of A1C. McNemar's test evaluated the difference between the 
number of patients with A1C levels > 9.00 pre and post entering the ICCCM intervention. Of the 
initial 204 participants, 182 participants had data from one year prior to the ICCCM entry and 
one year post ICCCM entry.   
Table 20. Difference in Number of High A1C (9.0) Pre- and Post-ICCCM 
 Post (T3) A1C Grouped Total N 
Pre(T1) A1C Grouped N ≤9.00 (%)  N > 9.00 (%) 182 
≤9.00 83 (45.6%) 13 (7.1%) Significance 
> 9.00 41 (22.5%) 45 (24.7%) p = 0.001 
 
As shown in Table 20, there was a statistically significant difference among the groups (p 
= 0.001) indicating that more patients improved their A1C after participating in the ICCCM 
intervention. Consequently, the null hypothesis was rejected.    
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Absolute change in A1C. The change in A1C pre and post the ICCCM intervention 
violated the independence assumption for parametric tests. Therefore, the Wilcoxon signed rank 
test was used. The change between A1C just prior to starting in the ICCCM and one year post 
ICCCM (T1 & T3) was evaluated for the 182 participants. As shown in Table 21, there was a 
significant change in A1C over the year with z = -5.650, p < 0.001. Consequently, the null 
hypothesis for the difference between the change in A1C pre and post intervention equaling zero 
was rejected and more patients had statistically significant lower A1C after the ICCCM 
intervention than before the intervention.  
Table 21. Change in A1C Pre- and Post-ICCCM Intervention  
A1C change between timepoints (Pre 
ICCCM – Post ICCCM) 
 Z Significance 
A1C pre ICCCM< A1C post ICCCM  58(31.9%) -5.650 < 0.001 
A1C pre ICCCM > A1C post ICCCM 114(62.6%) 
A1C pre ICCCM = A1C post ICCCM 10(5.5%) 
 
Absolute difference in A1C. The difference between A1C for the year prior to ICCCM 
and A1C for the year after ICCCM initiation was evaluated for the 164 participants with data at 
all three timepoints using the Wilcoxon signed test. As shown in Table 22, there was a 
significant difference (p < 0.001). Consequently, the null hypothesis for the difference in A1C 
pre and post intervention equaling zero was rejected and more patients had statistically 
significant lower A1C in the year after the intervention than in the year before the intervention. 
 
Table 22. Difference in A1C Pre -and Post-ICCCM Intervention 
Difference in A1C over one year N(%) Z score Significance 
Difference Post ICCCM A1C (T1-
T3) < Difference Pre ICCCM A1C 
(T2-T1) 
53(32.3%) -4.470 < 0.001 
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Difference Post ICCCM A1C (T1-
T3) > Difference Pre ICCCM A1C 
(T2-T1) 
110(67.1%) 
Difference Post ICCCM A1C (T1-
T3) = Difference Pre ICCCM A1C 
(T2-T1) 
1(0.6%) 
T1A1C = at ICCCM intervention; T2A1C = 1 year pre ICCCM intervention; T3 A1C = 1 year 
post ICCCM intervention 
 
Weight. Participants (n=171) were selected for this variable only if they were overweight 
when entering the ICCCM intervention (T1): their BMI was greater than 25 or if they had no 
BMI and their weight was greater than 185 pounds (Centers for Disease Control and Prevention 
[CDC], 2016b). The decision to use 185 pounds was determined as it was unlikely for anyone, 
male or female to have a height more than 6 feet and the BMI for a patient with a weight of 185 
pounds and height of 6 feet is 25.1 or overweight. However, 44 of these participants either were 
not overweight or did not have a weight both pre and post and 1 additional patient did not have a 
weight one year prior to ICCCM. Consequently, the final analysis included 160 participants for 
change in weight and 159 for difference in weight.  
Absolute change in weight. As shown in Table 23, the change in weight pre ICCCM and 
post ICCCM was statistically significant (p = 0.02). Consequently, the null hypothesis for the 
change in weight pre and post intervention equaling zero was rejected and more patients had 
statistically significant lower weights in the year after the intervention than before the 
intervention.   
Table 23. Change in Weight Pre- and Post-ICCCM Intervention 
Weight N(%) Z score Significance 
Post ICCCM wt < Pre ICCCM wt (wt loss) 88(55%) -2.280 p = 0.02 
Post ICCCM wt > Pre ICCCM wt (wt gain) 62(38.8%) 
Post ICCCM wt = Pre ICCCM wt (no change) 10(6.3%) 
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Absolute difference in weight. Next the difference in weight pre and post intervention for 
the overweight participants with weight information at all three timepoints (N= 159) was then 
calculated and compared using the Wilcoxon signed rank test. As shown in Table 24, the 
difference in weight for the full year prior to ICCCM compared to the year after ICCCM was not 
statistically significant. Consequently, the ICCCM study failed to reject the null hypothesis. 
Participants who were overweight at baseline had no statistically significant difference in weight 
for the year after the intervention compared to the year before the intervention. Therefore, 
although overweight patients overall had a statistically significant decrease in weight between T1 
and T3, the change in the difference in weight for the year prior to the intervention compared to 
post intervention was not statistically significant. 
Table 24. Difference in Weight Pre- and Post-ICCCM Intervention 
Weight change between timepoints (Yr after 
intervention (T1-T3) – Yr prior to intervention 
(T2-T1)) 
 Z score Significance 
Post wt loss (T1-T3) < pre wt loss (T2-T1) 79(49.7%) -.269 p= 0.79 
Post wt loss (T1-T3) > pre wt loss (T2-T1) 78(49.1%) 
Post wt loss (T1-T3) = pre wt loss (T2-T1) 2(1.3%) 
 
Blood pressure. Participants were selected for this variable only if they carried the 
diagnosis of hypertension at T1 (n=183) in the administrative data set (ICD codes). Blood 
pressure was measured in 3 ways: 1) change in blood pressure, 2) difference in blood pressure, 3) 
dichotomized blood pressure. The change (pre ICCCM (T1) and post ICCCM (T3)) and the 
difference (year prior to the intervention (T2-T1) and the year post intervention (T1-T3) in the 
systolic and diastolic blood pressure values of these hypertensive participants were compared 
using the Wilcoxon signed rank test. A total of 180 participants had blood pressure results for 
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both two (change in blood pressure) and three (difference in blood pressure) timepoints. 
Therefore, 180 participants of the 183 potential participants with hypertension were included in 
the analysis of both change and difference in blood pressure. Next, these participants were 
separated into groups based on systolic blood pressure less than 140 or greater than or equal to 
140 and diastolic blood pressure less than 90 or greater than or equal to 90. Since this is 
dichotomous nonparametric data, McNemar's test was used for this analysis after verifying 
assumptions.   
Absolute change in systolic blood pressure. As shown in Table 25, the change in the 
value of systolic blood pressure immediately pre and post ICCCM was not statistically 
significant (p = 0.48). Consequently, the null hypothesis for the change between post ICCCM 
systolic blood pressure and pre ICCCM systolic blood pressure being the same was supported. 
There was no difference in systolic blood pressure pre and post intervention.  
Table 25. Change in Systolic Blood Pressure Pre- and Post-ICCCM 
Systolic Blood Pressure N(%) Z score Significance 
T3 systolic b/p < T1 systolic b/p 79(43.9%) -0.709 p = 0.48 
T3 systolic b/p > T1 systolic b/p 92(51.4%) 
T3 systolic b/p = T1 systolic b/p 9(5.0%) 
 
Absolute change in diastolic blood pressure. As shown in Table 26, the change in 
diastolic blood pressure immediately pre and post ICCCM was not statistically significant (p = 
0.66). Consequently, the null hypothesis for the change between post ICCCM diastolic blood 
pressure and pre ICCCM diastolic blood pressure being the same was supported. There was no 
difference in diastolic blood pressure pre and post intervention.  
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Table 26. Change in Diastolic Blood Pressure Pre-and Post-ICCCM 
Diastolic Blood Pressure  Z score Significance 
T3 diastolic b/p < T1 diastolic b/p 88(49.2%) -0.440 p = 0.66 
T3 diastolic b/p > T1 diastolic b/p 77(42.8%) 
T3 diastolic b/p = T1 diastolic b/p 15(8.4%) 
 
Absolute difference in systolic blood pressure. As shown in Table 27, the difference in 
systolic blood pressure for the year prior to ICCCM compared to the year post ICCCM was not 
statistically significant (p = 0.478). Consequently, the null hypothesis for the difference between 
systolic blood pressure one year before ICCCM and one year after ICCCM equaling zero was 
supported. There was no difference in systolic blood pressure one year pre ICCCM compared to 
one year post ICCCM.  
Table 27. Difference in Systolic Blood Pressure Values for Years Pre- and Post-ICCCM 
Difference in Systolic Blood Pressure N(%) Z score Significance 
T1-T3 < T2-T1 89(49.7%) -0.709 p = 0.48 
T1-T3 > T2-T1 86(47.8%) 
T1-T3 = T2-T1 5(2.8%) 
 
Absolute difference in diastolic blood pressure. As shown in Table 28, the difference in 
diastolic blood pressure values for the year prior to ICCCM compared to the year post ICCCM 
was not statistically significant (p = 0.92). Consequently, the null hypothesis for the difference 
between diastolic blood pressure one year before ICCCM and one year after ICCCM equaling 
zero was supported. There was no difference in diastolic blood pressure one year pre ICCCM 
compared to one year post ICCCM.  
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Table 28. Difference in Diastolic Blood Pressure Values for Years Pre- and Post-ICCCM 
Difference in change of Diastolic Blood 
Pressure 
 Z score Significanc
e 
T1-T3 < T2-T1 87(48.3%) -0.096 p = 0.92 
T1-T3 > T2-T1 85(47.5%) 
T1-T3 = T2-T1 8(4.5%) 
 
Dichotomized systolic blood pressure. As shown in Table 29, the difference in the 
pre/post number of participants with systolic blood pressure <140 compared to ≥ 140 was not 
statistically significant (p = 1.00). Consequently, the number of participants with a systolic blood 
pressure less than 140 one year after ICCCM was no different than the number of participants 
with a systolic blood pressure less than 140 pre ICCCM. Therefore, the null hypothesis was not 
rejected. There was no difference in systolic blood pressure less than 140 pre and post 
intervention. 
Table 29. Grouped Systolic Blood Pressure Pre- and Post-ICCCM 
 Post (T3) Systolic BP  Total N 
Pre(T1) Systolic BP N <140 (%) N ≥ 140 (%) 179 
< 140 80 (44.7%) 33 (18.4%) Significance 
≥ 140 33 (18.4%) 33 (18.4%) p = 1.00 
 
Dichotomized diastolic blood pressure. As shown in Table 30, the difference in the 
pre/post number of participants with diastolic blood pressure <90 compared to ≥ 90 was 
statistically significant (p = 0.04). Consequently, the number of participants with a diastolic 
blood pressure less than 90 post ICCCM was greater than the number of participants with a 
diastolic blood pressure less than 90 pre ICCCM. Therefore, the null hypothesis was rejected. 
There was a statistically significant improvement in the number of participants with a diastolic 
blood pressure less than 90 post ICCCM compared to pre ICCCM. 
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Table 30. Grouped Diastolic Blood Pressure Pre- and Post-ICCCM 
 Post (T3) Diastolic BP Total N 
Pre(T1) Diastolic BP   N <90 (%) N ≥ 90 (%) 179 
< 90 143 (79.9%) 7 (3.9%) Significance 
≥ 90 18 (10.1%) 11 (6.1%) p = 0.04 
 
Data Analysis: Hypothesis 3b 
 H3b: Adult patients with Type 2 diabetes who received care at the ICCCM (intervention) 
site will have better clinical indicators (percent of patients with Hgb A1C levels > 9.0; 
change in Hgb A1C, weight, and systolic and diastolic blood pressure, systolic blood 
pressure < 140, diastolic blood pressure < 90) for one year than a sample of matched 
patients with Type 2 diabetes who received standard primary care within the same health 
system over that same year. 
Again, since the assumption of independence was likely violated, nonparametric tests 
were used to evaluate all clinical indicators. A generalized estimating equation controlling for 
baseline A1C and renal failure was used to analyze the dichotomized variables of A1C > 9.0, 
systolic blood pressure < 140 and diastolic blood pressure < 90 at T3. A general linear mixed 
model for quantitative variables was run to determine the effect of the ICCCM model on the 
intervention group and a propensity matched group of patients for the continuous variables of 
change in A1C, weight, systolic and diastolic blood pressure while controlling for the 
dichotomous covariate renal disease and the continuous covariate baseline A1C. Since the data 
did not meet all the assumptions of the parametric test, the Wilcoxon Signed Rank test was also 
run to ensure there was no discrepancy in the results after controlling for the covariates using a 
parametric test and the nonparametric test. Finally, since both the general linear mixed model 
and generalized estimating equations are robust to missing data and the level of missing data was 
not high, matches with data points for only one of the two groups (intervention or control) were 
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kept in the statistical model (Field, 2009). Hence the number of participants in some instances is 
different between the groups. The results of the generalized estimating equations (Table 31) and 
the general linear mixed model (32) for all the clinical variables are shown in the tables below. 
Table 31. Odds Ratio of ICCCM Group vs. Matched Group in Categorized A1C, Systolic B/P, 
Diastolic B/P Adjusted for BL A1C and Renal Disease 
Variable  N Unadjusted 
Mean 
Adjusted 
Mean 
Odds Ratio 
HGB A1C level 
> 9.0 
ICCCM Group 155 0.37 0.19
a 
1.802 
Matched Group 163 0.16 0.12
a 
1 (Reference) 
Systolic B/P < 140 
ICCCM Group 150 0.61 0.61
b 
0.799 
Matched Group 149 0.68 0.66
b 
1(Reference) 
Diastolic B/P 
< 90 
ICCCM Group 150 0.89 0.91
b 
1.147 
Matched Group 149 0.89 0.90
b 
1(Reference) 
a Baseline A1C Covariate fixed at 8.5013 
b Baseline A1C Covariate fixed at 8.5007 
 
Table 32. Change in Clinical Indicators Between ICCCM Group and Matched Group Unadjusted 
and Adjusted for Baseline A1C and Renal Disease 
       95% Confidence 
Interval 
Variable Group N Unadjusted 
Mean 
Adjusted 
Mean 
t Sig. Lower 
Bound 
Upper 
Bound 
Change 
in A1C 
ICCCM 
Group 
152 0.66 0.79
a 
2.948 .003 0.176 0.881 
Matched 
Group 
156 0.04 0.26
a 
    
Change 
in 
Weight 
ICCCM 
Group 
165 2.72 2.37
b 
1.490 0.14 -0.863 6.234 
Matched 
Group 
165 0.34 -.32
b 
    
Change 
in 
Systolic 
B/P 
 
 
ICCCM 
Group 
169 -0.48 -0.19
c
 -
1.129 
0.26 -7.366 1.993 
Matched 
Group 
169 1.41 2.50
c
     
Change 
in 
Diastolic 
B/P 
ICCCM 
Group 
169 -0.21 -0.38
c
 -
0.751 
0.45 -3.839 1.717 
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Matched 
Group 
169 0.95 0.68
c 
    
a
 Based on N = 308, Covariates: Baseline A1C = 8.5117 
b 
Based on N = 330, Covariate: Baseline A1C = 8.5773 
c Based on N = 338, Covariate Baseline A1C = 8.4893 
 
 HGB A1C level > 9.0. As shown in Table 31, these results demonstrate that after 
adjusting for the covariates of renal disease and controlling baseline A1C at 8.5013, the odds of 
the intervention group having an A1C > 9.0 after one year (T3) was 1.8 times higher than that of 
the control group. However this difference was not statistically significant X
2
 (1, N = 318) = 
2.798, p = 0.09, CI [-1.01, 1.279]. Therefore, the null hypothesis was not rejected: there was no 
difference between the number of patients with an A1C > 9.0 after one year in the intervention 
group compared to the propensity matched group.   
However, the unadjusted results (Table 32), demonstrated a significant difference 
between the number of patients with an A1C > 9.0 after one year in the intervention group 
compared to the propensity matched group (X
2
 (1, N = 318) = 20.160, p<0.001, CI [0.631, 
1.609]). The unadjusted odds of the intervention group were 3.065 times more likely to have an 
A1C >9 after the intervention than the matched comparison group. However, at baseline there 
were also more patients that had an A1C > 9.0 in the intervention group (N = 80) than the 
matched comparison group (N = 31). Consequently, as shown in Table 33, adjusting for baseline 
A1C attenuated the difference in A1C >9 between the ICCCM and matched comparison groups. 
Table 33. Odds Ratio of ICCCM Group vs. Matched Group With and Without Adjustments in 
Categorized A1C > 9 
 Covariates 
added to 
model 
Group Mean Odds Ratio Wald 
Chi-
Square 
Significance 
 
HGB A1C 
level 
> 9.0 
none ICCCM 0.37 3.065 20.160 p < 0.001 
Control 0.16 1 (Reference) 
Renal 
disease 
ICCCM 0.36 3.099 19.778 p < 0.001 
Control 0.15 1 (Reference) 
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 Baseline 
A1C 
ICCCM 0.21
a
 1.730 2.514 p = 0.11 
Control 0.13
a
 1 (Reference) 
Renal 
disease & 
BL A1C 
ICCCM 0.19
a
 1.802 2.798 p = 0.09 
Control 0.12
a
 1 (Reference) 
a
Baseline A1C=8.5013 
Change in A1C. As shown in Table 32, 308 total participants were included in this 
analysis. The results indicate that the intervention group had a statistically significant higher 
mean change in A1C from pre (T1) to post (T3) ICCCM with the covariate of baseline A1C 
controlled at 8.5117 t(308) = 2.948, p=0.003, indicating that the intervention group had a 
statistically significant larger improved change in A1C from pre-post (T1-T3) than the control 
group. Therefore, for hypothesis 3b, the change in A1C was significantly improved in the 
intervention group. Therefore, the null hypothesis was rejected; there was a statistically 
significant improved change in A1C for the intervention group pre to post (T1 to T3) ICCCM 
compared to the propensity matched group.   
Weight change. As shown in Table 32, 330 participants were included in this analysis. 
The results indicate that although the intervention group did have a lower mean change in weight 
from pre (T1) to post (T3) ICCCM with the covariate of baseline A1C controlled at 8.5773, the 
difference was not statistically significant t(256) = 1.490, p=0.14. Therefore, the null hypothesis 
was not rejected, there was no difference between the weight change in the intervention group 
compared to the propensity matched group. 
Systolic blood pressure < 140. As shown in Table 31, after adjusting for the covariates 
of renal disease and controlling baseline A1C at 8.5007, the odds of the intervention group 
having a systolic blood pressure < 140 at one-year post ICCCM (T3) was 0.799 times lower than 
that of the control group. However, this difference was not statistically significant X
2
 (1, N = 
299) = 0.746, p = 0.39, CI [-0.734, 0.285]. Therefore, the null hypothesis was not rejected: there 
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was no difference between the number of patients with a systolic blood pressure < 140 after one 
year (T3) in the intervention group compared to the propensity matched group.   
Change in systolic blood pressure. As shown in Table 32, 338 participants were 
included in this analysis. The results demonstrate that the intervention group had a lower mean 
change in systolic blood pressure from pre (T1) to post (T3) ICCCM with the covariate of 
baseline A1C controlled at 8.4893. However, the difference was not statistically significant 
t(338) = -1.129, p = 0.26, CI [-7.366, 1.993]. Therefore, for hypothesis 2b, the null hypothesis 
was not rejected: there was no difference between the systolic blood pressure change in the 
intervention group compared to the propensity matched group. 
Diastolic blood pressure < 90. As shown in Table 31, after adjusting for the covariates 
of renal disease and controlling baseline A1C at 8.5007, the odds of the intervention group 
having a diastolic blood pressure < 90 after one year of ICCCM (T3) was 1.147 times higher 
than that of the control group. However, this difference was not statistically significant X
2
 (1, N = 
299) = 0.141, p = 0.71, CI [-0.579, 0.854]. Therefore, the null hypothesis was not rejected: there 
was no difference between the number of patients with a diastolic blood pressure < 90 after one 
year (T3) of ICCCM in the intervention group compared to the propensity matched group.  
Change in diastolic blood pressure. As shown in Table 32, 338 participants were 
included in this analysis. The results demonstrate that the intervention group had a lower mean 
change in diastolic blood pressure from pre (T1) to post (T3) ICCCM with the covariate of 
baseline A1C controlled at 8.4893. However, the difference was not statistically significant 
t(338) =-0.751, p = 0.45, CI [-3.839, 1.717]. Therefore, the null hypothesis was not rejected: 
there was no difference between the diastolic blood pressure change in the intervention group 
compared to the propensity matched group.
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CHAPTER FIVE 
DISCUSSION 
 This chapter is divided into six main sections: study limitations, discussion of results, 
theoretical linkages, implications for healthcare, future opportunities for research and conclusion. 
Study Limitations 
 Study limitations incorporated 3 main areas (1) limitations due to the data collection 
process, (2) limitations inherent to secondary data and propensity matching and (3) historical 
biases.  
Limitations Due to the Data Collection Process 
Limitations due to the data collection process included (1) limitation associated with 
identifying the ICCCM population (2) the inability to measure variables (healthcare utilization, 
influenza immunizations and eye examinations) outside this healthcare system and (3) limiting 
the population to one healthcare system.  
 Limitations of care coordinator lists to identify ICCCM population. The care 
coordinator lists of patients varied over time in that patients dropped out of the study and/or 
clinic for various reasons. In the initial ICCCM study rollout, patients were not given the option 
of choosing to participate but were automatically placed on the care coordinators lists if they met 
criteria. This documentation process was later revised to only include patients who agreed to 
participate in care-coordination. Also, since the care coordinators deleted inactive patients from 
their lists, there may have been ICCCM patients who had completed a year of ICCCM but chose 
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to drop out of the study or relocated and changed primary care clinics after one year. It is 
unknown how many patients may have dropped from the study before or after completing a full 
year of ICCCM. To address this limitation, a chart review was conducted for all potential 
intervention participants to ensure that they met inclusion/exclusion criteria.   
 Limitations of healthcare utilization received outside this healthcare system. 
Information about healthcare utilization (hospitalizations and emergency room visits) received 
outside this healthcare system was not available and could skew the results. In a systematic 
review, Hansen et al. (2011) estimated that this could account for as much as 20% error in 
number and length of hospitalizations. However, for this study, it was assumed that this would be 
similar between the pre and post period and across the comparison and intervention groups.  
Limitations of influenza vaccinations and dilated eye examinations received outside 
this healthcare system. Similarly, a limitation for both influenza vaccinations and dilated eye 
examinations relates to documentation and care provision. Both can be provided at outside 
facilities and thus be underreported. The PCP and care coordinator have little control over 
whether and where patients obtain an ophthalmology examination. This is a limitation for all 15 
PCP clinics (both the ICCCM and the propensity matched groups). Since all clinics within the 
health system utilized the same process for documenting both influenza immunizations and eye 
examinations provided at outside facilities, it was assumed that missed information would be 
equivalent between the pre/post and control/intervention arms of the study. All participants 
should be equally affected by this limitation unless it is mitigated by another variable (i.e., 
socioeconomic status). 
Limiting the population to one healthcare system. This study examined patients within 
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one healthcare system within a large Midwestern city. A benefit is that the clinics followed the 
same policies and procedures and experienced similar organizational and regional cultures. 
Although site-specific differences were minimized, findings are not necessarily generalizable 
outside this healthcare system. Consequently, any transferability of the findings to other 
populations outside this healthcare system must be viewed with caution.  
Limitations Inherent to Secondary Data and Propensity Matching  
Health services research methods have limitations inherent to the process. 
Secondary data limitations. Study variables were limited to those elements captured in 
the medical record. Therefore, some variables could not be measured like socioeconomic status 
(SES), making a proxy variable necessary. Proxy variables (e.g. insurance for SES) were chosen 
based on previous research (Jack et al., 2009).  
Socioeconomic status limitation. Differences in socioeconomic status between the 
intervention group and propensity match were difficult to control and may have led to overt bias. 
The large ICCCM clinic served one of the poorest areas of the city, and the EHR does not 
provide an ideal variable to measure socioeconomic status (SES). This study aligned with other 
studies in the literature and used insurance coverage as a proxy for SES (Jack et al., 2009).  
Also, insurance coverage is recorded for a single point in time for both the ICCCM and 
propensity matched group. Since insurance is generally tied to employment in the US and can 
change over the year, it is possible that patients with lower SES may be more likely to face 
insurance policy changes or be without insurance within a year's timeframe. The intervention 
population may have experienced more insurance fluctuation in comparison to the propensity 
match sample.   
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Missing data. The amount of missing data for this study was minimal. In fact, less than 
5% of the data was missing for any of the three data groups: pre-intervention, post-intervention 
or matched comparison group. The data point most frequently missing was the A1C. Since lab 
work involves an additional charge, it is possible that not all patients in this population were able 
to afford additional expenses and thus were of a lower socioeconomic status than those with all 
data points. However, this amount of missing data is minimal.  
Data timepoints. Using a six-month timeframe before or after the three timepoints is a 
limitation in that there was a wide timeframe in which to collect the data for both the matched 
and intervention groups. Since the same process was followed for both the ICCCM and the 
comparison groups with the data element closest to the timepoint being used, both groups were 
similarly affected.  
Propensity match variable limitations. The most significant limitation of propensity 
matching is that the match is limited to variables chosen for matching; it is always possible that 
an unobserved unmatched variable could have accounted for the findings. An unmatched 
measure in the ICCCM study could account for significant differences between the groups. 
Matching on a greater number of variables minimizes this risk. In this study, to minimize bias, 
the propensity score variables were based on previous studies and included all demographic data, 
baseline A1C, number of years with diabetes and comorbidities as listed in the Charlson 
comorbidity scale (Xing et al., 2015; Jack et al., 2009; D’Hoore, Sicotte, & Tilquin, 1993). The 
Charlson comorbidity scale has been used to match chronic conditions in other research studies 
(D'Hoore, Sicotte, & Tilquin, 1993; Xing et al., 2015).  
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In the ICCCM match, an ideal match on renal disease, baseline A1C and the date of 
diabetes was not possible within this healthcare system. The date of diabetes diagnosis was only 
documented when coded in the administrative database, which could have been the date patients 
entered the healthcare system, rather than the date of original diagnosis. Consequently, it was 
decided that the date was likely inaccurate. Therefore, it was not used as a covariate. The other 
two variables were controlled statistically.  
Historical Bias Limitations  
 Historical bias is always a consideration in research. In this study, the Patient Protection 
and Affordable Care Act had completed rollout but was still being adapted in healthcare systems 
throughout the US due to Medicaid expansion and 30-day readmission penalties. 
 Care coordination for Medicaid patients. During this period of time, Medicaid was 
expanded under the Affordable Care Act, and Medicaid patients in all clinics had their own care 
coordinators in addition to the care coordinator within the intervention arm of the study. 
Medicaid care coordinators learned from the ICCCM system and used the ICCCM tools for care 
coordination (personal communication Julia Havey, Sr. Systems Analyst, LUHS, 11/16/18). To 
address this issue, both the ICCCM and propensity matched samples were well-matched on 
Medicaid insurance (Standard mean difference (SMD) = 0.102). Therefore, the difference 
between ICCCM and traditional Medicaid care coordination was incorporated into the study.  
Transitional care coordination for Medicare patients. To minimize readmissions, 
Medicare patients were provided a care coordinator upon hospital discharge. Medicare patients at 
the ICCCM clinic also followed the ICCCM model of care and the ICCCM care coordinator 
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worked with the transitional care coordinator. This issue was addressed by matching based on 
Medicare insurance (SMD = 0). 
Discussion of Results 
 This study evaluated the benefit of an interprofessional, nurse-led collaborative care-
coordination model of care for patients with type 2 diabetes in the ambulatory setting on patient 
engagement, healthcare utilization and clinical indicators. A summary of the findings is 
presented in Table 34 with significant findings bolded.  
Table 34. Summary of Statistical Findings  
Variable Pre-Post Matched comparison 
Patient Engagement 
Total Number of missed visits p = 0.28 p = .22 
Annual influenza immunizations p = 0.90 p =0.10, 95% CI [-0.798, 
0.064] 
Annual dilated eye examinations p = 0.63 p =0.01, 95% CI [-1.058, -
0.133] 
Utilization 
Number of hospitalizations p = 0.86 p = 0.59 
Number of emergency room visits p = 0.27 p = 0.24 
Number of days hospitalized p = 0.64 p = 0.48 
Clinical Indicators 
Percent of pts with HGB A1C > 9 (T1-T3) p = 0.001 p = 0.09, CI [-1.279, 0.101] 
Change in HGB A1C (T1-T3) p < 0.001 p = 0.003 
Difference in A1C year pre vs year post 
(T2-T1 vs T1-T3) 
p < 0.001 NA 
Change in weight (T1-T3) p = 0.04 p = 0.14 
Difference in weight year pre vs year post 
(T2-T1 vs T1-T3) 
p = 0.84 NA 
Change in systolic b/p (T1-T3) p = 0.48 p = 0.29 
Difference in systolic b/p year pre vs year 
post (T2-T1 vs T1-T3) 
p = 0.48 NA 
# with Systolic b/p at goal (< 140) (T1-T3) p = 1.00 p = 0.39, CI [-0.734, 0.285] 
Change in diastolic b/p (T1-T3) p = 0.66 p = 0.45 
Difference in diastolic b/p year pre vs year 
post (T2-T1 vs T1-T3) 
p = 0.92 NA 
# with Diastolic b/p at goal (< 90) (T1-T3)  p = 0.04 p = 0.71, CI [-0.579, 0.854] 
NA = Not applicable  
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 As Table 34 indicates, this study found statistically significant improvements in several 
clinical indicators including A1C, weight, and diastolic blood pressure in the ICCCM 
participants. However, patient engagement indicators, including annual eye examinations and 
unadjusted missed visits, demonstrated a surprising inverse response to the intervention in 
comparison to the propensity match. Healthcare utilization did not show significant improvement 
for either the pre/post study arm for the ICCCM group or the propensity matched comparison 
group. The following discusses each outcome in more detail.   
Aim 1: Patient Engagement Results  
The ICCCM intervention had no effect on any of the patient engagement variables in the 
pre/post study. However, there were surprising findings per variable as discussed in the 
following sections.   
Missed visits. Missed visits did not improve in the pre/post study as hypothesized, 
suggesting that missed visits are not related to care-coordination. This is consistent with the 
literature in that Wu et al. (2018) measured missed visits in a VA enhanced ImPACT team model 
and found no significant difference in missed visits between the pre/post or usual care/ImPACT 
model (Wu, Slightam, Wong, Asch, & Zulman, 2018).  
Missed visits may not be related to patient engagement. There are many reasons that 
patients miss visits including scheduling problems, not feeling well at the designated time, 
forgetting the appointment, and having extraneous circumstances like car or transportations 
issues. Hwang et al. (2015) found that patients with a high number of missed visits correlated 
with patients who were younger, non-white, spoke limited English, had Medicaid or were 
uninsured, lived in areas with low median household incomes, and/or carried a diagnosis of 
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either alcohol use disorder or depression. Therefore, missed visits may not be a good proxy 
measure for patient engagement.  
Missed visits may be more related to socio-economic or social determinants, rather 
than patient engagement. This is a plausible explanation since the unadjusted matched sample 
demonstrated fewer missed visits (p = .02), which is contrary to the expected finding. Hwang et 
al. (2015) found that lower socioeconomic status was significantly related to missed visits. 
Therefore, this study may not have adequately controlled for socioeconomic status, as insurance 
was the only available proxy measure. Further research is needed to identify a better proxy 
measure for patient engagement.   
Missed visits may be affected by health status. Missed visits were affected by baseline 
A1C and the presence of renal disease. Unadjusted missed visits were significantly less in the 
matched group. However, after adjusting for baseline A1C and renal disease, there was no longer 
a significant difference in missed visits. Hwang et al. (2015) also found that patients with higher 
A1C's had greater numbers of missed visits when controlling for other patient characteristics. It 
is difficult to interpret these findings without further insight into the mindset of these 
participants, but it is noteworthy that severity of illness in the form of the covariates (i.e. renal 
disease and increased baseline A1C) appeared to attenuate the increased number of missed visits 
for the ICCCM group. Since these patients are more likely to feel unwell than patients without 
renal disease or with a normal A1C, missed visits could be related to how patients were feeling at 
the time of the missed visit. Patients with chronic illness may also feel overwhelmed by the 
number of clinic visits needed between specialists and primary care physicians. More research is 
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needed to further explore possible explanations for missed visits. In the meantime, it is important 
for providers to avoid blaming patients for missed visits due to lack of engagement. 
Influenza immunization. Although there was no significant difference pre-post or 
compared to the matched sample, none of the influenza immunization rates (40.4% – 50.9%) 
approximated the HealthyPeople 2020 goal of a 70-90% influenza immunization rate (Office of 
Disease Prevention and Health Promotion [ODPHD], 2018). However, this low rate is consistent 
with the literature. In the 2013-2014 flu season, based on national vaccination coverage records, 
only 43.2% of adults (>19) received the influenza vaccination (Williams et al., 2016). In this 
study, care coordination did not affect these national trends.  
Optimizing influenza vaccination rates. Current influenza vaccination rates are low in 
this population. This study demonstrates the need to identify strategies to improve this rate. 
Currently, patients with portal registrations receive an email blast every October encouraging the 
influenza vaccination. However, this strategy did not yield optimal results. A better 
understanding of patient behavioral choices about the influenza vaccination is needed.  
Patients may choose against influenza vaccination. There are many reasons people 
choose not to receive the influenza immunization that could lead to low vaccination rates. In a 
secondary data study of the Behavioral Risk Factor Surveillance System (BRFSS) data, La et al. 
(2018) found that patients were more likely to have received the influenza vaccine if they were 
female, had increased age, higher level of education, higher annual household income and at 
least one chronic condition (La et al., 2018). High-need geographic communities generally are 
comprised of people with lower annual household incomes and lower levels of education. 
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Therefore, optimizing influenza vaccination rates in these high-need geographic communities 
may require different strategies for outreach.  
A qualitative study focusing on why patients choose to receive or not receive the 
influenza immunization will be needed. Of particular interest, in the ICCCM arm, there were 
patients who changed their decision to receive or not to receive the vaccination as well as those 
who never received the vaccination during the 2-year study period. Therefore, a mixed method 
design using quantitative methods to identify these populations and qualitative methods to 
understand patient decision-making can identify the problems and provide opportunities to 
improve the influenza vaccination rate. This will be of paramount importance if the 2020 goal is 
to be actualized in this healthcare setting. 
Influenza immunizations documentation accuracy. Without an integrated IT system (i.e. 
one that can interface with all clinics where patients receive vaccinations including Minute 
Clinics), it is difficult to assess the accuracy of the influenza immunization data. An integrated 
system would not only improve vaccination documentation accuracy but also provide an accurate 
assessment of interventions to increase vaccination rates. According to the CDC, in the 2014-
2015 flu season 42.3% of influenza vaccinations were given in nonmedical settings (Centers for 
Disease Control and Prevention [CDC], 2018a). This would indicate that possibly a significant 
number of patients choose to receive the influenza vaccination at an outside site. With the 
increased number of Minute Clinics and work settings providing influenza vaccinations, this 
number has likely increased. The absence of an integrated IT system is a barrier to capturing 
accurate influenza vaccination rates. If primary care clinics are going to coordinate their patients 
care, it is important for them to understand what care is being received at other sites. This further 
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emphasizes the need for an integrated IT system, if the HealthyPeople 2020 influenza 
vaccination goals are to become reality.  
Eye examinations. There was no significant difference in eye examinations in the 
pre/post study. This is consistent with the literature. In the Physician Group Demonstration 
Project, after 5 years, eye examinations significantly improved with no significant improvement 
after 2 years (Department of Health and Human Services, 2009; Kautter et al., 2012). It is 
possible that eye examinations is a longer outcome measure than hypothesized, which may 
explain the lack of significant improvement in the ICCCM group after one year. There were 
interesting additional findings related to examination patterns.  
PCP/care coordinator has minimal influence over dilated eye examinations. The fact 
that care coordinators and PCPs have little control over whether a patient receives a dilated eye 
examination may influence these findings. Although care coordinators and PCPs can encourage 
an outside eye examination, since this service is not provided within the clinic, any control over 
the service is muted. The care coordinators' role was to encourage patients to obtain an eye 
examination and to elicit and document any reported eye examinations at each clinic visit.  
Eye examination rates. This study demonstrated that 45.1 -63.7% patients reported 
receipt or received the eye examination per the EHR. The matched comparison group met the 
HealthyPeople 2020 goal of a 58.7% eye examination rate (Office of Disease Prevention and 
Promotion [ODPHP], 2019). However, the ICCCM group was not meeting this goal either pre- 
or post-intervention.  
Matched comparison group had more eye examinations. The matched comparison 
group did have significantly more eye examinations than the ICCCM group. It is unclear why. It 
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could be related to poorer eye health in the comparison group, SES or the length of the study. 
Retinopathy/eye disease was not part of the propensity match, so it is possible that the ICCCM 
and matched comparison group were not well balanced on this variable at baseline. It is possible 
that more matched patients were having visual acuity problems or were more concerned about 
eye health. It is also possible that matched patients could afford to pay for the eye examination, 
which is not necessarily included in health insurance coverage. Therefore, it is possible that SES 
or differences in insurance policies could have made the difference. Finally, as the PGP study 
demonstrated, it may take longer than one year to effect change in eye examinations (Department 
of Health and Human Services, 2009; Kautter et al., 2012). Further research is needed to better 
understand this result. 
All groups had more eye examinations than influenza vaccinations. It is interesting that 
in both the pre/post and the ICCCM/matched comparison arms of the study, participants were 
more likely to receive an eye examination than an influenza vaccination. It is possible that these 
patients were already experiencing eye problems or that they were more concerned about eye 
disease than preventive measures. It is also possible that patients were more likely to remember 
and report their eye examinations, as eye examinations require more effort and may be more 
memorable than influenza immunizations. It is also possible that this figure was underreported in 
either or all groups, which further leads to the need for an integrated IT system to effectively care 
coordinate these patients. Regardless, this health behavior was unexpected and difficult to 
interpret without more research to understand this unexpected finding. 
Aim 2: Healthcare Utilization Results 
The ICCCM intervention did not improve any of the healthcare utilization variables. 
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Although the literature indicates that transitional care with nurse care-coordination has been 
effective in reducing hospitalizations and length of stay (Coleman, Parry, Chalmers, & Min, 
2006; Naylor et al., 1994; Naylor et al., 1999; Naylor et al., 2004; Naylor et al., 2011a, Naylor et 
al., 2011b; Naylor et al., 2014; Hewner et al., 2014), this study did not support that care-
coordination in the diabetes population affected hospitalization or emergency visits. This is 
consistent with the literature on care-coordination (Peikes et al., 2009; Nelson, 2012a; Nelson, 
2012b; Hickam et al., 2013).   
Effect of time on healthcare utilization. The only care-coordination study that reported 
a significant reduction in emergency room visits did so after 2 and 3 years with no reduction in 
hospitalizations (Gary et al., 2009). This suggests that care-coordination models may take a 
longer period of time to impact healthcare utilization.  
Neither the TEAMcare intervention nor the diabetes care management team models—
both of which were based on the Chronic Care Model and utilized a care team—demonstrated 
improved healthcare utilization after year 1 or year 2 (Katon et al., 2012; Kearns, 2017). In fact, 
Katon et al. (2012) looked at cost and found increased costs for healthcare utilization after both 
year 1 and year 2. Therefore, it is noteworthy this study did not demonstrate an increase in the 
number of hospitalizations, which is the most costly form of healthcare utilization.  
It is likely that improved clinical outcomes do not impact healthcare utilization 
immediately. The complications of diabetes take years to develop, consequently it is likely 
unrealistic to anticipate that improving diabetes control will have an effect on healthcare 
utilization within one year. About one-fifth of the participants in each group were hospitalized in 
the year of study (19.3%- 21.5%). It is likely that it would take a significant amount of time for 
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an interprofessional collaborative care-coordination model to mitigate the number of emergency 
room visits and number of hospitalizations.  
Aim 3: Clinical Indicator Results 
Several clinical indicators were affected, including A1C, change in weight, and diastolic 
blood pressure. The following discusses each in more detail. 
A1C results. The ICCCM group demonstrated a statistically and clinically significant 
improvement in A1C both pre-post care-coordination and in comparison to the matched sample. 
In fact, the A1C had an average statistically significant decrease of 0.8% between pre ICCCM 
and post ICCCM. This is consistent with the literature (Shojania et al., 2006; C. B. Taylor et al., 
2003; Watts & Sood, 2016; Mullen & Kelley, 2006; Egginton et al. 2012, Ishani et al., 2011; 
Micklethwaite et al., 2012; W.J. Katon et al., 2010; Hickam et al., 2013). Furthermore, the 
literature is clear that improved A1C improves the microvascular complications of diabetes 
(American Diabetes Association, 2018). Consequently, this is a significant finding with 
potentially long-lasting benefits. Further research on this population would be needed to 
determine whether the ICCCM had an effect on the participants' A1C beyond one year. 
Most of the literature on care-coordination in a type 2 diabetes population uses A1C as 
the gold standard for diabetes management studies, and most found statistically significant 
improvement in A1C (Egginton et al., 2012; Ishani et al., 2011; Katon, W. J. et al., 2010; 
Micklethwaite, Brownson, O'Toole, & Kilpatrick, 2012; Mullen & Kelley, 2006; Shojania et al., 
2006; Taylor et al., 2003). In 2013, Hickam et al. found in their comparative effectiveness review 
that case management had a significant impact on glucose management. This study supports the 
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conclusion of Hickam et al. (2013) in that there was both a clinically significant and a 
statistically significant improvement in A1C in both pre/post evaluation and matched control.  
Finally, it is noteworthy that the unadjusted percent of patients with A1C > 9 was 
significantly improved in the intervention group in comparison to the matched group (p < 0.001). 
However, after adjusting for baseline A1C and renal disease, A1C > 9 was no longer significant 
(p = 0.09). This may be a power limitation due to the low number of patients at baseline (T1) 
with an A1C > 9 in the control group (33) compared to the intervention group (80).  
 Weight. Although weight is not a common variable in care-coordination research studies, 
this study indicated a statistically significant improvement (average 2.2 pound weight loss) in the 
pre/post ICCCM arm of the study but did not have a significant effect in comparison to the 
matched control. This is particularly significant clinically, as this population would be expected 
to gain on average 2.2 pounds each year of their adult lives (Lowe, 2015). However, weight can 
fluctuate, making it difficult to interpret weight findings, which may be why few care-
coordination studies used this variable. In fact, in this study, weight was very labile even after 
removing patients with documented bariatric surgery procedures with a large range in both 
weight loss or gain in all study groups. The total range for change in weight in the pre-
ICCCM/post-ICCCM year and the matched comparison group year was from 78 to 113 pounds 
with weight gains as high as 55 pounds and losses as high as 67 pounds. This large weight 
fluctuation makes it difficult to interpret change in weight. 
 Role of dietitian. It is important to note that the patients in the ICCCM had direct access 
to the dietitian who was available during clinic appointments, for individualized one-on-one 
education appointments, group educational classes and cooking classes to meet the needs of this 
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population. The importance of including the dietitian to help improve outcomes in the diabetes 
population particularly weight and A1C cannot be understated. In care-coordination research 
studies, although the registered dietitian could have already been included in standard clinic 
practice, only one study was identified that mentioned the inclusion of a registered dietitian as 
part of the care-coordination intervention (Mickelthwaite et al., 2012). 
Snaterse et al. (2016) systematic review and meta-analysis indicated that of the 9 (out of 
18) nursing care-coordination randomized controlled trials that reported weight as an outcome 
measure, only one demonstrated a statistically significant weight loss (.9 kg) (Allison, Squires, 
Johnson, & Gau, 1999). More recently, Holtrop et al. (2017) found no improvement in weight 
after a nurse care management intervention for patients with type 2 diabetes. However, in the 
same study there was a statistically significant drop in weight (5% of body weight lost) in obese 
nondiabetic patients with the same intervention in the same clinics (Holtrop et al., 2017). It 
appears that there may be other mechanisms involved in weight loss and diabetes since the 
results were so different in these two populations. 
The American Diabetes Association (ADA) states that people with type 2 diabetes with 
disordered eating behaviors tend to suffer binge eating, and people with type 2 diabetes treated 
with insulin intentionally missing doses of insulin (American Diabetes Association, 2018, p. 
S35). Either of these behaviors could lead to considerable weight changes. Some diabetic 
medications like metformin have been associated with weight loss and other medications 
particularly antidepressants, anticonvulsants including gabapentin are associated with weight 
gain (American Diabetes Association, 2018). Since medications were not evaluated in this study, 
it is possible that this may have had an impact on the weight fluctuation.  
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In addition, Lowe (2015) suggested that in the current obesogenic environment, obese 
adults would be expected to gain on average 1kg per year without any intervention. This further 
demonstrates the clinical significance of an average 2.2 pound weight loss during a time period 
when the expected weight change would be a 2.2 pound weight gain (Lowe, 2015). However, 
more research is needed to better understand both the significance of the weight loss as well as 
the weight variability phenomenon if the goal is to positively impact weight in patients with type 
2 diabetes in the future. 
Blood pressure. The following sections will discuss the significant blood pressure 
finding. 
Diastolic blood pressure at goal improved. This study found a significant difference in 
the number of patients with diastolic blood pressure at goal (<90) in the pre/post data with no 
significant change in systolic blood pressure. The ADA set the blood pressure goal for patients 
with type 2 diabetes at <140/90 based on evidence of improved cardiac outcomes (American 
Diabetes Association, 2018). This finding is particularly significant, as there was little national 
improvement in blood pressure at goal for adults with type 2 diabetes between 2008 and 2012 
indicating it is difficult to impact blood pressure (National Center for Health Statistics, 2016). 
Furthermore, increasing the number of participants with blood pressures at goal in this high-risk 
population is particularly important since controlled hypertension has been shown to reduce 
cardiovascular events caused by atherosclerotic heart disease (American Diabetes Association, 
2018). The leading cause of both morbidity and mortality in diabetes is atherosclerotic heart 
disease (de Boer et al., 2017). Consequently, this finding of improved diastolic blood pressure at 
goal is not just statistically significant but also clinically important. 
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The literature on blood pressure and care-coordination is mixed but there have been some 
studies that demonstrated improved diastolic blood pressure (Gabbay et al., 2006; Ishani et al., 
2011). Other studies found no effect on diastolic blood pressure (Micklethwaite, Brownson, 
O'Toole, & Kilpatrick, 2012; Snaterse et al., 2016).  
Although unable to provide statistical significance due to the lack of a control group, 
Kautter (2012) found that the PGP reported improved numbers of patients with blood pressure < 
140/90 over the five-year study. However, in looking at the raw percentages, half of the sites 
exhibited either no change or a decrease in the per cent of patients at goal after the first year 
(Kautter et al., 2012). This indicates that blood pressure may take longer to impact than one year. 
The ICCCM team care-coordination approach to patient care provided personal attention 
to participants, which may have contributed to improved diastolic blood pressure. More research 
into the etiology of this change would be needed to fully understand the mechanism for this 
finding. Furthermore, as the PGP demonstrated, improvement in blood pressure goal for both 
systolic and diastolic blood pressure (< 140/90) may be a longer term effect of a care-
coordination intervention. It is notable that this study demonstrated an improvement in one year. 
A longer study of this model is needed to illuminate the full impact of this intervention on blood 
pressure. 
Theoretical Linkages 
As shown in Figure 7, it was hypothesized that patient engagement would be the first 
effect of this new model of care. Participants would need to be engaged in their health behavior 
to impact any change in either healthcare utilization or clinical indicators. These health behavior 
changes would then impact how these participants use healthcare services. It was thought that 
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participants would choose to discuss health problems with their primary care clinic rather than 
use the emergency room or hospital. Then, also due to increased engagement in their health, 
participants would be motivated to improve their clinical indicators.  
However, it is clear that clinical indicators demonstrated improvement after one year with 
no positive difference in the measured patient engagement factors or healthcare utilization. It is 
possible that these variables, missed visits, influenza vaccination rates and dilated eye 
examinations are not measuring patient engagement or that patient engagement is not an early 
effect but rather a later effect of a changing healthcare system. Furthermore, it is possible that 
participants become more engaged after they see and feel positive results and thus both patient 
engagement and healthcare utilization improve only after improvement in clinical indicators.  
Figure 7. Expected order of outcomes 
 
Implications for Healthcare 
 The sequelae of diabetes occurs most often in patients who cannot maintain good 
glycemic control (Skyler et al., 2009; The Diabetes Control and Complications Trial Research 
Group [DCCT], 1993; UK Prospective Diabetes Study Group, 1998). Consequently, the major 
goal of diabetes management is to assist patients in improving glycemic control. However, 
finding strategies like ICCCM that successfully assist patients with diabetes to improve control 
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has been challenging. Incorporating successful strategies, like the ICCCM into health system 
redesign is essential if the goal is to improve health in this high risk diabetes population.   
Using Population Health Strategies to Guide Health Care 
Population health is a data driven approach to improving the health outcomes of an entire 
group or population of people, rather than looking at each member of the population individually 
(Centers for Disease Control and Prevention [CDC], 2018b). It provides a snapshot of health 
outcomes and distributions of a specific population served. Goals for populations can then be set 
by clinics, hospitals, insurance providers, etc. to improve overall quality in the populations they 
serve. These goals can be set administratively by institutions that serve patients but are also 
generally based on current performance and national health guidelines. National health 
guidelines are based on current best evidence that are used to set public health policy (e.g., 
HealthyPeople 2020). The ICCCM model used population health strategies to effect change. The 
care coordinators identified the target population using the Phytel system and then targeted this 
population for the intervention. The ICCCM team-based, care-coordination model of care did 
significantly improve clinical indicators, A1C, weight and diastolic blood pressure of the type 2 
diabetes population in a primary care clinic within a high-need geographical community.  
Using Interprofessional Collaborative Practice to Guide Health Care 
Essential to the ICCCM model was the collaborative care, team approach. Several 
IOM/National Academy of Health reports support the use of interprofessional collaborative 
practice as a healthcare goal (Institute of Medicine, 1999; Institute of Medicine, 2001). These 
reports emphasized the need for communication across disciplines and the need to include 
teamwork in healthcare redesign. The ICCCM model focused on working across disciplines and 
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with patients to improve care. The teams consisted of the nurse care coordinator, dietitian, social 
worker, and physician who met to refine system problems, and to discuss individual patient care 
plans. The goal was to ensure that everyone on the team was actively engaged in the care plan to 
help patients meet their personal health goals. This was achieved both through workflow 
modifications and team meetings. The ICCCM was a team approach to health system redesign in 
which each member of the team was equal and was essential to assist participants with their own 
healthcare problems. 
Differentiating Transitional Care and Care Coordination 
Transitional care models focus on crisis management for high risk patients over a short 
time period (i.e., post hospitalization) primarily through the use of telephone touches. Care-
coordination focuses on a team (two or more participants including the patient) effort to organize 
the patient's care to ensure all resources needed are provided (Agency for Healthcare Research 
and Quality, 2014). Care-coordination further calls for communication between team members to 
ensure the optimal exchange of information between the patient and all other team members 
(Agency for Healthcare Research and Quality, 2014). Rather than using scheduled phone calls, 
care-coordination is built on providing both a trusting relationship to those ready to embrace 
change and strategies to help participants who struggle with their own healthcare maintenance. It 
involves strategizing with patients to help them meet their own goals. Past research has 
demonstrated focusing on the relationship in care-coordination can improve clinical outcomes 
(Peikes et al., 2012).  
Care Coordination Team Members 
The ICCCM model has demonstrated continued success with patients struggling with 
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type 2 diabetes. Each team member played a unique role in the model. 
RN care coordinator. This unique team approach was led by the nurse care coordinator. 
The focus of this approach was on meeting the participants' needs rather than the needs of the 
health system. Nurses ensured that all team members communicated and that patients were the 
focus. Nurses led the team meetings and through the guidelines set by the ICCCM redesign, 
chose the patients from the population management system, Phytel who would best benefit from 
these team meetings. The nurse care coordinators met with patients to mutually identify health 
goals, communicated with patients regularly, and provided or coordinated the needed support to 
maximize behavior change. The RN built relationships with participants. Having a close trusting 
relationship with patients has been identified as an essential ingredient to impact patient behavior 
(Nelson, 2012a; Peikes et al., 2012). The combination of an on-going relationship with the 
participants, a modified workflow redesign for team communication, and nurse care coordinators 
working to their full capability contributed to improving patient outcomes in this model. 
Registered dietitian. The dietitian on the team worked with individual participants and 
provided group education to promote healthy eating habits. The dietitian met individually and in 
team appointments to provide Medical Nutrition Therapy to patients. This included 
individualized dietary education which led to an individualized nutrition plan. This plan could 
include carbohydrate counting, or exchange lists to help the patient with food choices. In 
addition, the dietitian provided affordable, healthy group cooking classes to help participants 
learn simple cooking strategies to increase food choices and simplify meal planning. Through the 
development of a trusting relationship, the dietitian was able to have an impact on participants' 
eating habits. Few models included a registered dietitian. Although several case management 
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studies include a nurse certified diabetes educator (Watts & Sood, 2016) or dietitan-provided 
education (Mullen & Kelley, 2006), the only one that specifically mentioned the addition of the 
dietitian to the team was Micklethwaite et al. (2012) who found a significantly decreased A1C in 
a diabetes population but no difference in BMI, or blood pressure. Furthermore, Holtrop et al. 
(2017) demonstrated in their care management study, that achieving both weight loss and A1C 
improvement in the type 2 diabetes population was not possible with care management alone. 
The ICCCM study was able to accomplish both significantly improved A1C's, weight and 
diastolic blood pressure at goal. It is likely that this was only possible with the added expertise of 
the full team including the dietitian. 
Social worker. The social worker was essential in this high-need geographic area as 
many of the ICCCM population experienced financial problems including loss of insurance, 
homelessness, and difficulty paying for medications. Social workers are uniquely qualified to 
address barriers to healthcare access. The social worker was able to find community resources to 
assist patients when times were difficult. This model further supports the American Diabetes 
Association "Standards of Medical Care in Diabetes-2018," which recommends including 
treatment for common social problems like "food insecurity, housing stability, and financial 
barriers" (American Diabetes Association, 2018, p. S9). 
Expanding healthcare teams to include a dietitian and social worker did improve 
outcomes. Katon et al. (2012) also showed improvement with the addition of mental health 
providers. Low income communities have greater needs for support due to financial barriers 
leading to housing and insurance instability and food insecurity. Embracing ways of increasing 
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healthcare value to this population will be an essential ingredient for improving health outcomes 
in the future. 
Physician. Having full physician support was essential for this model to be effective. The 
physician provided for the basic health care needs of these patients. Not only did the physicians 
fully support the team effort but they welcomed and encouraged this team model. In addition to 
daily communication, physicians met formally with the care-coordination teams monthly. 
Through these opportunities, physicians built a close trusting relationship with team members. 
The physician no longer had the primary responsibility for care-coordination, but rather was 
integrated into the process to ensure appropriate medical care, while other team members were 
responsible for coordination.  
High need patients. Patients with poor diabetes control identified either through Phytel 
or the primary care physician were the focus of this intervention. Through motivational 
interviewing and goal setting, patients identified and set their own health goals making this 
intervention patient-centered. These patient-identified goals provided the direction for the health 
care team to address individualized needs for high-risk participants who were willing to change 
their behavior. This included individualizing solutions for participants with unique problems, 
including providing cooking classes, financial strategies, and behavior problems, while also 
insuring access to medication and equipment needed to control their diabetes and health.  
ICCCM Healthcare Implications Summary 
This interprofessional team model integrated interventions, targeted those with the 
greatest need (low-income patients with poorly controlled diabetes), and built relationships with 
patients to collectively improve health outcomes. Each member of the team contributed their 
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expertise and trusted each other to provide that expertise. This workflow encouraged a fluidity of 
communication among team members including the patient which was instrumental in meeting 
patient needs. The result was improved clinical outcomes.  
Implications for Nursing Practice 
Ambulatory care delivery is being rejuvenated with the changes in health policy due to 
healthcare reform, the Affordable Care Act, Precision Medicine, value-based care and population 
health (Paschke, 2017). Ambulatory care nursing is also changing rapidly with nurses being 
expected to "enhance patient safety and the quality and effectiveness of care delivery" and 
"provide the leadership necessary for collaboration and coordination of services" (Paschke, 2017, 
p 1). Due to the close alignment to the American Academy of Ambulatory Care Nursing 
(AAACN) standards, the ICCCM further demonstrates the importance of these competencies in 
ambulatory nursing (Haas, Swan, Haynes, 2014).  
The AAACN stresses that ambulatory nurses must have leadership skills to lead a team 
approach to patient care (Paschke, 2017). In fact, RNs are responsible for providing the 
leadership needed for collaborative processes and coordination (Paschke, 2017). The current 
standards for care-coordination and transitional care were used to provide the guidance needed to 
develop the care-coordination role in the ICCCM (Haas et al., 2014). These nine competencies 
include self-management support, advocacy, education and engagement of patient and family, 
cross setting communication and transition, coaching and counseling of patients and families, 
nursing process, population health, teamwork and collaboration and patient-centered care-
planning (Haas et al., 2014). The ICCCM included many nursing activities to meet these 
competencies including a care plan developed through motivational interviewing, which centered 
176 
 
 
on the patient's values, preferences and goals and provided solutions to socioeconomic issues, 
while negotiating services for the patient. Care coordinators coached the patient and family in 
self-advocacy and assessed patient and family readiness to learn as well as their understanding 
using educational methods like "teach back." Care coordinators collaborated with all health team 
members to ensure all understood the care plan developed with the patient. They used a 
population health tool (e.g. Phytel) for management of the diabetic clinic population not only to 
identify high-risk patients but also to ensure that all guidelines for patient care were being 
addressed. Teamwork was a core principle of the ICCCM and included a focus on the patient to 
identify the patients' goals and to ensure that care always remained targeted on the patient's 
personal health priorities.   
Implications for Healthcare Education 
It is widely recognized that to improve population health, interprofessional collaboration 
and teamwork are essential, therefore it is critical that students learn to coordinate care across 
disciplines to improve patient outcomes (Institute of Medicine, 2015). The ICCCM study 
demonstrated the importance of a team approach in ambulatory care. In the past, healthcare used 
a hierarchical model with the physician at the top of the tier (Institute for Transformational 
Interprofessional Education, 2015). However, the IOM has stressed the importance of 
educational institutions to collaborate with practitioners to promote interprofessional teamwork 
(Institute of Medicine, 2015). To achieve this, healthcare education must include opportunities 
for teamwork across all healthcare disciplines. Therefore, understanding how to effectively 
collaborate with physicians, nurses, dietitians, social workers, psychologists etc. is imperative to 
our current health system that relies on increasingly specialized fields. Furthermore, experiential 
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learning, a key to interprofessional education requires an environment that reflects 
interprofessional collaboration (Committee on the Learning Health Care System in America & 
Institute of Medicine, 2013). 
Achieving high functioning teams does not happen without intent. The ICCCM model 
used TeamSTEPPS in training the provider teams to work together as equals (Agency for 
Healthcare Research and Quality, 2018). TeamSTEPPS provides a scientific curriculum designed 
to improve 'communication and teamwork skills' for the healthcare professional (Agency for 
Healthcare Research and Quality, 2018). Incorporating an evidence-based model like 
TeamSTEPPS into educational curriculum can facilitate this transition to future teamwork in 
healthcare (Agency for Healthcare Research and Quality, 2018).  
Aligning with the IOM recommendation for collaboration with practitioners, the Institute 
for Transformational Interprofessional Education (ITIE) at Loyola University Chicago (LUC) 
was developed to promote interprofessional collaboration between practitioners and educators 
within LUC (Institute for Transformational Interprofessional Education, 2015). LUC and Loyola 
University Medical Center used the ITIE model to create the Interprofessional Collaborative 
Care-Coordination Model (ICCCM) within two ambulatory care clinics to provide an 
environment of experiential learning in collaborative practice. The ICCCM model concentrates 
on the 4 competencies of values and ethics, roles and relationships, communication and 
teamwork (Institute for Transformational Interprofessional Education, 2015; Interprofessional 
Education Collaborative Expert Panel, 2011). These are the core competencies developed by the 
Interprofessional Education Collaborative Expert Panel (2011) and embraced by ITIE (Institute 
for Transformational Interprofessional Education, 2015; Interprofessional Education 
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Collaborative Expert Panel, 2011). 
Numerous challenges were met in developing the ICCCM as both a practice clinic and an 
educational clinic. In fact, the greatest challenge was getting all stakeholders at all levels 
engaged in the process (Vlasses & Michelfelder, 2015). Working with both the university and the 
health system, two separate business entities to develop a clinic that met the goals of both 
education and practice, was challenging (Vlasses & Michelfelder, 2015). Equally important 
challenges faced were getting buy-in from all the physicians and practitioners in the ambulatory 
clinics, hiring, integrating, and training all personnel involved in the ICCCM, and both 
developing new tools and integrating existing tools to capture the model's outcomes in the 
information system (Vlasses & Michelfelder, 2015). The challenge of developing trust between 
all practitioners was also key to the program's success (Vlasses & Michelfelder, 2015). Despite 
the potential challenges, developing practice areas that provide hands on educational 
opportunities for healthcare students of diverse disciplines is needed to provide experiential 
learning. 
Finally, teaching students the importance of continual workflow evaluation and redesign 
(Plan-Do-Study-Act (PDSA)) is imperative for continual improvement in healthcare systems 
(Agency for Healthcare Research and Quality, 2013). The ICCCM members met regularly to 
continually improve the model which was a continuous focus of all team members. This method 
of evaluation is essential to continually improving the healthcare system and will be an essential 
ingredient for new health professionals of all disciplines to have in their toolbelt.  
Implications for Health Policy 
The Patient Protection and Affordable Care Act (PPACA) is the current overriding 
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healthcare policy in the US (Congress.gov, 2010). It focuses on the Triple Aim – access, quality 
and cost (Bleich, 2013). Despite numerous legislative attempts to repeal it, the ACA remains the 
law of the land, and estimates are that about 20 million more Americans are now insured 
(Sommers & Epstein, 2017). Furthermore, The PPACA placed an emphasis on transitional care, 
care-coordination and care innovations to improve chronic care management (Newell, 2013). 
This study is one of a few US care-coordination team studies to analyze a new care model to 
improve chronic care management. The ICCCM study demonstrates the value of an 
interprofessional collaborative care-coordination model to improve diabetes outcomes.  
Future Opportunities for Research 
This study, which evaluated an interprofessional collaborative care-coordination model in 
a diabetes population, is one of few US studies to evaluate a well-defined team model of care. 
The ICCCM study demonstrated the value of a care-coordinated team approach to diabetes 
management to improve A1C, weight and diastolic blood pressure. However, further research is 
needed to fully investigate the reason behind missed visits, weight fluctuation and patient 
engagement. Furthermore, the benefit of this team approach on patient satisfaction, long term 
health gains and provider satisfaction was not addressed in this study and will need to be a focus 
of future research. The following provides suggested directions for future studies.   
Longitudinal Study 
A longer longitudinal study of the ICCCM model needs to be conducted to fully evaluate 
the effectiveness of this model. One year is not enough to evaluate the effectiveness of this 
model on healthcare utilization or patient engagement. As the PGP demonstrated, it may not 
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even be enough time to effectively understand the benefits of the model on clinical indicators 
like blood pressure. 
Qualitative Research to Study Patient Perspective   
Qualitative research exploring what participants found helpful in their own self-
management will be critical to fully understand the ICCCM results. Targeting patients who 
improved their A1C, weight and blood pressure can provide insight into the most effective 
elements of team-based care. In addition, targeting those who did not improve health outcomes 
will also provide a clearer picture of what elements did not provide needed support. Furthermore, 
using participatory action research can provide a clearer understanding of patient behavior and 
patient needs which will lead to the best supportive measures to assist patients to meet their own 
healthcare goals in their own environment. Changing behavior is extremely difficult. 
Understanding patients' perspectives of their needs in health behaviors is essential to improving 
population health. Patient behavior can only be fully understood with patient-focused qualitative 
studies. 
Patient Engagement Research  
Few studies were found that included the variables of missed visits, influenza 
immunizations or annual eye examinations. More research is needed to further understand what 
constitutes patient engagement and what variables measure patient engagement. Qualitative 
studies are needed to learn from patients as only patients truly know what strategies help them 
meet their goals and to identify other variables that measure or enhance patient engagement. 
 Preventing missed visits historically has been done using a carrot and stick approach, 
currently this health system is dismissing patients from the system if they miss six appointments 
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throughout the health system in an 18 month time period (personal communication Amber 
Baskin, Clinical Coordinator, family practice center, 12/21/18). Although it is clear that missed 
appointments are associated with certain patient demographics, it is unclear why these patients 
are missing appointments (Hwang, Andrew et al., 2015). Punishing patients particularly those 
with higher healthcare needs who may have other priorities like finding a place to sleep at night 
will not solve the problem of missed appointments, help patients in need, or improve population 
health (Chokshi, 2018). Rather, research to facilitate an understanding of these patients' 
problems, concerns and behaviors that led to missed appointments will provide meaningful 
solutions needed to rectify this ambulatory care problem. Furthermore, if the goal of healthcare is 
to promote health, and the underlying assumption is that patients with chronic conditions who do 
not show up for clinic visits are less likely to achieve optimal health, then finding solutions to 
this problem is imperative to achieving optimal health for this high need patient population. 
Team Care 
The US has few studies that incorporate a team approach to care management. Although 
many organizations including the ADA, the National Academies of Medicine, the Robert Wood 
Johnson Foundation and the World Health Organization have widely accepted a team approach 
to care as the gold standard and in fact recommends this approach, there have been few studies in 
the US that use a team approach (American Diabetes Association, 2018; Institute of Medicine, 
2015; Robert Wood Johnson Foundation, 2011; World Health Organization, 2010). International 
studies that have combined collaborative healthcare teams with care-coordination can provide 
some guidance, but the US healthcare system is very different from the healthcare system of 
other countries. Consequently, these international studies cannot be directly transferred to a US 
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population. Therefore, there is a great need for more research on collaborative care-coordination 
models in the US. Furthermore, mixed methods research evaluating team management of care 
will be needed to fully assess the effectiveness of individual interventions, as well as optimal 
team makeup.   
Conclusion 
This is one of few studies to provide very specific details describing an ambulatory care 
model that measured the effect on patient engagement, healthcare utilization and clinical 
indicators for the type 2 diabetes population in a primary medicine clinic serving a low SES 
community. It provided an initial step to redesign primary care incorporating a patient-centered, 
interprofessional team approach to best meet the needs of this Type 2 diabetes patient 
population. Findings demonstrate significantly improved A1C, weight and diastolic blood 
pressure. Further research will be needed to critically evaluate how this care model affected 
patients' self-management skills. Furthermore, studying this model over time will reveal the 
sustainability in patient behavior, while enhancing our understanding of patient engagement and 
healthcare utilization. Health system, administrative and policy support will be critical to 
integrate preventive care in this acute care-focused US healthcare system. 
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NOTICE OF CONTINUING/ANNUAL REVIEW OF A RESEARCH PROJECT 
  
Date: 06/26/2018 
  
Investigator: Burkhart, Elizabeth 
LU Number: 210082 
TITLE: The effectiveness of an ambulatory care redesign on patient 
engagement, healthcare 
utilization, and clinical indicators 
 
 
 
Dear Investigator, 
 
Continuing (or Annual) Review #1 of the above-referenced research project  
was performed on 06/26/2018 by Expedited Review. 
The project was assigned a status of "Expedited Approval". 
 
Details of this Board review can be accessed through the on-line Research 
Portal 
or by clicking the following link: 
 
http://portal.luhs.org  
 
If you have any questions regarding this review action, please call the IRB 
Secretary (708-216-4608) 
or Dr. Kenneth Micetich (708-327-3144). 
 
 
Kenneth Craig Micetich, M.D. 
Chairman 
Institutional Review Board for the Protection of Human Subjects 
Loyola University Health Sciences Division 
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08/03/2017 
  
NOTICE OF FULL APPROVAL OF A RESEARCH PROJECT  
 
 
Investigator  Burkhart, Elizabeth 
LU Number  210082 
Title  The effectiveness of an ambulatory care redesign on patient engagement, healthcare 
utilization, and clinical indicators 
  
 
Date of Initial Review  08/03/2017 
Type of Review  Full Board 
Meeting Date  08/16/2017 
Action of Initial Review  Full Approval 
  
 
IRB Findings  1. The study is of minimal risk and qualifies for expedited review 45CFR46.110, b-1, 
HHS Secretary Category # 5).  
 
2. The requirement for consent is waived:  
 
a) the research could not practicably be done without the waiver;  
 
b) the waiver does not adversely affect the rights of the individual;  
 
c) the research involves no more than minimal risk;  
 
d) there is no information that would need to be provided to the individual.  
 
(45CFR46.116, d1-4).  
 
3. The IRB finds that:  
 
(A) The use or disclosure of protected health information involves  
no more than minimal risk to the individuals;  
 
(B) The alteration or waiver will not adversely affect the privacy  
rights and the welfare of the individuals;  
 
(C) The research could not practicably be conducted without the  
alteration or waiver;  
 
(D) The research could not practicably be conducted without access to and use of the 
protected health information;  
 
(E) The privacy risks to individuals whose protected health  
information is to be used or disclosed are reasonable in relation to the anticipated 
benefits if any to the individuals, and the importance of the knowledge that may 
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reasonably be expected to result from the  
research.  
 
(F) There is an adequate plan to protect the identifiers from improper use and 
disclosure;  
 
(G) There is an adequate plan to destroy the identifiers at the earliest opportunity 
consistent with conduct of the research, unless there is a health or research 
justification for retaining the identifiers, or such retention is otherwise required by 
law;  
 
(H) There are adequate written assurances that the protected health information will 
not be reused or disclosed to any other person or entity, except as required by law, for 
authorized oversight of the research project, or for other research for which the use 
or disclosure of protected health information would be permitted by this subpart.  
 
4. The IRB finds that in # 3 above and the conditions of approval that the 
requirements detailed in 45CFR164.512i2 are met and the requirement for patient 
authorization waiver is met.  
 
5. This letter should be shown to medical records to allow the retrospective chart 
review to begin.  
 
6. Refer to conditions of approval.  
  
 
Re-Review Date  08/03/2018 
 
Informed Consent Document required?  NO 
Reason ICD not required  
 
  
 
# of Participants  0 
Participants Compensated?  NO  
  
 
 
IRB Number  210082080317 
Date of Approval  08/03/2017 
Frequency of Review  Annual 
Date of First Review  08/03/2018 
  
 
Conditions of Approval  Conditions of Approval:  
 
1. Please review the information section of this approval letter. You are required to 
review and adhere to the conditions of approval as stated in this letter (refer to 
project summary) as well as the LUMC P-6 policy regarding access to and release of 
patient information for the purpose of research. For questions you may contact the 
IRB office at extension 64608.  
 
2. Institutional policy requires that patient identifiable research data must be 
collected and stored in a secured location. The medical center provides a centralized 
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research server for this purpose. If you have not already done so, please e-mail Joseph 
Koral (x67904, jkoral@lumc.edu) and request an account for this server. In the 
request, please include all domain IDs of the individuals that require access to this 
resource. If you have questions regarding information system security please contact 
Dan Smith (x68207, or dasmith@lumc.edu).  
 
3. You are bound by the usual and customary medical, legal and ethical 
considerations governing the confidentiality of the medical record.  
 
4. The data you collect may not be sold or given to any third party outside the scope 
of this submission unless it is to a journal for publication. Data to a journal for 
publication must be de-identified.  
 
5. The chart reviewed is to be identified on the data collection form by a unique code 
number and the master list kept under lock and key. If you are not collecting data 
elements that can directly or indirectly identify the chart reviewed then this 
requirement is not relevant.  
 
6. The link of the patient to the project is to be destroyed when it is no longer 
necessary.  
 
 
 
  
ITEMS SUBMITTED 
FOR REVIEW 
 07/17/2017 abstract  
 07/31/2017 PhD Proposal  
 08/03/2017 Retrospective Review Template  
 
 
 
YOU HAVE FULL APPROVAL AND YOUR PROJECT MAY BEGIN.  
The following is for your information and will help you meet local and  
federal IRB requirements.  
 
1. You must use the final IRB-approved version of the Consent Document. 
Spelling and grammatical changes may be made as necessary, but any other 
changes require prior review and approval. 
  
2. You are required to maintain complete records of this project.  
Any changes in the protocol and the Consent Document must receive prior IRB 
approval.  
Use the online Research Portal's Project Amendment form to report changes.   
A change to the protocol necessary for the immediate safety and welfare of a  
research participant may be implemented prior to IRB review and approval. 
  
3. Federal Regulations require that projects undergo periodic review  
of research activity at least once a year. This review must be substantive.  
The frequency of review and next scheduled date of periodic review for your 
project  
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can be found under the "Annual Review" tab in the Research Portal's IRB 
section.  
You will receive notification 4-8 weeks prior to the scheduled date of 
review.   
At that time, you must provide information regarding the status of the 
project.   
If the information is not received, the project will be suspended.    
It is important that you not let approval lapse. 
  
4. The IRB must be notified any time that the project temporarily or 
permanently  
stops enrolling participants along with the reason. Use the online Closure 
form to  
submit these notifications. 
  
5. Any notices or advertisements soliciting participation must receive prior 
IRB approval.  
Use the online Amendment reporting form. 
  
6. The IRB must be notified PROMPTLY of  all serious and any unanticipated 
adverse events  
associated with the project (or the device or the drug). This includes any 
notification  
received of adverse events occurring at other performance sites. Further 
guidance on  
adverse event reporting may be found at the Office for Human Research 
Protections web site; 
http://www.hhs.gov/ohrp/policy/AdvEvntGuid.htm#Q5 
 
Reportable events include, but are not limited to: 
a) a serious adverse event (including events that produce injury or death, an 
event  
   leading to hospitalization or lead to prolongation of a current hospital 
stay); 
b) the enrollment of a patient on a study that is no longer enrolling 
participants; 
c) pregnancy occurring on the study where the study excludes pregnancy; 
d) any patient reporting a billing problem as a result of project 
participation; 
e) any participant who has voiced a complaint about some aspect of the 
project 
or the consent document; 
f) any unanticipated, untoward, or unexpected adverse event not covered above 
including  
   rare adverse events or adverse events that occur at an unexpected rate 
g) protocol deviations 
h) investigational drug/device brochures, revisions 
 
Adverse Protocol Events are reported through the online Research Portal. 
  
7. The IRB may suspend the project to new participant enrollment or may 
suspend the  
participation of current subjects if there is a perceived safety and/or 
regulatory issue. 
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8. Prospective consent must be obtained from all research participants. 
  
9. The IRB may review your records relating to this project, including signed 
consent documents. 
  
10. The Institutional Review Board of Loyola University Medical Center is 
appropriately  
constituted and has been granted Federal Wide Assurance Number FWA00017487.  
  
11. If you are unsure of your reporting requirements or of what is expected 
of you  
during the conduct of this research, please call the IRB Office (708-216-
4608) or  
Dr. Kenneth Micetich  (708-327-3144). 
 
12.  The Loyola Institutional Review Board is appropriately constituted as 
stipulated in  
45cfr46 and is compliance with Good Clinical Practice Guidelines insofar as 
those guidelines 
are consistent with the U.S. Food and Drug Administration regulations (21 CFR 
Parts 50 and 56)  
and the Department of Health and Human Services regulations (45 CFR 46) 
pertaining to the  
protection of human subjects in research. 
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